var title_f29_32_30208="Midurethral retropubic sling";
var content_f29_32_30208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/OBGYN/67708/Midureth_retrop_sling_conv.mp4?title=Midurethral+retropubic+sling\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Midurethral retropubic sling procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 390px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30208=[""].join("\n");
var outline_f29_32_30208=null;
var title_f29_32_30209="Epidermal nevus - inguinal";
var content_f29_32_30209=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Epidermal nevus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A verrucous, brown, linear plaque is present in the inguinal crease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30209=[""].join("\n");
var outline_f29_32_30209=null;
var title_f29_32_30210="Patient information: Vein ablation (The Basics)";
var content_f29_32_30210=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87610\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/43/12978\">",
"         Radiofrequency vein ablation",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/3/1075\">",
"         Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/34/30242\">",
"         Patient information: Doppler ultrasound (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/48/19202\">",
"         Patient information: Endovascular surgery (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/16/21762\">",
"         Patient information: Superficial phlebitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/47/41714\">",
"         Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/17/35091\">",
"         Patient information: Chronic venous disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/44/12998\">",
"         Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Vein ablation (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H15095309\">",
"      <span class=\"h1\">",
"       What is vein ablation?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Vein ablation is a procedure that is used to treat different types of vein disease. It works by sealing up or removing a diseased vein, so that blood cannot flow through it anymore. The blood that would normally flow through that vein finds another route back to the heart.",
"     </p>",
"     <p>",
"      Vein ablation is done only to people who have not gotten better with simpler treatments.",
"     </p>",
"     <p>",
"      Vein ablation can be done a few different ways:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Sclerotherapy",
"        </strong>",
"        &ndash; For this procedure, the doctor injects a chemical into the diseased vein that causes it to collapse on itself. The vein stays in place, but it no longer carries blood. Sclerotherapy can be done in a doctor&rsquo;s office with local anesthesia.",
"       </li>",
"       <li>",
"        <strong>",
"         Radiofrequency or laser ablation",
"        </strong>",
"        &ndash; For these procedures, the doctor inserts a special wire into the diseased vein. This wire heats up the vein and seals it from the inside (",
"        <a class=\"graphic graphic_figure graphicRef87609 \" href=\"UTD.htm?12/43/12978\">",
"         figure 1",
"        </a>",
"        ). The vein stays in place, but it no longer carries blood. These procedures involve no surgery and can be done with very little anesthesia. They can often be done in a doctor&rsquo;s office.",
"       </li>",
"       <li>",
"        <strong>",
"         Vein ligation or stripping",
"        </strong>",
"        &ndash; These procedures involve surgery to remove the diseased vein or veins. People who have these procedures must go under anesthesia and be treated in a hospital or surgery center. Veins are removed through many small cuts.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15095324\">",
"      <span class=\"h1\">",
"       Can I choose which procedure to have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No, not usually. Your doctor will recommend which procedure would work for the type of vein problem you have.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15095339\">",
"      <span class=\"h1\">",
"       How do I prepare for vein ablation?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on which procedure you will have. Your doctor will give you detailed instructions about your specific procedure.",
"     </p>",
"     <p>",
"      In general, people having sclerotherapy or radiofrequency or laser ablation just have to take a pill to calm them before the procedure. Some people have to stop taking certain medicines before the procedure, but that is not common. People having vein ligation or stripping have a more complicated preparation, because these procedures involve surgery.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15095356\">",
"      <span class=\"h1\">",
"       What happens after vein ablation?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After having a vein ablation procedure, most people are asked to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Walk around for a few minutes multiple times a day",
"       </li>",
"       <li>",
"        Avoid sitting or standing for too long",
"       </li>",
"       <li>",
"        Prop up their leg while sitting (for example on pillows)",
"       </li>",
"       <li>",
"        Avoid heavy lifting or exercise for 1 to 2 weeks after the procedure",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Depending on the type of ablation procedure you have, you might be asked to wear special bandages or stockings called &ldquo;compression&rdquo; bandages or stockings. These bandages or stockings will put steady pressure on your leg and can help prevent bruising.",
"     </p>",
"     <p>",
"      Also depending on what type of procedure you have, you might have to go back to the doctor a few days after your procedure for a test called an ultrasound. This is to make sure you have not developed any blood clots in your leg. It is very important that you have this test.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15095373\">",
"      <span class=\"h1\">",
"       What problems can happen after vein ablation?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The problems that can happen are different for the different procedures. In general, the problems can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood clots in the legs",
"       </li>",
"       <li>",
"        Bleeding under the skin that forms a soft lump called a &ldquo;hematoma&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People who have vein ligation or stripping can also have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Wound infections",
"       </li>",
"       <li>",
"        Nerve damage",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15095390\">",
"      <span class=\"h1\">",
"       When should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Call your doctor or nurse right away if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        You are wearing bandages or stockings and your leg or foot tingles or feels cool, or if the toes on the treated side turn white or purple &ndash; These symptoms probably mean that your bandages or stockings are too tight. You can remove them, but call your doctor or nurse, too.",
"       </li>",
"       <li>",
"        You have intense pain or swelling that does not get better with the pain medicines your doctor prescribed &ndash; These symptoms could be a sign that you have a clot in your leg.",
"       </li>",
"       <li>",
"        You bleed through your bandages even after the doctor has adjusted them, or you bleed and soak your bandages",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15095407\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/47/41714?source=see_link\">",
"       Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/16/21762?source=see_link\">",
"       Patient information: Superficial phlebitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30242?source=see_link\">",
"       Patient information: Doppler ultrasound (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/3/1075?source=see_link\">",
"       Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/48/19202?source=see_link\">",
"       Patient information: Endovascular surgery (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/17/35091?source=see_link\">",
"       Patient information: Chronic venous disease (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=see_link\">",
"       Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?29/32/30210?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87610 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-791DB7C3D4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30210=[""].join("\n");
var outline_f29_32_30210=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095309\">",
"      What is vein ablation?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095324\">",
"      Can I choose which procedure to have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095339\">",
"      How do I prepare for vein ablation?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095356\">",
"      What happens after vein ablation?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095373\">",
"      What problems can happen after vein ablation?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095390\">",
"      When should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15095407\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87610\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/43/12978\">",
"      Radiofrequency vein ablation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/17/35091?source=related_link\">",
"      Patient information: Chronic venous disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/44/12998?source=related_link\">",
"      Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/3/1075?source=related_link\">",
"      Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30242?source=related_link\">",
"      Patient information: Doppler ultrasound (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/48/19202?source=related_link\">",
"      Patient information: Endovascular surgery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/16/21762?source=related_link\">",
"      Patient information: Superficial phlebitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/47/41714?source=related_link\">",
"      Patient information: Varicose veins and other vein disease in the legs (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_32_30211="Plaques in carcinoid heart";
var content_f29_32_30211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F74687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F74687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Location of fibrous plaques in carcinoid heart disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 292px; height: 373px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF1ASQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6fopAMAAdBS0AFFFFABRRSEZPt6UALRRRQAUUUUAFFFFAFLV9UsdGsJL7VryCzs4yA007hEBJAAyfUkCsQ/ELwWuQ/i7w8jDqr6lCrD6gtmrXjA4tdL9P7Vs//RorcZFYDcA2OmaAOXHxE8GGFpV8V6E8agklL6JsY68Bqs6H418M69qBsdF13Tr68VS5ht51dgo4JwD05FdABgALwB0xS5J6k0AMjkSUZjdXA4ypzQ0iLIsbOokYEqpPJA64H4iuB0TSb/S9A0fUAhhmS3s4Zre2tmWTywyFzIOSzAZGAMj5vWn6g+rT2095BDffaUt9T+zkwsHXJXyQARnJwMDqcVj7V21R6bwEXO0Zpq7V/Ox31Fchc22oW97cm3m1GRIbuz8kM7srI8iLN/vDaWJzwvJGKpyS6yunX7Qf2kb8afdGcMjlRcDHleTkYP8AFjZxjGecU3Ut0M44Hns4zXT8Vf8A4Hrod0SBjJAycDNLXH3cOpwaiYbUXM8SXkckTTgyAZgk3Hcei7tvTgE44zitTwqxazzK2pG6McZnF4rqBJg7tu4Y69dny9MVSnd2sZ1MLyQ51K+349+xuUxpEV0RnUO+dqk8tjrj1rjpJdaSO9imivJEsF8lXXcpufMkGJAV+ZtkeCdvJJYDnpWs7XVbx4Ynlu0Mct1HBdPDIhjVol2N8+WxuJxuJzjHtU+08jWOAVm5TVl/lf8Ay+/umjuLu4itLWW4nYrDEpd2AJwB14HJ/CszV/Emk6PMYtSu/IcY4MTsOenIUiudu5Na1HTY7m6t7i3guLhUntdjlo41jIJ2p8+DL3Xnbt7ZrqtAM/8AZFv9qmkmlAIMkkTRswycZVuQcY68nrVRnzO1jGthXRjzOSfTT/PY5uT4o+CoziTxFZIcE4bcDx16jt3qNviz4DUAt4p01cjIy5HGcZ6evFdxk+ppdx9T+dWcpxkHxP8ABM8sUcXibTS8rBIwZcb2OMAZ6nkfmK7KsrxdJs8J62xbAWymJznH3D6VrN94/WgCWD7h+tSVHB9w/WpKACiiigAooooAKKKKAKtZOo3V1FrulW8MiLb3HmeYpTJO1cjBzxWtVO5062ub62u5VkM9tnyisrqBnrlQcH8QaUk2tDWjKMZXntZ/fbT8TCj8Wf6GLmWwdUkthdQqsoLOu9VIPACnLDHJ49Kspr88ly9klip1JJmiaLz/AN2AsaSFt+3PSVBjb1PoM1cOg6aYIoTbfu4ofs6De3CblbHX1VeevFOuNFsLiSWR4nWWWXzmkjmeNt+xUyGUgj5VUYHHFZ2n3Ov2mEv8D6/8Dr95lSeK1MQntrJ5YFtbe7kJkCsqys6hQOcsCh7ge/q6TxFJHN5c9uIpYZ5IZo0beDtt/OGG47Fe3XI96tX+l2cTWsaWg+zzmKznCsQBCgkMYAB4Adh0wcHngVbm0awmmllkgzJJI0rne3LGIRE9f7gA/XrzRafcSq4S79x9fyXn3v8AgZa+JW8qXzbWOGYRQTRI85IdJS4UcKTu+RvlAb8agtvFUk88Mn2QR2X2a4muC5IeNoZdjYBAyODwQD06dK15tC06YgvAwcJFGrpK6soj3bMMCCCN78jk7iDmiHQdOh8ny4GHlebt/euciRt7hsn5gW5w2RRap3K9rg7P3Hf/AIHr3/roQ6BrZ1Z5Va0kgKosisclWDZ4yVHzDHIGRyME1WuvFVvbRSGS3l8yIz+dGpBZBGQM/wDAi0ePZwexrW07TLbTgRaiYLtChXneQKB0ChiQo9himPo2nyXF9NJaRtJeoI7gtz5igYAI6dPT0HoKdp231M+fDe0b5Xy9P6v8/XyMmLxI8r2qvbPCzXLQsMMVceRJKCrMFP8ABg8dRj3q5oWttqcoSW1+zl7aK7j/AHm/Mb7sZ4GCNvTnqOasJotkvlZWeQxOZEM1xJIVYoydWY8bXYY6c5681Naaba2bo9tFsZIEtlO4nEaZ2rye2Tz1oSnfVhVqYZxahFp9Pv8AUzPGuRpVi4Gduq6f26Zuox+HWt+ud8eMi6HamTOP7W0wcepv4AP1NdEetaHEFRXNxDa20txdTRwW8Sl5JZXCoigZJJPAAHrXB/FHx4PDUK2VhNBDfytGj3VwEaK2D7scNJGGchGIDMqqBl2GVV/PtPntL67eHxrb67danNeSzKtjdxSCNFkjQr5+5JYyjOFZI/LXJbCEAmplJR3KjCU9Iq56XP8AFfwHDerat4p015WIAMLmVDn/AG1BX9eK6jRtY0zW7Q3Wi6jZajbA7TLaTrKoPoSpODXD6Vqvw8EbWTpp9oCx2yX+B5pIRiVnYkMf3iZG/ILYIBNXpvAGiXySX+jXU0Ms8BWCcTm6jTghWj3EsgGR/qXjPHBHWqWpLVtDuaK850PxLrWg6mmk+NEVt1tHIlzCGlAPmeW7lwihogWiySoaPd8+VIkPo31oAKKKKACiiueg8Rm88XXWi6bbi4WwCi/nYsgt2dN6qOMM2DGcDjDE5BTawB0NFFFABRSUtAGH45x/whOv5yR9hm6HH8J/z/jW633z6g1j+MFV/CWuI6lgbGbgf7hrXf7zY65NAE0H3D9akqOD7nPXNSUAFFFFABRRRQAUUUUAVaF5YA0UUAZvhu8k1Hw7pl5cGM3E9tHJL5f3RIVG4D0w2Rj2rSryHwF4lk8Natr2g6uyf2Va65cW8EywlBZJLvuEMjYwYyGAL8bWZQQVIavXqSknsNprc5L4qtcQeBdQ1CyhimuNLeHVFjlJAYW8yTMMjkErGw49a1PFE89vpI1CydyLR1uXRP8AlrEPvr7/ACkke4Fa7xpNG8Uy7o5FKMp7gjBrC8Cy/avBGiGZopZPsUcUxQhlLqoVxwT/ABA8dR0POaGrqxdKahNSaukbsbrLGskbBkYBlYdCD3p1YHhFmtra60iU5k02XyUyeTCRuiP/AHyQv1U1v0Rd1cdan7Obj0/To/mgooopmQUUUUAcz8Q/+QBaf9hnSf8A04W9XPGWtPoWhz3VvD597IwgtYj91pnOFLn+GNfvO38KKx7VT+IZxoFnzgnWdKA5/wCohb/0zXLfHWOa+tNC0lJEit7+8W3lcpuYCaSO1YDsMx3UvPUHBHIoA8nuNAu9UttbN+YZNQ3iazR3WMzIVjmRpN+GWV/N+aQOQGfblfLi2+nWvhi38V+G4NZ8NSNpWqPzNA6mKCWZVKEsi/dVh8y4ypVw20ls0vxO0528Vi6sogzHTGjMGQFuGPmADYSEYgAZ3dBgDgtS/CHWpD4h1nRzcrc2rL58Ehk8xy0ZVJMsBggBoUC53L5ZDZPJ54SvUlBnTONqcai06HnuqHxR4UsnPivSpLeRZVMN9Z263VkFIxICIwrRIflO1wfmXdkkAVf02azSJ5dJvJocyvfJ9juniLMQSFkw2REpDZDMqAZyo4C/RQOOlefeJvg74H8Q3gvLjRIrS9DFvPsGNuST1JVflJPckE0Sw63i7DhipLSa5kcnd69LqVimk+JY5NYjV2T7W1oIbq2uA2xJlVcIY2bIPKjYRuLrLiuq+DHiYa14dSykULJaRqYWV3dZIdzJgFwHzHJHJHh/mwiM3364vxF4WfwTfwppniq4vIryQNLp2px/aZJFJJklkmLjYpJOW2EsSFUMxCtc+E+pNb+NGtTuEOpW32xojEqGG4kLrICOCoYWW/GA2XJcZYbbpqcXaTv+ZnVdOS5oJr8j2uiiitTEyvFOsDQPDuo6qYHuWtYWkjt0BLTPjCRjAPLNtUcdTXN/CDQ5tI8LG7vmD3mpzPeMQxYbGYsnXnLZMrDs8r4wMAZfxivb69m0nwvpMv2ea+cTSXOGzCd6xwFeMbhK4mHIOLV8c4r0eztorOzgtbcbYYI1iQHsqgAD8hQBNRRSHgZPSgBaKT0rO8SatDoXh/UdVuSvlWdu85DHG4qCQv1JwB7kUAcT431+/urvxVo1nDavY2ejSvOZGIcSNEzDK45B3QgHKjHnZztFekt99vrXjfhvTmj+C/jDX7lEOoa7p13dyXBjwZ4vLkZHKnoHLSSKp+6JQvRcV7I33m+tAEsH3D9akqOD7n41JQAUUUUAFFFFABRRRQBVooooA8B+LVlo+meOdTvdcW4vbOWGPUHsHlYQSs0YhI2lPLdwlsWVWcHqQOpX3DQraez0TTrW7kElzBbRxSuP4nVQGP4kE1518TfD7eJfE9vpQMRhuhYm6jfJ8y2SefzVwP8AZfg44ODxgMPUzyTWUI2lJms5XjFf1/Wgn864n4UbrfStd01v+Ydrt/CowRhXmM69efuzD/64rt64eTw34g0zx5e654d1GybS9TVGv9LvFZV85UCCaN1BIYqqqQRg4ycnGNTI2NV/4l3iTTtRHEN2PsFwfcktEx/4FuX/ALaVo6hrGnac229vYIpcZERbMj8dFQfMx9gCa8k+LEfje00+O8vNVhk0xtolg0+38pIHDZRizFpCc4+bcBkD5QeTtfs+Ig8J6pOEUTT6lI80gHzSMUjJLHqTkk5Pqa51VSqunY9mrl0pZfHHOS0923XfS/n+ljtNP1XVdQR5YdDe0g3Yj/tC4EMki/3tiK5XPo21sHkA8CzpEOro0r6xeWU27HlxWts0Qj9cszsWPvhfpWnXPSeNvCsd9JZyeJNGS6jbY8TXsYZGzjBG7g5PQ9a6DxjoaKarB1DKQykZBByCKdQBznj5d+g2owCRq+ltz7X8Fcv8b4bmKy0bV7UCX+zrsXLwlM71hZLtiCOQdtowHqWArqfHjBdDtSSB/wATbTBz739uP61Z8X6J/wAJBoF1YJObW5O2W1ugu4286MGjkx32sFJHcZHegDj/AIqaR/aeqeHb4FnskS5t99vK6OGkETqQ6YIQrDICcjJKr/Ea5Hws5tPi5pV28bpa6hZszTXGxmjIZ1WMNuyoLXEfyjIPy9lATb0dpPEfhTUPA+p6glpr1rxYuheOaFoiskQIIUl4z5fzA4dNjgkMQMW+jS//AOEfu7e3jlvLe+t7smcORHAqrcsdwA5IhTGeBhevIXmmuWtGXR6HZTfPh5Q6rX+vxPdq4Pxz49h0fUxoGkp9q1+aIuFCkpb5xtLYGC2CW2kqNoyxUFdzviN4qutPhOk6DHI+rzkRtOAAlqpwSdzcGTYSQo3YHzEEbVfyvR7G206B7hJ5DqOqhA9uJSJ55HYSeXjDsSfNYEF5CNpYvkyOLq1eTRbmVGg6mr0SLQsJftkkt/O2qau91vRTIWmlkuAEKgbV3KISRvXaqhJNqRKrqel8AeGDYfE28uHaGRba28mSaLfumulVXkdy5Jfi82hiSRsIJBzna0v7P4F0WXV/EboNavN4it0d22qFLiJRlwp2pvkkHyjBJbYi4u/DHQLuwtrrV9auZbvVdQ25eWAwlIhlseWQCm+R5ZdpAK+YEI+SnShJK8nqxVpxk7QVkjuKKKyPF+tL4c8LatrLIJPsNrJcKhON7KpKr+JwPxrUxOJ0azuvEnxUvNXvSkdlpDslrEnPnbfNt43bjGVf+0Pf507dfTCAeteY/s9aPLp/gUX11N5txqMocnOcLEqw8HJBDNG8mR/z0/GvT6ACiiigAryn41XUmtXei+DNODPdXt1bz3RwdqQ+ZgA8jJwksoxnH2YnHSvVu9eSfDe+k8cfEPXfFtncufDdkz6fYxlsrNMAgeYD02qNvXiY9OQQDufiKAPh14pCgAf2TdgAdB+5eujf7zA+tc98QV3eA/EwwGB0u6G09/3L10T/AHzQBJBwmB61JUcH3D9akoAKKKKACiiigAooooAq0UUUAeceMZn0z4r+Fr6SaSO2uLWS0wpUK0hubZFUliByJnwBycHGelej1538ZXtLO18NajcwozwavCgkIOUUhpDjHo0Ubf8AABXoh6mgAooooAiubeK6tpYLmNZYZVKOjDIYHqDXmCXqfDyPVNC8P2z6teNKb8Qjd/o0LhFAYgfMw2uwQEFguMqWXOj458ReIbjWz4a8E2qtqHlK9zeyOirbBiOhfIyFKsfkfO4AKfmKQ2vwi0S51C71DxY58QXlxIkmJwyxRlE2LgFmc8ZOHdlBJKquTUShd3W5vTxE4QlSv7srXXochpmr+J/EE2o2l5f3+p2ls3lOmlxmOEyoTviV1TcSGURlZpArrJuyCDjU0j4b63Lp1nJK9lo9yTFNJbKxmiikREVQI02khTFGVzM+0LgHGAPXrO1t7G0htLKCK2tYVCRQwoESNR0CqOAPYVNUexT1nqHt5LSGhj+G9FbR7GGCW+nu2ijEaA/JHGoAAVEHYADG4u3+0cmtiiitjA5n4hDOgWn/AGGNK/8AThb10x6muf8AHEQm0W2Unpqmmv8A9830B/p/+qugPU0Act4w8Lf2zc2Wo6fKttq1pIhWQySIssYDjYxRgQQJXKsOV3MOVd1bxXxLba94c8NhNZk1NDZmWCKaSVERS4cRufuQshX92VEgdg+TGCFCfSdIyhlZWAKsMMDyCPQ1Lina5UZON7dT5y8Pw6jcTx3FxDreq3gAnm1sQXD200pwsyRsI2YR7o4/uqPlQbdm1cdT4PvdI0K/W20aFPEWvLCVN3FCsQtLbH7qEJGpdUGQoYRhSSxJXkDvZPh94Mkk3v4S8PF853HTYc5/75re0vT7LSbFLLSrO2srNM7YLaJYo1ycnCqABzSjTSd92VKq2uXZHEeGfDms6rfrrXjRsTNC8S2QO0KGk3bSqSOiphEygZ955kZsIieg0UVZmH1ry74neJl1hpvBXhqWG41y7ISRicpAQy9QAScHBfjCor5O8orbnxV1jVtO0KCy8N2082r6nL9miaFthgXHMm8qyrlikYZuA0qnkAir/gzwrpngvR5I4GTznXzL29fKmZhuYsdxO1QWYgZONxJJJZiAanhvSIdA8P6dpNqS0NnAkCserbRgsfcnJPua0qCCOoxRQAlLRSd/agDG8a6h/ZfhHWLxX2Sx2riI8/60jag455YqK5v4E6SNH+FehIBEPtURvAYhhSshLRkDAx+7Kdec9cnmpfjZHLJ8N9Q8hWZo7iymO3qqpdwuzfgqk/hWj8Lpobj4aeE3g8vyxpVquIzkKViUFeSTwQRzzxzQBb8djPgfxEPXTbn/ANFNW4pJVSd2SB97r071h+OM/wDCEeIQxGf7NueRwP8AVNWtYMWsLZj1MSE/kKALsH3D9akqOD7h+tSUAFFFFABRRRQAUUUUAVaKKKAOB+NaOfBvmR2xumglefyABmQJbzMQCQccA89utd6rB1DL0PIrmPiEivo9uWZgEuV+6M5yrLgjByPmwf14robFi9lbuQAWjU4AwOnagCejpya5DxF4/wBH0LxDZ6TdSFpZWxNIpG23z93f9f0HNWr7xC13a3A0C2kvNqMTdk+Xbpx1D4y/r8gP1FR7SLbSex1vA4iMYzlG0ZK6b0VvU5f4GA3Wi6rrF9BAmq3tyktxJGSciWGO6C5JOAGuZOM4GTXZ61qFx9itZ9IJnt3l2zTWyCZkQBuVXPzfMADjOOeD24H4PaHDqXhoz6rcXV6jm1lMM0pMblrC1YFxn52CsF+YkfLkAV6Zc6bbXEEULK8UcR/diCV4SvGMAoQce3Sh8zXYUfZUpJt83fTT8bX/AA+ZixeJooNNupXdrxrWzmu3dYjCSI2YFCjcqwxg579h0q1c68YNQmh+yE20FzDayzeYMhpdoQhccjLqDyMZzzT7jwzpVxbiCW3fyvLeJgs8il1c5cOQwLZPOWzySaVNBt/7XutQnZ5XllSVI97BEKoqglc7WPGckcfhU2mbc+Ebbs+v5q2zttfyXZmVD4zSa1a5j0+d4XjWWApn51aREAYsAqsd6kDJGM8jFWv7euVvnszZg3jOkccDSBVUmNnOXGeMKeg6kfWryeH9ORWRYZRESCIvPk8tcOHG1N21fmUHgD8qlutHsbqWSWWJ/Nd1cyJK6MGVSoIKkFeCRxjIJzRy1OrCVXB3fLB2/wCGt19bnK+J9cOo6fZW1tazqZLqznkkDqPJ2X0Ssp9fmUjj68V3R6muZ8SaRaRaXAbeIRtHcWUSkMeEF3E2OT6jqea6Y9TVxT6nLWlTlL90rIKKKKoxCiiigAooooA8r1o3Os/tBaLYZH2DRNNOoFdudzy+bHzyOMiI9Dyg6Ho34j6xZ6jq82mxp9quLOKSER2180UrO6IXiwHUbiGiUEhtu/qu41D8Q3v9C+J0GsWsTtBqmjDSDNDOUlt288gSKNjjPmT26jKscv0wCDnRG7aeL7RGYrmffPNMLYoryYQ7mUMVUfOx2lgSy5XcQxPNiavs42W7OzB0Payu9kcX4bj1DxC6TWfiK/8AtEWwAG7uhHPuCuZGaAo+Fad9hk+dgCxOzCJ7x8MNZu9f8CaVqWoK63EokQmQqXdUldFdtny7mVQx28ZJxxivI764nhNxei1sjqDFnsYLohULqVV5JD0VVeNlL5Iy6bXBfB9l+H+nLpXgbQbJHlk8qzj3NK4dixXc2WAGeSecU6E5Tu2RiKcYWUdyx4r8Q2fhnSH1C/SaRFO1YoQu9zgscbiqgBVZiWIACkkjFcb4F+LWn+J3WC60y6066M7Qn97HcRLgOVYuhyARG2MqBkHBIBI5b4yXlxqvj+w022h+3WGm2Ur3luIjKvmSbCVZNjKzCLDICCSzDHeucGjCG6WOwnu4Gkl8pDJcFVdtoKvI8fzO8k8kfBkLOr5RgSygqVuV8qHSw/PHmZ7/AD/2d4s8MXcVpdw3On6hBLbGaFg64YFG6dwcgjqCMHFcR8DtWj/sm+8O3MbWepabO8jWMoAaNJHJfaB1jE3nKp/uBCeorV+Fd1Ld2V/LLCoV5FMUqRoFaP5gAHUkuchmOc4LnDMDxgrbyw/H9bqNIVimhnhkdS3mMTb2rYbsVHlDHuXraEueKkYVIcknE7vx1/yJHiL/ALBtz/6KatWx3fYrfzMl/LXOTk5wO9ZHj3jwL4j/AOwZdf8Aolq33++aoglg+4frUlRwfcP1qSgAooooAKKKKACiiigCrRRRQByHxQeKPw9btNHcyD7bBgW6bm3buCR/dHUnsM1q341SXw3EmgNbJevEirLckhYwR97AByfbp/I43xWFufDcX2sR+Ulyk26SQRqjRhpFZmPAG5V60vwp1m71bwpDFqaAX9iI7eSRVZVmUxI6SANypKuu5T91gw7Ck9dC6bcGp2vbvscLF8Fr25mabUtej82Ri7skJkLE8k5LCvXoLSS30SOzMpmkjtxCZCNpchcZ74z1q9WP4p1638O6aLudDLNI/kW0CsFaeUgkRqWIAJ2nqe3fpWdOjCldxO7G5pisw5Y15XS2VkvyRyPwGGzwHDCYkikjW1DquerWNq4Jz0O1lyOgOQOAK63xLBfNbwXWkIJL62k3JEz7VkVgVZSTx33fVRXmn7PNwbGLVfD73VtdNBFbXXm2sm+Jmw9uwQ4B2j7MuMnnORxyfYzyMVbtJHFCbpTvbbp+hxFx4evor+Abru5hiihWGeJot0bqSXJLkFdx5JXOQSCOAKedG1OANc2tqjXryahvMkgw6PI7Qq3PK424Hb25rtaKj2SOv+0arSTS/wA9La/f95zfhDT7mwk1ATQTQW0jo0McnlLg7cNhYjtXkD+uazhpd6mlvA2kebfMwF1cu0T/AGlfMBJUM3JxyA4AAGOeh7Win7NWsT9enzudlrbv0+f3nmes6JqcXhq3jHnRb7wWziR0zHC90jRuAvy7lIUAL03H0rbh0q/j8V2tyto0MMVy6vJGYgj2/kuEyc+Yx3bODwD24zW14q50cY/5+rX/ANKI602ni3H94n5il7JFPMajveK1v07/AD6dCSimowkBKEMBxxzTsH0NanAFFGD6GlwfQ0AJRS4PoaNp9DQBgeMPDFl4p01La9yksLGSCYDPlsVKnKnhlIYgqeCD2IBHjd94Y8U+G7EQy6C+uQh47dUtGDDZhgArEPIFOEPzqpUkkyvkk/QJIBOTjFMaaJcBpEGfU1MoKasy4TlB3ieM6B4F1nxFr9teeI9Pi0zRYXM8ltJIs818xAKo7BEPljoVlUk7R97KtH7VUDXdsoJa4iAHJJcVC+q6dHjzL+1XPTdMoz+tEYqKshSk5u8j57vruZfiJ41fUoTcaja3rTQweQZGa2RImRdwUsqkGLhQTllIV9pFFpb3FzNFBqNwVud8CbredyVTz5QoHlGPYCqxqZMKB5RLBghA7z4kaJZ6nqNnrfh7UbJNUjkVLhVuoU8yIqVLDerKXHycN8rBezKjL5zeS6zaxyWDaJp5vG2lbiO/3jYAowrLGQjEoWGZSVfaxYnLHkq0pOV0juoV4qKUnax6X8K9YitrfxB/a62lrcWkUV5O6BgwtsSeWzhokYlY4wCSSdwbhOhf8O7bUdc8Y6x4o1eN7WJC0FnYuAHgZxHu8wc4cQxWoI3fK5mGBXF+HPDd/qV5FceINSs9KLkidYNQVkMO4OsYTzG3OGAIdggXLYQ/Lj2TS77w3pGnwWOnX2l2tpAu2OJLhAFH58k8kk8k5Jya6aStFJnJWac20R/EVS/w98UoBktpV2B/35euik++a4z4g65pMngHxNHFqunvI+l3SqqXKFmJhbAAB5Ndm/32+taGRLB9w/WpKjg+4frUlABRRRQAUUUUAFFFFAFWiiigDzv48wS3Xw+uoIGwzeYxXklwkEshUY7kIce+KqfBSVwdcgkhS3LPFcGEKqspKlF3BSVU+UkAwp2khivUgM+PmqW9roOn2Ultc3txNP5yWVqzrNcxhkgkjj28lsXQwPxHI42vhV4Z1Hw/pU8mtTtLeXQi+WSRpJI0VOjsWYbtzOSqkqudqlgNxhpuaZpFpQafWx3FeT/He3lWbwzfli9qs1xZPbhQd0ksYkSTJII2eQzBlIcNsK56H1iuZ+IWiXeveHJbbTmh+2RkyRRzkiOUlHQo+CDgq7Dr+QzTmrxaQqbtJNnlOn+KYPDPiyK8u7yS4kF0yXwMLvIthPHFslkkWNUBilhckfwpv+8cs3vUUiSxJJE6vG6hldTkMD0IPcV8ya5ourazcxrNoet2fiS0cxws9lI/mrtGxXmgVYm+bcd/mKsfmfx803RvE3iH4V69qXh4mxi0y0YSppskMskTeY2V+zzrllD7udy7VO7A9Yot8iUlZouulztxd0z6fpBx0ry3T/jAjQySav4T1yzSNVeSSBoLpEUgHd8rhz1HRSR3xW5a/FTwfcHA1OeE4yftGn3MIH4tGB+tamJ29FcX/wALQ8GfaWg/t2EOq7iTDKEx7Ps2nr0zVSb4w+BYU3Sa4wGM5FjcnA9/3fH40AdpqunWer6dcWGp28d1ZXC7JYZBlXX0NcpL8KvAUrEt4R0YEsWO22VeTj07cDjp19TTrD4o+DL4sLfW1BABxLbTRZz0xuQZ/D29a2LLxb4bvmxY+IdGuTnGIb6Jz+jUAYTfCTwEwAPhXTQoIO0IQpPuAcGs3Vvh38NtEtzc3nh+yiYBnihR3MkzKM7I0DZd8cBRk87RwcV6SwEkRAZgHUgMhwRnuD615J8OVt/DfjG/sNcs2k1q5ka0/t2eZ53mZY4XFuZJMsodWEqIDjhk5aLLAFK6+DGl6n4XupLjRltdTmnN1HYHUJJljQhQbdpC2NxAJ3DIR24LKuGw/hpo/wAOdenuNL1vwtZWesJtC/abc2f2pSzgYhLny5VIZGQdxlSVPH0NXmPxY+GMvjFXn0vVHtZnKtcWNzJI1ldlQArMisNjjauHAPCgEGgDU/4VH4Ayf+KT0rn/AKZf/Xq1D8MvA0Uaqvg/QcAY+exjY/mQa8b/AOEy8aeC4EtL6+ubOWBVgj0/WdNe7EznGDHcpLllO/ABdiNhH91a63R/izqxsl/tO38NyXSJumEVzfRYOAdoUWsoJ56K7Z7UAd2Phv4IH/Mn+Hv/AAXRf/E0p+HHgjJP/CH+HhnPTToh1/4DXH6d8X59RBS00GF7sIW+ztdXMbMeyqZLVVJPYZBP54tX3xG8RxQCfT/B1lfwqG85l11ImhIx8pR4gxJ5+6DnBoA6/wD4QjwmI/K/4RjRDG2QUNjGVOeTkYxUf/CAeDP+hQ8Of+CuD/4mvOh8ZtWNzFFJ4Xs7cuWGH1Nm6FhnPkgEEow4z0z3FPuPix4lZ3jtPCtmQGRPPa+OxS2eSCq5xwcA568dMgHoi+AvB6MGTwl4eVh3GmQA/wDoNSJ4K8KouxPDGhKvIwNOhA5Xaf4e68fTivJJPiz4zg843ej6PbJGxHmuk/luBncwOc4GO4BORgVLpXxq1B2L3TeErm3ckRmK7vbYtjOSN9s2R+H8xQB6vH4M8LRgrH4Z0NBt2YXT4QNvXH3elW18P6Kv3dH0wfS0j/wry+P424J8zw9DMi4zJZ6zbsvPoJfKY9/4R0rY074z+HJrx7TVLTWdJnTHNxZmaNs91kgMike+QKAO6Gg6OCCNI04EdMWsf+FaVYdp4t8O3ce+LXNOGOqyTiN1+qtgj8RXN6n8WfDVl4jtdGhN5ezSzRQvPbxqIIjJKkatvdl3rucZMe/HOelAHo1vnYc9c1JUcH3D9akoAKKKKACiiigAooooAq0UVz/j/Vr3RPCGo3ukwGfU9iw2ce3cGnkYRxZHcb2UkegoA5Oe60zxJ8VbF7eRJ5dGmks8FgQWWMyTlQOuyT7GpPZiw616WOleR/AvR2sbzWWvEmkuoIoIUluYFjkjDl5XXgnO8skjHjJYHnANeuUALSYGc96WigAryP442ElveaRq1uLiO3uXTT9RdF3wyR78xJONy4jLO4LDLHfsH+sIPrlV760g1CzmtL2FZbeVSro3Qj+h7+1TKPMrFRlyu585X3h2x1+4s5NVfVjdWcUwjF1fyzvCw81ehEiAjCbvLJTKHKEKAedXwo8cE2pXQtNRjMJmtUk0+2jkRAYzt+e3aOUYl4dSi7jzjkL6Xq3wh1ZFMeh6rbr5UiNBPO5VykRJgSYeW4l8sO4DEg/LGw2spLSnwj4s/tW88u0Qfbl2PcG8UwwBWOwI3+tYbCcl1YliSAgyrcijWg9NTtcsPNWeh5lFpt9qV/8Aa7rULe+SQxNGLuygeESyqmwvMm2WXKADK7HbfGVDqrgei+BfBkvinQJNXu49MsJfPxpyW9oklnKqH5pWjMjl1di6giRcoqkYJzW34X+FLp8/jTUodaIREEMcLxowWMKQ5LnepILbcKMs2QRhV9SjRY0VEVURRtVVGAAOgFdMFP7TOSo4bQR43dfBy7uopP8Aib6dp/lw7beCw09jE0gC4aXzpJCVABAVCmARycVy1/8ACfxQZpNOstM0v7PMF3SXTwzWgCqO4jjkVieB+6YLjqc8fR9FaGZ8pWz6r4csriw0671Tw7qcMau2n20nzcsQxS2ciNizAhWGN3UZyMpdWYu7E3Gt6xajxTeTtKt3qLjzCVcLHLGkAO3HlxKuGK5HIGSB9M+INA0jxBarBrmmWl/EhJQTxBzGTxuQ9VPuCDXzhrMlp4G8Qajoum6jO0SA+TfRTR28YUuQ1vIOsjoyn5gesjAgEE0Ae+fDTxSPGXgzT9YaEW9zIvl3MI6RTLw6+3PODyAeea6ivG/gG40rUPEmhGP7PFJdy3trAIyojGU8xecdpYDjA4YdsE+yUAMljSaKSKZEkikUq6OMhgeoIPBFcjL8M/BzSb4dCt7N+cNYO9oVz1x5TLj8K7Gk9KAPPbz4S6FMZfIv9ctxKrxyK12LpHRn3lWW4WRWBbnkEk89eapXvwz16SN4rP4ia3b24bMMRtoSkYzwNqBBxjIwAAcEAdK9QooA83t/hrqrweTqfxE8WXCKwZfJkijOc5ySyOTyBjpirVt8J/DISP8AtF9Z1aWMfLJqGq3D49SFVlUZ4zgAcCu+ooA4yz+F3gW0z5PhHRDn/nraJL/6GDWlB4I8J26FLfwvoMSk5Kx6dCoJ/Ba6AEHoaWgDlf8AhXXgnfu/4Q/w5n/sGQY/LbTz8PvBpUr/AMIn4fwc/wDMOh79f4fc109IDQBy0fw88IQyCS18N6XaSAht9pbrA2QQQcpg8EDFVo/C2i6drujadpemW1hp6ibUZIbWFI0nniMSxGXC/PtMpcZOQyIf4a7ICvP/ABx4mtdL1u11DTZ4dSutHWWPVdOtcy3CWsuws2FyEZTGj4fG5VYA5IoA9Hg+4frUlRW53R55weeRipaACiiigAooooAKKKKAKteDfG28j1zx7peiLNAsekxGZwP3kwnnUhGjjTLs8aIX2YAwSxyAM+8EgAliFUckk8AV8waNdS+IrnxJrsVr9suL25e9s43hRj5EgaNImx95WRFU5JK4GFwGrOpLli2aUoc80j0v4Z2Vv4b8QSabpcUYs7+MzXAAwUnAJXaAcbSqyc4JOAMgKN3qleH6XqdxYeLdHa4tBFpsN/b26zIzKJJJkaFQIgDtVfN2EuRyOFUSfL7jUYaTlD3mbYuMY1HyqyCk5z7UtFbnKJ3zS0UUAFFFFABRRRQAUUUlAEGo3cdhp13eTECK2heZs56KpJ6c9q+SPEb31jq2j6lawrvvRKt4qEQC4MZSTznLkpIzMJZMHLjzOudu36j8dWN3qfgfxFYaYhe/utNuYLdQ4QtI8TKo3EgDkjkkV87XumpcWel3mjLd3hSZUERinUTGZCsZESyAL8hYsVMYJK/KFZVGNSVpxN6UeanPysdz8LWjvPG8uo7Z7e4B8rynO8Sx3EAYS7yzs4P2FAvzkAZ47n2vueK+cfhdHLpvxls7a+E1rNLp6RxWrxtEGVUucMFZiTtVFXOAcseBzX0fWxgFFFFABRRRQAUgFLRQAmMdKOo/xopaACo55UggkmmbbFGpd2PZQMk1JXjPx38QXEk2n+HLCa3g+0XCLI7sA7NtLHaCPuxqY2JALBpI2TBQ0AZ0/jPxH8RPGkGkeGUn07w+kzF5mLwSTwJt3zSMBuEZLBUjjZXfdksgGR3+g/DDw1pmmWtpd2S6oYGEub0BozLzmQQDESNz1VQTxkk81k/AjSLS18PXup28EMTXVw9rH5RZlENuzQqAX+b7yyMQT1Y4r06gCaD7h+tSVHB9w/WpKACiiigAooooAKKKKAOE+MN1JafC7xO8AJlksZLdAuc7pR5YxjvlxXj3gu3uY9HvHFottPC8USRWf72Jo4tzRhC7ANiQSLkuTxgkfKw7/wDaDvZF8PaJpVvLAJNS1NUeKeMuksaRySENgHgMsZ6fl1HnfhDTov7MulmsYWYySpHOLsGOYu4iBWQKGTcIoowyFzlgRzgDmxdvZ2Z2YG/tboseJYZn0eSyQkXlxqFqYFEjbbvN5H8yB3PH72NW2/KPlwACqr9Hnqa8X8H2dlceM9MtbWMNhTqAuLZsJJHGFBZiVIyZnA2BjhRkbdzKfaKWEVoX8x45r2iXZBVXU76HTrQ3FwX2b0jGxSzFncIoAHqzAVarM8Rae+qaatrGwU/aLeVjvKHakyO2CvIOFOMd8cjrXTK9nY5qKi6kVPa6v6dSS01W1uhH5Rk3NM1uVaNlZHCliGBHHAzn3HqKZca1p8Ns063MU0aTRwOYnVtjPIEGeeOW5+hrDn8NXX2dLZLhPIiuprhbgszTlZIJU+bj5mVpFwc8qPUc0tP0271VrnfaRW0ITTYwGSRFcQTtI4Cuit90gDjGTjPXGXPLa2p3rC4d++pe6rX+bt+WvkdYNY04zWka3sDNdhjAVcESbSAcEcdSBU9ze2trJHHc3MELynEaySBS59AD1rBg0K6g1iK9UWsirc3DlWYgqkpQ7h8p+YFDx3z1pPGOi6jrENxBaSxeRNaPCFed4dkhzhztUlx0+UkDjvmq5pWbsZKhQdSMefR7v5/5W9Tag1SxnluY47qIyW0nlSqWwVbAOOfqKlt7yC4d1ikBKsFz2b5VbK+oww5Fc9deHpp5b2N4rN7a41CG8y5JLKvl7kZduP4DjnnPanf2HeW2sSX1ktoy/azKkTOyARm2ii7KcENH0xjB6jpRzS7B7Cg1pPW342X56+hvPf2iNEr3VurS48sGQAvnpjnnODj6U+1uYLuLzbWaKaIkgPGwYZHXkVyUPhS6XSTbStatJ/ZdlYg5JG+FnLnp907lx9OQK6LS7F7O81aRinl3V0Jowv8ACohiQg+hyjHj1FEZSe6JrUaME+Sd2vx2/wA39xo182fFvQHsNUvtItRdW9gIZNXtmjjU8efHJKEOFGY2XB/eIVSWPhsV9J1z3j7w8ninwhqmlFIjczQSC1klyBFPtIR8gZGCeSOcEjvVTjzI5oTcWfPPgm4nh+Ofg66e+89LqK6jaQ7CGQo2zAikdOWIPDcFs88V9T18u6d4UvPDnxm8F2etT2yz+UZlWHDxxwrMqwx7vLTfKWzucqM5U9q+oqogKKzLbWbWXRLLU3LxQ3cUckaFSzneoIUKuSTz0GazNW8X2diwaNGuIVtXu5HTIIRSQQBj72QwwxXGOSKlzilds6IYStUlyxi7nTUHpVb7bD9i+1AuYcZyI23f984z+GKoHxFp4uLOENKzXTvGv7pgUZcZDgjKnkdR+lNyS3ZEaNSfwxZsUVjjxHpjkGG6jkjyweRW4TarMc+uAp6dKtXGrWNuHM1yi7Nm4ck/OSE49yDilzLuDoVU7OL+4vUVm2et6feTxw29wTI+7AMbLyv3l5HDDuvUelaVNNPYicJQdpqxDdzpaW01zMWEUMZkfaMnAGTgfSvl7Sv7S1vUPEHiTVLW4bVwbiN4ms90dv5fmOYy0gCP5YcjnkhcDnGfdPi7fzWPgTUBbPEkk48pjIxUeUAXmAwQdxiSUD3xXz3pmkXOnT6RYadf2Ur3NxaWU8JuGuCY5ZFR2BXKggksQOBknPIBZJ9SeGdEtvDfh7TdFsc/ZrCBLdCRy20YLH3JyT9a06DycnrRQBNB9w/WpKjg+4frUlABRRRQAUUUUAFFFFAHh/x2/tGTxb4MXR10+S5hg1G48u/VGhICwrkh+M/MeeoBY84weT8NS6oumrHeBI5hciSZ41ztIYeaAVO1QbkSYUlI/LO48KRW/wDH23lm8aeGDZmD7atjemBZ4Z3SRw8G1D5QyM5PJwB3PTPGai9vd+BNVS6t4/tVja3AtvtEYtXMhjzcCPYQSpbzlYRkRkAIuVBauXFK6S8zswbtJvyPfPh1o0Om6DBebpJL7UYo7i4d3DYJQEImOAgySOpJJZizMxPVVDZwC2tIYFCARoqfIuF4GOBk4Htmpq6UrKyORtt3Zk3N9dy6rNY6dHBugiSWWScnHzlgqgD/AHCSe3HXsi63Et0LeaKRXDrBJKg3RJMyhgmeCeo5xjkDg8VJc6Uk96b22u7m0neMRu8BQiRQSVBDKw4LNgjB5NRLoEC3YmNxcsnmpO8LMpR5VUKHPy7s/Kp4IGRnFR73Q606DXvdvO9+v/A/Ehg8TWtzFC9ra30xmVnjQQ7WdFxuYbiMgbgPckYzmnjxLYvLEIlnlhcwjz1T5F87AjySc/MWA4BxnnFKvh+GO1sYra6urd7OJoI5oym8o2NynKkc7VPTqBQnhyxjhMMRlji3WrKqsML9nZSgHHT5AD/Sl75f+yef9P8Ay1XnuRv4osIp7+KcSRyWdvJdOpKMTHHjcQFYkdRw2Cc1MfENoqTmWO6haJEfZLEVdw7lF2g85LDGOvI9apnwlZLbTQvd3f2drS4swpZAIo5ipfB25JGwYLE++au6npC3+uaXeyBPLsxIx5O5mO3aMdCoI3fVV96PfG1hLpK/X8Nvv/C/U16KKK1PPCiiigAooooA8O+L9vMPjP4EuYtqK3kRl87SQL+23D34bGP9r3r3GvGvjWFHxH+HBY7S10oxxl/9P0/A9ePvfgfevZAQRxQByyeF7ltF03Trm+tZV04R/Z2+yMASiGP5x5h3Aqx6Y55zUp8LI9nc27zxRrcWMtmwt4PLUeYzMXALHn5j1Jyec10tFR7OPY63jq7+11vst/uM3ULC5vtGa0lu1S4baWmijKqcMDgruztIGCN3IJ5FZeneGZLCaKaC6t0kS6ecpHa7Y9roqMoUNx93IOT15BrpqKbgm7siGKqwi4Rej8l1Odk8MrLpllZSXR2W4mDMEwXEiOnrxjfnv0psfh24aVpbu/jklL2rfu7coAIWLYwXPXPXtXSUUvZxK+u1u/4Lvft3MW30Pybm2l+07vJvJ7vGzG7zQ429e2/r3x2raopMDOe9UklsY1KsqjvN/wBbnkP7QmpXn2XS9F0+WON7rdLKzSmLC+ZFHt3AYAZJZxjqccBjxXMfDiz0m0+IejadaXN1PHbM86fadNkgUyLFIgYSO7Al2eQqoAz5RO44XNj43X4bxkkT3E0bxNYQxIk0iY3famdgYyGQkmD5gf4BnsDladqktlr01pPZ6pdq8mltBdWdtJcrCsN2ZbgNtXzM7IgQApGB6MNzMz6Spaq6df2mp2i3On3MVzbtkB423DI6g+hHcHkd6tUATQfcP1qSo4PuH61JQAUUUUAFFFFABRRRQB4V8crz+zPHfg67a41SOB7W+jl/s6TY+A1uRk54GSOx5C8dxzKQapf+D7azlvZwdRtZI7m7uSfNXkoJZCWBU7s8M2WUP1YjPUftGW9/DqPgTWNMjaSa11Ca3UKwU7pYsjkuoHETDkgc/geU8I2GpHR4PtzTWrabdyyOkUYnklR42VZAV8wiRWLKGRyNqspHOBy4u6imujO3A2c3F9UfQ+i3v9paNYX+APtVvHPgAgDeobv9awL5r9PE8ojF5cwSZAULKkcC+Sfby5AW9wwLY5ArP+DOqC88KTWD3MdzPpV5NaNJHKJF2bt8ajHTYjrGVIBBQ9sE95W7XOk0Y0qnsZSur3TX9f1+Bw1nHqwtreVvt6SQHTkSIKyptYos+UAwcKWzn7uM8YpwutXmijty+oQSx2d2s832V2Al82IRkcfMdu/G3PGSK7eip9n5nT9eTd3Bf0rdvn6nP6LJfv4euykEsV2pkFuJ3dt5x8p/eAOBns36jFYrtqDW8n2ebVUtgsBf7RDOXeX5/MUFRvVT8mWX5QcY4Jrq9dvJNO0m5vIYxKbdfNZDnlAcvjHfbnHvV1GV0VkIZWGQR0IocL6XFHEOCdTl0b/Kz/p+p5/dQ3z2+q3LWuopdXGhKkMRDzBpVFxlG4wT8yYDAElumcitmO71H+2re1ZLzaNSlMjeS3l/Z/IkK/Pjbjfs79eK6mihU7dQnjlNNOC2fy0S/C33nnywayNC84y6sb3+xRdbSz5+2BchceueCnQ9wTXoNFFVCHKY4jEuva6S3/EKTHOaWirOYK4D4v8Aia90fQpLDQLjydcubeaeN1RHaGKMDc4Dsq53MijJzyxAO0iu/ryD4saDdL40t9cgga4S+0s6Unllt0cqO0yjavzSBwWypZExEQ7AMMRUk4xbRpSipTSlseV6DZi2vdAu457i6kfXI2l8/wA5Ejb7TazSzkzgOWcW5JJIyCON2c/SPiPXJ9I1bTl2q1gYZprohSzqqtEoK49DLk+wNfMuk6/cWvhrSjf6I76fFKoSSWVysl0qNAXLFlXeryKGOMfKCGGQa+tpbSFr+O6ZP9IiR4kbJ4VypYY6clF/L605JtaFUJwhO9RXWunyOPXxNqUWmTy3MUIu0N2RFt+UeXHvVWOe2cEjrjtWvDr05uDBPYhGitEu7iXz1EcSsZAMk8/8syenGfbm8+i6e7Oz24Yu0jMCxIJkGH4z3FEWi2EcU8fktIk8AtZRLI8m+IFyFJYnj94/546AYhRmup11K+FktIWf/B9e34mLH4lmupYYUh+zyrdwRyYDMrxyBsFSyqf4TyBj0JrU1fW49Lmkjmhdj9naeLaf9awYL5Y/2ssmP972NOg0HT4ZPMWKV5N8b75biSRspnbyzE8bj+dWr7TrS/e1e7hWVraUTQk5+Vx0Pv8AQ98HqBTSnbV6kTqYVzXLF8v4/n3/AAMK98TNHdT2qwqG2TLHNGzOFkRCxVvlCg8HgMTxyBUtl4jUxQRXET/a2eJCMgblaLzDKP8AZAD/AIqR6Vdbw/ppuGmMD7i0j7fOk2BpAQ5C7toJ3NnA6nPWp4tJsY72G7S3UXMMH2ZHJJIjznb/APX68n1NJKd9ypVMJy2UXt+P37FDw94hGsy4W0lijeETxOdxBUno2VADcg4BI9+K3ao6dpVppzZtFlRdu1YzM7Igz0VSSqj2AFS6pf22l6dPe30nl28K7mIGSewVQOSxOAAOSSAOTVxul7xy4iVKU26KtHzPn/4sawt98QtPtNPkklht7i7lnFvKo3BI7WJhJuIGzekinOQSpHTNWfASTeHtTvfFa6fFfyXqvo1nDpqrGsci7CEZXYcF1KlywIYYcAkBeBvYotX1m7ZLzzrxEyWuraCcTyG4d5Io9zqxJuJ5EX5CG2pg8iulu28I6N4L0C21UXniaCxuGe+f7JItuyXEbzSmEKgTCmRJhvGWRQVJAGKMT2fwfq8eo+Ib37LOzrPYWl7dRm2MIS4YNGSA3zBtsShkYnbsXuTnsq8g+Furx/8ACXrZTXs93czaZGiSvKskcsSEvFLGclgJN1w2CxwvlL1RgPYKAJoPuH61JUcH3D9akoAKKKKACiiigAooooA88+NFjZXfw/vJtSso76Cxnt7zyZFyMJKu/HuYzIPxrxnT44Df30FrBcxXMulf8S7mBHgjy0Tx28qohVt0kIUtxkHJOMj6K8VaOviDwxq2juyoL+0ltd7DIUuhUH8M5r5g8NXe7VNFknFykkgmguRLaqDBdERg4C/PkmLazcAPsJ4yBnWV4M2oS5akWe5fCPUv7V/t6eLaba3uhZKwnaQl0Bd9wYAxkGUKU5xt4JGK9Cryv4TzQ+H9I8USzw3MdrJqz3fzQKJMyomfkTJAyON2HwRkdK9L+22omjha4iSeT7sTOA54z93r0pUnFQSQ60KkpOTXV/gWaKyLDxBp15C06zxxQGUxRySyIolbp8vOe3QgH2q9cX1vb5EkqlwwUopy2SQOnX+JfzrRSTVyZUakZcrWpW8Q6jFpOh3t9cQTXEMMZZ4ol3Mw78enr6DNeK6B8VNfVrHStI0GPUtqiCGEOfOKjgMXJxhV5PAzt6jOR6B8XPGFp4c8H3vlX0Md/cyx6fGVk+eF5m2l8AEgqm9xweV6GuF+FPgXWtI1LwrrWohWmcXC30aFT9ncrKEzt45UpngYbggdK563PzxcHp1PYy2WFWGrUsTH3mm4t7XSdl69u/3Gmvib4saUkF/r3h/Q5LEtCs9vCGSUGQhCqussoBViSSw2lMc7iVX1Dw1rNr4i0Cw1ewEq215CsyLKu10yOVYc4YHIOCRkdTXMfFfV47fQn0uK4slu7ob3Sf5ysCFWkfYFYnAK9hjOdy43DV+Gtpd2XgLQodTSWO+NqktxHKWLpI/zsrFiWLAsQSTnI5rdPWx4jjZXOloooqiQooooAK5L4leG7jxNoEENi0a3tncrdwCXIVmCshUkdCVdsEggHBINdbWJ4m8UaN4atjLrN9FA3lSTJCDulkSNdzlEHzMABkkDA7kUmr6DTs7nyYV08Nq+l6ZpllGIb6YyxShFu7RI51k8sr527EZ+TcqupEZxknNfWfgjVJNa8H6Pf3JH2ua1j+0qM5jnUbZUOeQVkDqQeQQRXyz/AGxB4r1TW9bt9KlisNWbzJls2gBiLDy2yZgoZvlycEBi7D3r0nwV491TQdNtbC8tbVxdzuto2pPNBNdStK25d8EEsMshYj7pDMWLMNxLM0rCep7xRXmd1448YgyRW3gcvKsbtvFxclGYAFVXdbJknOMnaBzzxzEmp/FbUJNltomh6fCZMGS8fa2zjlNkkmT977yj6UAeo0V5q8fxWgWKSI+GbryYsPHJcOhmbnnAh69OjKPbvUqePNU0zVLC28TeH7y1gvHMKypD86S4LKuxHlSQFQfuSGTIP7vA3UAei0Vzmv8Aiyy07wVN4ksGi1K18kSWwjmVEuGbhBvPCgkjLHhRknoa8QvfiJ461q9vpNLfybaywhij8uzWWTKEACaOSQo6yLtkLRAjBwhKqVKSjq2VGLk7RVz6Pnljt4JZ55EihjUvJI7BVRQMkkngADvXhnxT+IkOo6pZ6Dpkc9zaSCO6D2aBpZgWQJIpfbGi5YmN2J+ZVk4VEE2Lo1r/AMLDv1vNb1i71HwxYRNc3yrLG9qQjSkI+95NjELE3yH7pOdhClsrw6LjUrGO709Z7g6hO8l1qNt/aJO52yyrL5YWRkCled2NgBJAyBO6uKUeV2Zr2EOl6EQtv8JZLKFy4V4dYS4kTjDOqvmPcABzuzkAZqxHd3Xizw9c+FXFnd2N1dJPNfTTtDJBMksW+J4Zh5iHzWTAP8L+WG6OKF22oy3FvbadZ39tphVzJJa/vPPmCxkl0kmWQuoOVzlTlflw3Exs9d0nUoY4Uu9Fh169ttOujFEEU+ZKuZdvmHbJtQxA7QcSNliVFMR6F8PfA2heG/GF5L4at2+z2du9rPcybPnlZlIiXYq58pVbcSCSZgCxKEL6ZVTStOs9JsI7PTLaO1tY8lY41wASSxPuSSSSeSSSeauUATQfcP1qSo4PuH61JQAUUUUAFFFFABRRRQBVr5z+Mmi3+nax4kfTtpSSFdajuFN0J7bjDrEyRvGreZDvBJQ/ORnbmvoyvJ/j34buNR0201eyjExt4p7G6h3FN0M6gBwykHKSKmB0IdvxGOKu0kbnh/wxdWfgJ7WEIdT1JkvLhZ2eNY2KoBGAQxARI0jA/wBnJ5JrYuNDuJry6uP9HV5r22uRySQsYQMM46/K2Pr2rA8PePG1vRrafS4C++4WwDSR/MJViMkhKBgCOmACM5J6YzqXPiLU4YJXe0gge1tFup45MsW/eOpVcHAyEyCc4zjBrC8D1YUcTBcqSTf36tfqkvLqQt4TuVt7RVEEuyCW3mhE7wqwd92QyqSeOCCPTnjm23hlzFqZC2oubm6tpUkOSwjjWAFS2M9YnI69R6mprfXriTxBDaqiyWM801usoj2bXjDbhktluVYH5QPc1bk1G5fWri1ga2igtFieYzAlnDk/dwRtwB1OcnjjGaFGHT+tAnWxSfvPpf8A8m7f4lbY4X4gfD2/8ReHktImtUn06WS6tJU+aS4cyb9jbgAhYblLZPJB4AxUH/CVeMrLQ2t9F8Eut/CkXlRGApDMWVNw3FlEbKS/XcpCDDfNxt3nj6PSoxPq01lDazLFLbSykQGZGfBVFLlmbblgMAnB+XvVBvizo13Ef7L1XTzcNLIsNvKCryKPug72QKzYYgctjHyk5FJOK1THVpYmraE0rX/Hf/g67ehT+H/w81Ui21DxrNE1zHN562ygSTMdgA86bLE/MZflRjkPtaSRMqfWqhs5/tNnBOF2iWNX2ntkZxSpcQuwVJo2Y9AGBNbJJbHly5m7PoS0UmRu25G7rjvQTggetUQLRRXE/F/xTceEfBVxf2MsMN5K4t4Zpl3LESrMX2/xMFRtqngttHegDmfit8ULnSRfaX4NW3utStreV7q8YGWKzdf+WeFBDS4EjbT93yzlSM7eI8b+C7yw1e2sVefVkiZbvUdY1UyywSyHP+jmJIZYxwVfdICRvUKy4Ard8A2Gk6VYXF9fXEs9lpAgu3ZId0l/PIJFjCgHbKN7YUKCTIFBYsh3YugHVfEXizV7jVbSCa/e4llkaG1S7aAIFjVMSGNTGm1egLZQZJLc5wnzamlSChp16k+mwLp2j29p/aOl31xcLK1kbPVJXXgHHlhIY1ONpUYJAY4xjcayU8J6yfDlzPeDWfNZiqLLGt0VlQFkfzAkfRynDDjHHRhWxrUV7Loc8swg+yyXYQqYhZrImd8QQRsrtxHhgjkgc5YEkVbC3vYWgm1DQrS2ty/lPLZ/2oZWA2+koLfeALE4UnJJORWhmfQPh/VrfXtC07V7M5tr63juY89g6g4/DOK0K4P4FTyXHwl8OGZAjxQvBsCkbBHK6BSDzkBQDnnI55zXeUAFVtRsrfUrGazvoY57WZdkkcgyGH+e9WaKAPmXXNJki8aXfh++S6utM0x2uEgldpFuyzWcRlZSQHfybp1O3lnV2OWc10ttbaZD4W8Wf2rYwXXn+XcWsc1vJDKBIHiMSLIVdQfIkcrwCJG4YHnQ+K1k0njUzW8TrMbC1QPFHGzszX9vsA3qwzujHBHbPbFVvCWmO3iPQllNpDNqGdTWC3QRxrbqVZHKqMO7bZFDPhtspPBXaMWm6qfSxspJUmvM9D12x0/Sfhtqtjd3tvpNqdOminvCAojeRCGlOOrFmJ9ST6mvDvDECafpFrb61ZapoUlwihHNuEmA4HyzSzggEBQFAIBY455Hov7Qt7c/2Homj2Fk1/dahqCP9mEZkEqQ/PtKhSCC/lZDYHuOo4HStBvfJeeXTpnlKMphFwtlEhCh2aPyyj8bQScsACT14rYxIGn01r7yzd6FfSSKWzrOp3MMrkEsQIohMmBn7xYsfXpU6afDa3nhJ44oImi1uy+W0a9kjmDTxgO8s0KqWGGwoK+uDxiK6tG8+bVLS408piPMFtc2EiQg4CgHa8jElepUk888tm7o0uoav4o8L2slzd3FuuoQTKRGFtzs3SLt8uJUDFEY43Y+U/e60AfRtFFFAE0H3D9akqOD7h+tSUAFFFFABRRRQAUUUUAVay/EcSzaakbxpIjXdqGVlDAj7RH2NalU9WsF1Kxe1eeeDLJIssDBXRkdXUgkEdVHBBB6EGgDyT4Vppej6BNNr+o2MWkSWds8r6iiQpLIzy7JGaQ8thcbifmAQgKABXfQeIPBLbbWDWPDZ81PKWFbqD50HzbQueV+bOOnzZ71L4c8D+G/DsSLpekWyyqAv2iYGacgDABlfL4HYZwOwFbktnazR+XLbwvHgjayAj8qiEOVWNZ1pSe4xdMsY703a2Vst2TuMwiUOTjGd2M9MiqHimXT9N0yfWL21tJZ7NMwNMqhjJnCIrHoWcqo9yKhm8LWaXhvNIluNIu9u0mybbC/U/PAcxMcn723f2DCvPviP4gvWi0Pw5r2lOmoXk/lGeCNntZpHzCjRMfukGTzdrEPGUBG4AMasifaTve55kNKGvzXmszXd4fL8qZfKslWF/3UD+Y8a4VYmMiFI2xuTBYFy7Ve0+Sx1fwnZx2UKo8uCq4lu2tSjRK7bA5Z4i0Ey+YWUHCqchmrY+J1ymjfFvUJvIb99BZ30kjEyxqgDxHbBwHf90vIOcDHA+YY/h26s9PjvNEs4JMWtq9xZz3lq1szsSTHGI5SxJVg7Kxkyd/C4yw5sTD3brodWFry9pZvc6b4f+Krjwi8FreXPn+H5plj8qeRUuLN3C4XyzI5G3dHuQlTlz8u7b53pN9pz2Y8V3Gm2PlXa2ubN4YPm8wQt9zA5OcDivKpIP7VW/S3WQaXeKbnznlkibhk3bd6EBQEi+ViFf8AfZHBC+h/CDxNFqWn3mgSTzT3uiTNaiaVg7ywDBiZyP4wjKrHozKWBIPCozdVcst0azf1aTnDWL/Rp/p+Jp6xb6jaXZW1kvp4vIQSzhd0u0zjzNpA+9s3YA5x0GcVFeXd7bm9TTxq7wS28AtC8ErsHEsnmZLDI+Up97qBxmujfWbRZ3gJfzluVtdm3kuyhwQO42knPsfSsy48VQbLqO2jK3cDwho5WVvleUJn5GODz0OD04rSSS6mlKdWaSdO+35q39dm+5j6ve6jajxBPDJeSKlndyx3GJY0hKp8gCsPLbBHDKc+o644T46ee3h23aX7bJof9rW21bkvFIZSCGILYdVxk8Ywc4K4Br1u98QaS1iftmXglSZZI5I93CNsdWX/AHiFwepOK5f4iXthrvgq4dwyw290kFyrSqpjEq+SSWXcCNs+SBnIyME5UnKm7XG684U+Z0u6d9ui/Dbsr+Z5To8GrXnw4+IM139mme3mtZLRbuF2hnMchkETR7nyz7gQikjdKnQnhfCdja6e97b28ZmtIrmSCE/2gibEix5kLRFnk3GbzCckBlJ52Gn+FtSMfw+tNK1a1Ml1d6hFdpvizFhgsSxv5kbLmPMJJCDIBYDKM1FjZadBdTWsKJG3nNe3KhftcmWRpSvlRqCE3SbVO7naQEJAoguSSh5fqcmJqOvet5pfcrGnqZs9N01Lm+hazuJ4jKZrvT9Os/vDhQ91IHOCedgzwcgM2S29tUvRaSLazzacsjq80N99oxMdu0FoYwigAk4bjcRjBdmZk8k50k3Wh3UNzeO6xsZ9HCxtuBI3CR5PnGOx4G4sFxupj2TPDZ2+rxJJCu+S3i08Mk0gCqCS8LyBYy2NvXgjaem3c4z0f9nxdnwh0FNjIyNcoytnIYXMobOec5B616LXmn7O3lx/CuxtIi5Wzu723JfO44uZSM5AOcMOtel0AFFFFAHz7+0XHLD4iS4Fu01lPpZtrwHJDRr9puQuFG4DNvuLAjASut+BH23UNCsNQ1A27wWmmQWWnvb71Uw/xAhueNiAE5PB5yWFc9+0lp7XWu+EXiMil4NSgmMaBi0bwBCMFlBIDtgFgMFuRya1v2dNZe70zV9FnlgkutGcQ3DQHchd57lgUcHDIU2bTx0/EgGN8cLnTNb8a2eh6lDeSpp9qLgNb6gtmqmUkPvby3YjasXTCgM5Y8CsjUdVjs9Ft7OSWKOVX8mCGdRehJGA2jzpGQ7cAEEJhsYBI21Y+L+own4gasiPcOkNnAjmC8kWMT8lEkijQs5AO7G4DsQaxBqVxaJbf2OdKuXRnVY/7LubmWJDgmRgPnyCVALOE6kdcAA1LO2N5LctMLOx01JMpOrxSNIxJLqTtjwCMEoB8udvAPGj4F0+UeNPDPmSX0ix39xOjzaa1sAn2SUYDGRiuCygpgZyCQMYrE0Wx1PVJ1fUJDADCJPMsysZLbc5+aWPy1b025zwc4LV1Pw7gnvvjM7Zu307R9D2xG5uzdSJLPN/FIZHJLCNyOenHAwKAPcKKKKAJoM7OeuakqOD7h+tSUAFFFFABRRRQAUUUUAVaKKKACiiigAoHHTiikoA8f8AjJpqf8JloN4qak8t3aS2zCz1M2Z/dyI6seCH2rJK2ME8ZGME1xEWtTf8JRa2C3l1HeLC0u+/nll85S674Y/MEREoEeSzAhAGI5Jr0r9oPQf7V8FQamkPnyaHeRai0X9+JSVlGdrYwjFs7TjZ0PSvNbu30m703U1ttQWSfymmtXjhmYRyx7mEglMSKGBeRuACC6HIYrmKkeeLiXTnySUjevYnF/HfyJuktZvNN5MLczPGGlSVVKqCAAzSHqx81wMMxAzvNl8PeLdJ13SwEeRksrnfOqGdfMKR+eckvwGTdgsDJvfAh8sUfD91qcii5FrqIspWHlQ3LSO8cJRhI7GS4ZDiRxnf84AIK/KpVvi9lXwrr8UsOpWqR2LyvJMxPnsqKVjZyHLFdyBsOoLF9uSrFfMptwqKx7NVRqUnc9b0/wAVeDtWvLPW5NSNpdzJ9kNpdZieKXbuZZEx8siB2UnOBuIz0rY0zw7plxp9vLZ6jNeWTQxJbyRyRMnlo4ddpRcEZXrzn1714TpOjy61qsmuPcLHfXtsjX0N9ZTIbgMNhV3mBjGEZ1zsZQMg5G1h2fw61vWbfxNpUEtuyW+qSyxXschVvs+yOVkI2kKG3xtGSBtb0XCZ9CVlJJrc8+FepyXjN6W/Db8z1CXw1p8s2pySCUm/C7xv4jIwcp/dOQGPqQK5/wCJdtHp/wAL/EsE9+SLu1e3ElxCp5kGwKFjCDv944A6sQoOO7rzL4zyal9q8JwWE8MUD6hvlDw+azOoATaNrYI3O24jC7cnpVStBOSRmqtSranJ3Wn+X6HiHh3QX1LSNR0XV3SdA4kT7DLBZugm/eBYllaPBDmXcDx8i8MNtaGk+IPEIneO5tLyGM3QiN7LClw73cbZkXzkZNikSRFNhKbFJGQGw/wlPPbWEifZ7e5itZpYFngsbdvLIYY3PMrM28MWGwFm3DaOpNbxXc6ta6tZ6Tol1Pb6TqU0FxcWotlhlguI5YQksczbFV2GxAVfhVIIzgVdk9TC7Wh2Obtg2oywwXCrG6o97JGJIGk2CR1e4lVxlR0DD1yTiq8Dpp9k8hgd7i4yy3C6tYeWreqxtPIWYf3wS+MDPGKntoEuYIotS0y3urmBDcXly0tq0k2CCrBndwHzzkMWyOo4zpJNYQG4+xaNeC72GPdP5JRWT5lIaEEMfmbAyTnHTNMR13wXRrfSvENm5nY22tTLvnmEzyb4opdxfc2cmQkZJOMZ5zXoVeVfAu9SSXxRZiIQTJcwXMkAiEYUvCse4AKoAJgPAyOOvNeq0AFFFFAHlv7RVndXHgazuLKLzza6lAZIdm/zEk3Q425BY7pFwARXn3w3vbLwp8TVu4I7y107Wj9iuvtMv7lWKBoJVflSCUcbW2EeeuN2K9d+NEAuPhpq4MqQ+U1vceY6swXy5435CkEj5egOfTmvCX0rUNf8H6u9/aac8lzsijtV0xrKWYRuhTMjYCrnqd4+UnlSpFAD4dHfX/FviDWy0kn9o3BdTbXttEYkfa0aruuF3koFDZA5BGCQa6rVItPs5YJL3TdY1kTsFmtpWiuBOdmc7DGsQbIZSNwYYUrnORn2PhaW3mvXFjcRpHGxSKbxLHHuJJz97fzjg7gB83fmugl0bTNLto7qHTrWwkaOWObydQhuV8lgcnaoWRycDCqrZHAXJGADEvhfzalE7i2t9MdhPbRzR2xkgZmLOzAOGBZ9pbCc+uSFrrv2ebazurDxJ4hs7f7ONR1D7LEqhFXyLZAiHCogyWaUk7QTnkcVxkNnDp+ipf6PJfWawwG8Nwmo7FXKlnxE7pOVO0ZDOcbiMY5r0v8AZ+0W40T4TaGl/wCZ9su0a+mMhyxMzFxnJPO0rnPOetAHoffNLUazxNcPAsimZFV2TPIViQDj0JVvyNJdXEVpbyT3MixwxruZm6AUXHyu9raluD7h+tSVU027hvIXa3fdtba6kFWQ4BwynlTgg4I6EetW6L3BpxdmFFFRmaMTiEyJ5xUuE3DcVBAJx6ZI/MUCtckoqMyxrOkJcCV1LqvcgEAn8Nw/Omm5hF4tqXAuGjMoTHVQQCfzI/OlcfK30JqKKKYirRRRQBx3ivxlNoniTT9GtNKN9NdW8ly0huPKWJEZV5+Viclh/k1mD4iymGOZtNsY4TH5kkkupFFjAUsSWMWCBg5YHHQ9CKy/iNbSS/ErR5fOSK3/ALMngkySGbe4xsboG+Vic54B44yOW1QwEz302nzbDZSNLcW/lx7VwmFldnbcypHCfmHl4U5BAVF46taUanKmd9HDxnS52u52o+I2rGDzW8N2cXI/dy6wN4UlsyfLEwKhV3cEsQThSQVqKH4najJdLbnRdISRw+wnWmIcoWVwu23JJUqAwAO0succ45fUfstq39ty2a2vmbop7uSQK4j4cAS7+I/m3ZUthcHCsCKm3rMjLcwuYXjX5YowzMxUAsXXKkFtr7FAIKl842rWf1mp1NvqdLdXf9bvY7vwv4ql8UalqWh6xo8Noq2MVw+y6aVZI5i6FDujjIIKMDjPQ/j5F4V0vxFo1zq2nXegXOuXunzvZzXpMzGdBgwlv3+HBjbdt24AfBIwQfQvhtLKfHerRzKiv/Z8MjiJiY9+9lJXcAeQq8HptA7CsD45eHbe18XaR4hY2MUOogabdT3lq06RyKGMJwpBAcF1OM52xrgbia7aUnKCbPOrRUJuK6HFeHbC403Vta05otRthZJA8aRJHFLFEcFoiGjLeWW2nLEKqtgFeQanisW2mWniKzd9MjDwxwqLONo5LZETIWT5uXaNMj5ACiMcbcJW7H4e8PeUllperWtlrcrqEbSriQR3kkeTCZI2j2yRjqw3ZIDEEZNYmp6tL4j0qTQZLic3xhjS/tbWfe6MDIskSM02xmOFYo2cBWILth156lOSqXWzOmlVj7JpvVHZPfWEcds9p4k1GQOQ8ptdTiDsCqr5kiyWa5yqAA98DHAGM+WSHSvE8Gr6YbpnQw3cYv54pDeXDZDiIwqU81oomgxxneT85QVT8PWXiC9syt6uoSXcUjyzXN/p1msas/UkrIeWZFJJwScHnFWLGDVNO8XQLC9vHaGxMs4sLRkaUl1SMr5LFHkL4ADY3AY5JyNq11BtHPQSc0nsz6NtpkubaGeLPlyoHXIwcEZFZHjHQB4j0OWyjvJrC8UmS1vIcb7eXaVDgHgjDMCPRjgg4Iu6DZnTtC06xYKrW1tFAQvQFUC8flV+tGr7mSbWqPkue0a58ST6rNe2Gn2k7CG4xbW85hu4huCtI5OX4d8OQyhMEAiMv3f9k6hrnhize3+1at5E/miSCFSBnBCqqskeRncWwGO1e/XqfGfwxbUtTubrw7NFppvhK1y0U0lvKs0iMrSI6g8MSjOmAHMa5PLZ8ms7f/hG3fQ/Edpp0OpQSbpI5if9Ii8zKvGXlOUYhVB25B54YECaacVyvoaVGpPmXU2fstlo2qLDq1t5E7DyorK6U2s+xQD1h3Axbi3yr8p6kdz08Om2Wmpa3UWkK8IieQ3mn2U0UiY+aJvOmViwClhv+UfMTkZ20y4udY1DS7S40TWpPtWT/o+mF5mmYlsF3kfaI1VWBUcjqecAYE+jyxtFNqGhw2M0Cm78y9toRLxt3NiPcUAZc7gSckZYY4szKmoG8sPFkmoRrdLq/wDYYPmNePNLA0TNI7ORgoMSxqE5VjgEMCSfpK3kMsEUjKFZ0DFQ2QCRnAOBn8q+afGEcwTw3qkjXL2kk76fJazLKvkGeF0VomESovKKAQTklemSa+k7GOeKyt47yZZ7lI1WWVV2iRwBuYDtk5OKiKam/kaSacIr1MPxkfE62oPhVbBnx8wuM78/7H8P514gtz4xbxzoy66b1rv7ZEY4rkmOJjuHTaCoHqVB4r6SpGVWxuAODkZHQ1lVoe0d+Zo9bLs4WCg4OjGV01frr59jzj4t3mtp8N/EDXVjaW0a2xc3FvfM7R7SCGAMacggdx9a8d0KVNItmGnvrNikiMYxfXlmACWBLhWgQHjIzjHzdcjA91+NL+V8KvE0mcbLNmzzxgj05/KvI7eSaVIrjQ2un0qNw091pt/EI3divmHLjf1IztHXqSeBtyvv+R5vtof8+1/5N/8AJGpZ6gNPsrmHX7CeeJwA41DVBBG6kk58sHbwSBuGOgUdMVjSvfjxJObTSzp8m4OINJtxHcr5nyRO0pMrB8AjcVAbH3RkmtSPUNQ0uSW6vLjV4bFWBgZr62jM3AO/cYmZ87gBgLgD5sn5jBfW0kyadfrpsJu4JgI+UNx/skK7o2791jKsPlJIXgFTlff8he2h/wA+1/5N/wDJGdq1xH4rNh4ft7ZdS1G9nMRmu72O6u2gBLy42MiKRHnazAAE4HLZr6J0u8mnYxSaRd6fEijaZWh24HAUCORiPyAry74aafqGufEfUfEGoTGTTtGgbTLKMT+ZGJ5NjyvH7bPLUnqxJ9MD2KhJ9xSqxasoJff/AJmG63dr4ou7pLCe4tri0t4RJE8YCsjzFshmB6SL0Brl4vDeovptzBdQXMt28ASZy0IiuZBIjb8g7iflYgsBgEj0r0SipdNPc6KWPnS1ilfTv9nbqY3hvShpusawy2XlxXEyyQzqV27PKiQpjO4HcjHpjnrVO60bV5LzUILaYw2iJPPYzGXkTyoQAQOcIxkb0+dcfdrq4PuH61JT9mrWIWMqKXPo3ZLXXbS/rb82cJYaBdFrdHs7qO2NzE08EzQiMqscoYgIx3ZLIGzy2BxwalstDu4LvT5p7FpDDb3VurCRMw5mzEeW6bOOMkeldtRUqkkaSzGrJ7L8ezXfz/I4VvD+pQ6bp0VmkqyDTpFus3Jy8xa2JXcWJyVjkAYcD1GaXUtFvbjc2kac+mx/ZmQxF41JzLCzKArEDciOPT1xmu5oo9khrMaqadlpd9evfXUxfCllJY2M8bxXMKvMXSKfyhsG1RhVjJVVyCcepPrRW1RWiVlY46tR1Zub3ZVoorntHvb270q21q4u4I7WaH7S1uYwqpGVLAb88EcZJ44PA7DdtBwpOcXK+35u+n4EHiTwvLrGqpeRah9mAgEDR+XIc4fdu3JIhHp9M+prIu/h7NLdx3Vtrj2kyAbWjtt5U/KTgyOxAYqpK5wcD0zWtD4sLrIn9nyPcrLFEscbkK/mbtrBnVePlOeMehNS3mv3S6Vql7FZhILKKbdIZAzCSNCWwmOVDArncMkdMc1k/Zy1audKw2JhaO3zXX5nMTfC+4kjCL4q1GAgxHfBbwq58s5XcxUlhnJwcj5mAABxU1r8MvLeU3fiPU7lJLcWzwmC2SKRApUB1WL5wFJUA8AEgDmulm8RiG+kjltStpHctatP5mTvEXmZ246YGM5zntUTeI5PKi821NtJK1q8Y3iTdHLMsfPTDDdz1AzwTR+7XQPYYmVvO3Xv/XyF8M+E7bQdSvL6O6ubme5iigzNs+RELEYIUEk7uSxJ+UdOc3PF+hW/ifwvqei3e0RXsJjDsgfy36o+DwSrBWHuKqadrVzqGuWKrEsWnXNpcTxnduaTZJCqsRj5eHbjJ688iujrSLTWhz1qU6bXPu/82v0PlfRJ0tbWFPEkV9ZpHHsljvtMsEgaZSI5QG4dgJFcE555IAwBW9F/Z1lLcXUVv4Tg+1TSXW281mWGVSHeTOzBBxkt04H0zWl8V9F07wj41TxJcTXMWm6+4gulVR5cVyqYVz86ZDoGyM8snfPFWK7lvILaU6pBHaiVZoEuzFHkK2118sRPGQd2OHJXA5X5hVGJjW1vPf6h/Z0F5MgikniuLmyvoLkbyVHlxxyQqGzsQbARgrzyAT2Hg3wVBe/EuC91RdXik8OWcT20F3DHGrtK0qhgRJIxUGNiASOQOwGaEC2t3NPZ3upC9vYLhBLpthb28rABwgw/kWzjDZBAZmwMeoPS/BDZNqXi+4gtIraCO5t7SJY3dhtWLzcHe77SDOcqp2r0GeSQD1WiiigAryj9oewjuNB8O3rJsls9YiIuUCebErRuMKz4xucRDGRk7eRgEer1jeMPD1n4q8OXujajuEFyow6MQ0bqwZHBBByrKp98YPFAHjdtYanLZW8V/El1dBiDbWgWSSKN+Dkv8gIwQQNp65yoJFfS7cR6nNLNcG2sN5M9uz+SXwm1Y1UIWkC5xyygDaTkHNY+mte6FreqafrdxNpepQTpaR20OoeZa3JYq5mDzu7qNrpjgsFYL97JHVaUBe2dzcQR216ksMcbX1pqTqkRCoEj/dtHhflBBX7xbO4gkUAYPiuSe4024nv4ZrXULB0vox528yPEfNTJZtnJjA2ABvm4yMCvo6KWKeFJrd1khkUOjqchlIyCD6YryCKy3WUs/n6rbaLF5iLvt7aWIxlR8gLFtuWbG4cEpgE5rsvhJKp+H+lWizrO+mq2nOQwYjyWKKDj/YCH3BB70AdhRRRQBxnxlCf8Kq8VNIwULp8rjORkgZC8c8kAceteS+G9R0vU9ZtruGDQJUiDh7m/uL2a6SUgbvmLybMk7SCxO3J+7gH0r4738Fn4AaCee6gN7e28Cvaxq0nyv5zbdzKo+WJuWIHbvXGadrdlFaLBHrmq2fkbXSG4tordnJXldynAA6njvkb6ACLRNRn1RtT0zTLi4s9jYbTljMRf5g2PORZGPTPXkkAjHOV4xmh0C2trzxLPqJtIrY3EyTWKJ5soVsBmJWQyb3A+UhDvzmtHT47+8uLiCyj1KzlkHmBbfbPPdAZ+djIoVVZT03JgbQoUEZdpWlvr/wAWLXSbtdRks9M261fxzDbH54OLeMkSOThi7bGIA2EDK0AenfDHw7/wi/grTtPkJa8cNc3bsgQtPKS8nAAAwzFQPRRXVUUUAFFFFAE0H3D9akqOD7h+tSUAFFFFABRRRQAUUUUAVayf+Ef03Dr5DmJ94MBmcxfOCGxHu2jIY9B3rWrmfFYEmqaPFJZyX0TmbdboVw/yDGQzAHHuaidkrtHRhueU+SMuW9/wTfdFy10rSUvpY4lkku4jDM5lnkkYY3eWSWJz/F/nFTXGg6fcG782GQrdq6zRrPIqPuXax2hsZI4zjPvXMf2Lq0cCx3FsLwPDaRTnMcjHYsm7aJCFYhinLdQSeTxVDUNN1Cy8PXEmo2s0wismSBjJGTasJZDuPI5KGMArnG0jisuay1ieiqDlP3a+rst9fzXX+rneHSrJpC5gBYz/AGk5Y/6zZs3df7vGOlQQeH9Nhi8tIGKbomAeZ22+U4eMLknCqwBCjj2rHlstXOpJFFFKka6hNcfajIpQRtbyKo27txw7Lxjtn3rMtfD96unPHNbah5pWLzUVrcxzOrZLEbh5me5fBIx36U5f3TKNJ21r226+fr03/wAjr7LRbCyuxc20TpKqui5ldlRXZWYKpOFBKqcAdq0azvD8VxDo1rHeQxQTquGjj+6vJwMZOOMcAkDoCRWjWsbW0RwVnJzalLmt1Mjxb4fs/FHh2+0fUl/cXUe0OAC0TjlZFz/ErAMPcV4PpV1rK6jdaOukeGxqunolvqrzSS2Tb2+46yJGQQw2urAg/OMqvSvo+vOvi54MutZsBrHheC1HiezX5BLCjLeR5BML7uD0BXd7rwHY0zI8zCC8s4m1SbSp4hukEr6297JEnWTy4phHHIxBGV+Ybdvy/wAJbomrxeHfi6bixuJ7dL25Mc9tJZ/ZRcQLBCrsUC7CUKeYCCnDMRncVNXR/Fnii70qANYx6nZtOEzYaHIr2/lthgPKjO1887TtK8Z+8MS/YNe0q21sap/aLx6tMJXvJNONv5RWJgYy5cLgBY8M3GEdNpZhWdVuMbo1oxUpcsup9MUVyHw58VXHiWzu49RsmtL2zcAnBVbiJiwSZQeQrFHGMkZU4Zhgmp8V/FWo+GNHjfS7NmeclDdsAUgPbj+8e2ePr0pyqRjHnexphcLUxVaNCn8T76HYfb7U6l/Z4nQ3vlGYxA5YICBk+nJHXrzjoatV5B8A4p7t9d1q9kknnmdIfNc5YnlmyfxWvX6VKbqR5u5tmWDjgsQ8OpX5bXfna7Pnb4sifR/i6Zj9qEGpWKSx+VbG6jZhiKTMZ43ARw4YcjevrkWWbVL1bZJorG7htpGRrSe5+y7ECkeYyLJtLDKsd26P5sg5FeueOvC8PinRxDmOLULcmayuHQOI5cEDcCDlD0YdccghgpHh3hfW7KWXW4JoFluYIXtp+fsSRyq8isFYb1Kbgv7z5TgZKj7taHAdFpzTWd6ySW4ae2QRmfUGeaNsNyAGU4zkjcMHj5cjrufCGSSz8VeJLE3lrcwXyx6mq26ooim3NFKm1cDosJzgZJPU5NcnM3la28Xm3Lbi4SGJSYXG07EjnYujMAFLN1GcBV4FXfCmspa+JdA1KKe4ImnXS51uBkCOZAAqSEDeRMluC2AODjhhQB7tRRWJ4215PC/hHV9bkQOLG2eZUJwHcD5F/FiB+NAHkPxav7vxP4sGm2Vlqt1ZaPKFijihlSC4vtm/LTDCDYuBhj1LjuCI5La8l022t7WDX7cqFtmgQOGAPzF1IlXBDfKOcEf3TxXF+C5dN1cJrFzdz6lfNJ59zPBaSQosjtvKllO4jcXycYYFc9BW3c63DJDN9ptCW3ySfaL23jaEZIVWMjxAruwSNpGGBHzcggHQXb3FtaXlxqMc9pZQ5nu5JnWA7VQsWXZy7fKcqXZgevIAbuvg3ok+m+FW1HUURdT1qX+0JgOTHGwAhi3Y6JGFGOgJbHqfKfDun6d4x8R6d4bQrJpswe/1SK1uisbQxkFYzGq7BumMXRshQw96+kQAoAUAAcADtQAtFFFABRRRQBNB9w/WpKjg+4frUlABRRRQAUUUUAFFFFAFWiiigAooooAKKKKACiiigAooooA8x+IPg5rbUH8S+HbBbiWRt+rWKxmZ7qML/rIIywXzxt4GQGychmCg+aapr3h7WNY0rU49P1mxkgla4iVYYztcKFLNGFkBYFjy2GVhwVINfTNedfEH4dSazLd6t4U1GTRPEU6oJJI5Gjhu9hJTztmGyM8OORgZyABQB5Vo+s6pZapp1w37jVpGWCxvYvtH2Sbcz4inVgDjaU+U72ZlJDry6euafr9n48vIdOWMw29sBcahazEEuwxtjHZ0DEFmGRwoP3sV4dZ3V1dbtL1C0vra/wBxguLO4nWGRZixKuAXMjKAzDzgOWBO4cA6GraN4i8PMk9k9vdXFu/2hJ7SwuVuArAgrHLHtQ4GMRkqrBMN1AHPycsuWO3U74VOWHtp/FtH9X8uj7+h9IaPpFho1s9vpdrHawvIZWSPoWIAJ/QVfrzT4bfEYa8LW01OKVXuAwtr9kCJOwZh5Lr/AATgLyuApIJG3IWvS62i1bQ46jnKTc3dsK+efiR4d07wd46m1ea7ksbTXWke3aBJJjDc4BcFA6YUlmfIOWLFTtGC30NXFfFnwdp3i/wu66gHWfT915aypj5ZFQ8MP4kPRlyCR0IIBFEHmNxbJe6JaLPcXV7dmdm824vZ4TCChOQoZgXwoBBbAJJ+ZsZgu4INa0YW1nqGoWesEZjlkSSGGzl6ptJZm3ggsMEEbRuCk5ql4C1TTTYiZLKTS5r60R4xd3qPGq7FK4cc7csx28H5hkZBNbupaNHNDcvp5Nnb3D7ZJpXx5pJVvNQRkbQdzYUKWbLknLHcAev+CdXm17wnpWpXSLHdzwL9pjXoky/LKo5PAcMPwrz348aybhNO8LWsQuGupUuryNblYmMSkmJQTluZVViVBIWNumRVj4MudO1bWtFj1BdQs7hY9VtZUR0CbyYpVAcDC741cYGD5hx6niZZrrVtV8V6ja6m503U7l8JBqk8X2hEPlLhUhOFaNBypIOOSeFUA0dNt7LSbeaKV7sTGVVijScysmVaMl3cqPUlSuBtViAOKbA17pGnTzXlzZ21kjy3D3IMQ2nbkmRVaRjgkAKWXaOAOABe8/XLDT7qbQ7m4hMMTxzT3t1LdSlwBtaNZiX5IOQEyxyACa57wvoVx458UJp9zBY3Oj24iudXuri0RpZQrEw2ys2ZF3EO7An7mOfm+YA9R+D+hXmn6DNq2sKE1XWGFw0IVQLaAZ8mAbQo+VTk8D5nau+oooAKKKKACiiigCaD7h+tSVHB9w/WpKACiiigAooooAKKKKAKtFFFABRRRQAUUUUAFFFFABRRRQAUUVg+JJpLqSDRLJylxeAmeRTgw244ds9ic7V9yT/CaUnZXNKVN1Jcv9JdWc9q3hew+INydR1DzYoLN9mmTw7d6srZabDAqwLKAFYFcLnHINeO+KdD8VeGdQSz8SXNrc2E83mQaiYFisQACFWZjJH5TqcFVYurEjBJXB+nbeGK2gjggRY4Y1CIijAUAYAFFzBFdW8tvcxRzQSqUkjkUMrqRggg8EH0pRVkOtUVSWmiWi9P61fmfLcWgwHT7u/ttet9OeaZJLgCzmuJrmTbJmfzUeUK2WlAlAYglGyCUY+o6H8U7230uCTxR4evkCkxte20kDCcK23zltzIJgpGG2hGIzxnjJ4s+GV/9tgu/COptFbxxrE2lXbI8exTwsUssUxiUDIEYUr0xtxXGrNZaW8cGreHNO8OX1xJ5SnW7nZ58x6uPIiSNwTj5g/PoOTVWM73PeNB1rT9f05b7SLj7RbFipJRo2Rh/CyMAynBBwQDgg9CK0Rwc18+wrZG5iu9B8TTQX8imCS38OfaVW+li2qSBMk6OEyoBAAwTuYjGNDS/iprmh6fFD4mGkXE3zrHLqN0NMnmwWx8io6EnAGRtGWGcc4BHnf2NfAvxD8VaBaOljbicywbLaZ1aGQ+Ykf7uOVsKpwGAH3W6HOeyTWWureF4ZbtLO3f7TIgmuZCW6grBLHJwpVTgxcE7wu75lr/ABCum+Imm2t7/wAITqGm6rbn/RtTlniEUvlvvMJcHLxHBOTtCnJB6g5Nj4msp9Oimi8LnThakyRRyXJugSGb5Y5EKZYtkZzgEYbPNAHc/DDV5Lr4gXdql5Yz3J0h5rYxmBl3GdQyu0KjldqfKeQDwFyVHnvw/htbLRIpriHQnltUWO7gvLITz+aqhciSTcGXG8/IQpHccb9zxLrOl634dvmjvL37TbzrJC0LIfLjcgTRw8bUd42mA3gk7/mA6jndP1HU7+5u9N0LRrjUdXaZo47J/s87aYERAhdwpSNThVBZxgg/L8oyAdne6jFb6bp1tp9np51rU2jttOsY1tE3SHcQ8sMcbEQIAHYkgjOATnNeteAfCVl4O0BNPsgHnkcz3dxtwbidgN8hHbJHAHAAArE+Fvw9i8IC81LUBZTeItQ/4+ZrWLbFCmciGHI3bM4JJ5Yjc3OMd/QAUUUUAFFFFABRRRQBNB9w/WpKjg+4frUlABRRRQAUUUUAFFFFAFT8KWrVFAFWirVFAFWirVcDo/iy+uNBu76Z45DBpA1CQi2aIxSFCwUBj86nDYI4+XrzxEpqLszooYWdeLlDpb8djtKKzE15n1SCBbXNrNdyWSz+Z83mJG7t8uPu/u2Gc5z2xzWHZ+K9R/4RuxmltInv5bO0uFZpPllEjojEgAbTlsgDI5HoRSdSKNI4GtLZduq63X6a9jr6KivtQNjbWs1zCQJZY4pNrZERc4BJ7jcQM++aw7nxjHGqmCxmmJR5toJy0QdlVlAU5LbSVBwMdSKpzitzOnhatXWCubGo3kGn2M93dPsghQu5xngenqfas7w3ZzpHPqOoIV1G+IkkQ/8ALFB9yL/gIPPqxY96cNdF3ex2z6eGtpLp7WN5HGTMiNKDtxwMIec5BA471BoXiO9v7XRBPpwNzf2i3btFKAiIdmWwef4+ByeOveo54tm6w9WFJpK199Vtq/0d/RG/RWN4e1+fV7eze3tRKht4JLmVnEZVpIw+FXnOAwJ5HXjNZ2ieMHnsdKWW3kuZ5La1a6kjU5DyopyqhSCBuDHJGB0z0p+0iR9QrXkktVv8zqqpavpWn6zZNZ6vY2t9aMdxhuYllTPrhgRnnrWvRWhxnlHiT4NeHtSsXh0ia90N/LEcYtZN8KgFiB5T5AXLsSEKZ3Hnk55G2+F3jrQLVLfwzquh20SSiYvZmWykfCsCCu2RWJyuCTgbcYxjH0LRQB82aT4e8dhVn1jwhctqUbmVJbe8sXUOSdzAtIr5Py9WYfKMg4qaPwV4y1fUpHvNGmtC5DK97dW5iQqPlGEkmI75ITJJHPLE/RtFAHh2i/Bd5X2eJ9UifThvBsdOjMXnKxB2yTcHbgAYjWIH9K9Q8N+G9F8MWRtPD+l2mnW7Hc628YXefVj1Y+5JroaKAKtFWqKAKtFWqKAKtFWqKAKtFWqKAI4PuH61JRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWTJ4d0uSyitGtf3EVo1iqiRwfIK7ShIOSMAdc889eaKKTSe5cKk4fA2isPDw/wCEgj1EzqsUUzXCQxq4zIYzGS2XK9GboiknHPXNr/hH9M+yR232b9zHbpaoPMbKxoQVAOc5BAOevHWiikoR7GksVWla8npZfdt+ZcubG3utOexuEaW2ePymV3YkrjHLZzn3znPOc1Vm0OwlW3URPD9ni8mM28zwssfHy5QgkcDg0UU7J7kRqzj8MmvmSx6TZRyROkOGiuGukO9uJGRkLdf7rMMdOaZp2jWOnNC1pCyGKMwx5ldgiEg7QCTgfKuAOmOKKKOVdgdao1bmf3/13Yy10DTrRrc2sMkP2eOOJAk8igqgwgYBsPgd2zTYPD2m2/2f7PDLCIIo4VEVxIgZEGEDAN8+Bx82eKKKXLHsP6xVf2397NaiiiqMgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In patients with carcinoid heart disease, distinctive lesions, termed carcinoid plaques,&nbsp;develop on the right side of the heart (tricuspid and/or pulmonic valves); such plagues are occasionally found on the left side of the heart.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Roberts WC. Am J Cardiol 1997; 80:251.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30211=[""].join("\n");
var outline_f29_32_30211=null;
var title_f29_32_30212="Crohns disease of vulva";
var content_f29_32_30212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Crohns disease of vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 256px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Ridley, CM, Neill, SM (Eds), The Vulva, 2nd ed, Blackwell Science, Oxford 1999. Copyright &copy; 1999 Blackwell Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30212=[""].join("\n");
var outline_f29_32_30212=null;
var title_f29_32_30213="Calculator: WHO Assessment of Malnutrition in Boys 2 to 5 years Old";
var content_f29_32_30213=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"WHOGrowthBoys_form\" name=\"WHOGrowthBoys_form\" onkeydown=\"clrResults();\" onkeyup=\"WHOGrowthBoys_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: WHO Assessment of Malnutrition in Boys 2 to 5 years Old",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"      <tr>",
"       <td align=\"right\" width=\"50%\">",
"        <center>",
"         <span class=\"medCalcFontIO\">",
"          Input:",
"         </span>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Age",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Age_param\" onblur=\"WHOGrowthBoys_fx(); minMaxCheck();\" onchange=\"WHOGrowthBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Age_unit\" onchange=\"WHOGrowthBoys_fx();\" style=\"width:105px;\">",
"             <option selected=\"selected\" value=\"1|0|mo\">",
"              mo",
"             </option>",
"             <option value=\"12|0|yr\">",
"              yr",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Height",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Height_param\" onblur=\"WHOGrowthBoys_fx(); minMaxCheck();\" onchange=\"WHOGrowthBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Height_unit\" onchange=\"WHOGrowthBoys_fx();\" style=\"width:105px;\">",
"             <option selected=\"selected\" value=\"1|0|cm\">",
"              cm",
"             </option>",
"             <option value=\"2.54|0|in\">",
"              in",
"             </option>",
"             <option value=\"100|0|m\">",
"              m",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Weight",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Weight_param\" onblur=\"WHOGrowthBoys_fx(); minMaxCheck();\" onchange=\"WHOGrowthBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Weight_unit\" onchange=\"WHOGrowthBoys_fx();\" style=\"width:105px;\">",
"             <option selected=\"selected\" value=\"1|0|kg\">",
"              kg",
"             </option>",
"             <option value=\"0.45359237|0|lb\">",
"              lb",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"         </table>",
"        </center>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <center>",
"         <span class=\"medCalcFontIO\">",
"          Results:",
"         </span>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"right\">",
"            <span class=\"medCalcFontOneBold\">",
"             Z Score Height",
"            </span>",
"           </td>",
"           <td nowrap=\"nowrap\" valign=\"top\">",
"            &nbsp;",
"            <input name=\"Z_Score_Height_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"           </td>",
"           <td align=\"left\">",
"            &nbsp;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\">",
"            <span class=\"medCalcFontOneBold\">",
"             Z Score Weight for Height",
"            </span>",
"           </td>",
"           <td nowrap=\"nowrap\" valign=\"top\">",
"            &nbsp;",
"            <input name=\"Z_Score_Weight_for_Height_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"           </td>",
"           <td align=\"left\">",
"            &nbsp;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\">",
"            <span class=\"medCalcFontOneBold\">",
"             Height Percentile",
"            </span>",
"           </td>",
"           <td nowrap=\"nowrap\" valign=\"top\">",
"            &nbsp;",
"            <input name=\"Height_Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"           </td>",
"           <td align=\"left\">",
"            &nbsp;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\">",
"            <span class=\"medCalcFontOneBold\">",
"             Weight for Height Percentile",
"            </span>",
"           </td>",
"           <td nowrap=\"nowrap\" valign=\"top\">",
"            &nbsp;",
"            <input name=\"Weight_for_Height_Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"           </td>",
"           <td align=\"left\">",
"            &nbsp;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td colspan=\"3\">",
"            &nbsp;",
"            <br/>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"center\" colspan=\"3\">",
"            <span class=\"medCalcFontOneBold\">",
"             Decimal Precision:",
"            </span>",
"            <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"WHOGrowthBoys_fx();\">",
"             <option>",
"              0",
"             </option>",
"             <option selected=\"selected\">",
"              1",
"             </option>",
"             <option>",
"              2",
"             </option>",
"             <option>",
"              3",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"         </table>",
"        </center>",
"       </td>",
"      </tr>",
"     </table>",
"    </center>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Assessment of Stunting",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"      <tr id=\"rr1_1\">",
"       <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"        <span class=\"medCalcFontOneBold\">",
"         Z-Score &gt; -2:",
"        </span>",
"       </td>",
"       <td align=\"left\" style=\"border-left: 0px;\">",
"        <span class=\"medCalcFontOne\">",
"         No stunting",
"        </span>",
"       </td>",
"      </tr>",
"      <tr id=\"rr1_2\">",
"       <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"        <span class=\"medCalcFontOneBold\">",
"         Z-Score &gt; -3 and &lt;= -2:",
"        </span>",
"       </td>",
"       <td align=\"left\" style=\"border-left: 0px;\">",
"        <span class=\"medCalcFontOne\">",
"         Moderate stunting",
"        </span>",
"       </td>",
"      </tr>",
"      <tr id=\"rr1_3\">",
"       <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"        <span class=\"medCalcFontOneBold\">",
"         Z-Score &lt;= -3:",
"        </span>",
"       </td>",
"       <td align=\"left\" style=\"border-left: 0px;\">",
"        <span class=\"medCalcFontOne\">",
"         Severe stunting",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"    </center>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Assessment of Wasting",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"      <tr id=\"rr2_1\">",
"       <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"        <span class=\"medCalcFontOneBold\">",
"         Z-Score &gt; -2:",
"        </span>",
"       </td>",
"       <td align=\"left\" style=\"border-left: 0px;\">",
"        <span class=\"medCalcFontOne\">",
"         No wasting",
"        </span>",
"       </td>",
"      </tr>",
"      <tr id=\"rr2_2\">",
"       <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"        <span class=\"medCalcFontOneBold\">",
"         Z-Score &gt; -3 and &lt;= -2:",
"        </span>",
"       </td>",
"       <td align=\"left\" style=\"border-left: 0px;\">",
"        <span class=\"medCalcFontOne\">",
"         Moderate wasting",
"        </span>",
"       </td>",
"      </tr>",
"      <tr id=\"rr2_3\">",
"       <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"        <span class=\"medCalcFontOneBold\">",
"         Z-Score &lt;= -3:",
"        </span>",
"       </td>",
"       <td align=\"left\" style=\"border-left: 0px;\">",
"        <span class=\"medCalcFontOne\">",
"         Severe wasting",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"    </center>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <span class=\"medCalcFontOneBold\">",
"     Notes",
"    </span>",
"    <ul class=\"medCalcFontOne\">",
"     <li>",
"      Moderate malnutrition is defined as moderate stunting or wasting.",
"     </li>",
"     <li>",
"      Severe malnutrition is defined as severe stunting or severe wasting,",
"or edematous malnutrition.",
"     </li>",
"     <li>",
"      Patients with edematous malnutrition (Kwashiorkor) should be considered to have",
"severe malnutrition even if stunting or wasting z-scores are not in the severe range.",
"     </li>",
"    </ul>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <span class=\"medCalcFontRef\">",
"     <b>",
"      References",
"     </b>",
"    </span>",
"    <ol>",
"     <li>",
"      <span class=\"medCalcFontRef\">",
"       Percentile conversion from Z-Score is done by table look-up in the standard Normal Table. Percentiles are provided for Z Scores between -3.09 and 3.09.  Values beyond these extremes return percentiles of 0.1 and 99.9 respectively.",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"medCalcFontRef\">",
"       LMS Parameters for Boys: Height for Age. World Health Organization 2008, Child Growth Standards: Methods and development.",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"medCalcFontRef\">",
"       LMS Parameters for Boys: Weight for Height. World Health Organization 2008, Child Growth Standards: Methods and development.",
"      </span>",
"     </li>",
"    </ol>",
"   </form>",
"   <br/>",
"   &nbsp;",
"   <br/>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30213=[" /* <![CDATA[ */",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"n = new Array;",
"var L = 0;",
"var M = 0;",
"var S = 0;",
"",
"n[0] = 50;",
"n[1] = 50.399;",
"n[2] = 50.798;",
"n[3] = 51.197;",
"n[4] = 51.595;",
"n[5] = 51.994;",
"n[6] = 52.392;",
"n[7] = 52.79;",
"n[8] = 53.188;",
"n[9] = 53.586;",
"n[10] = 53.983;",
"n[11] = 54.38;",
"n[12] = 54.776;",
"n[13] = 55.172;",
"n[14] = 55.567;",
"n[15] = 55.962;",
"n[16] = 56.356;",
"n[17] = 56.749;",
"n[18] = 57.142;",
"n[19] = 57.535;",
"n[20] = 57.926;",
"n[21] = 58.317;",
"n[22] = 58.706;",
"n[23] = 59.095;",
"n[24] = 59.483;",
"n[25] = 59.871;",
"n[26] = 60.257;",
"n[27] = 60.642;",
"n[28] = 61.026;",
"n[29] = 61.409;",
"n[30] = 61.791;",
"n[31] = 62.172;",
"n[32] = 62.552;",
"n[33] = 62.93;",
"n[34] = 63.307;",
"n[35] = 63.683;",
"n[36] = 64.058;",
"n[37] = 64.431;",
"n[38] = 64.803;",
"n[39] = 65.173;",
"n[40] = 65.542;",
"n[41] = 65.91;",
"n[42] = 66.276;",
"n[43] = 66.64;",
"n[44] = 67.003;",
"n[45] = 67.364;",
"n[46] = 67.724;",
"n[47] = 68.082;",
"n[48] = 68.439;",
"n[49] = 68.793;",
"n[50] = 69.146;",
"n[51] = 69.497;",
"n[52] = 69.847;",
"n[53] = 70.194;",
"n[54] = 70.54;",
"n[55] = 70.884;",
"n[56] = 71.226;",
"n[57] = 71.566;",
"n[58] = 71.904;",
"n[59] = 72.24;",
"n[60] = 72.575;",
"n[61] = 72.907;",
"n[62] = 73.237;",
"n[63] = 73.565;",
"n[64] = 73.891;",
"n[65] = 74.215;",
"n[66] = 74.537;",
"n[67] = 74.857;",
"n[68] = 75.175;",
"n[69] = 75.49;",
"n[70] = 75.804;",
"n[71] = 76.115;",
"n[72] = 76.424;",
"n[73] = 76.73;",
"n[74] = 77.035;",
"n[75] = 77.337;",
"n[76] = 77.637;",
"n[77] = 77.935;",
"n[78] = 78.23;",
"n[79] = 78.524;",
"n[80] = 78.814;",
"n[81] = 79.103;",
"n[82] = 79.389;",
"n[83] = 79.673;",
"n[84] = 79.955;",
"n[85] = 80.234;",
"n[86] = 80.511;",
"n[87] = 80.785;",
"n[88] = 81.057;",
"n[89] = 81.327;",
"n[90] = 81.594;",
"n[91] = 81.859;",
"n[92] = 82.121;",
"n[93] = 82.381;",
"n[94] = 82.639;",
"n[95] = 82.894;",
"n[96] = 83.147;",
"n[97] = 83.398;",
"n[98] = 83.646;",
"n[99] = 83.891;",
"n[100] = 84.134;",
"n[101] = 84.375;",
"n[102] = 84.614;",
"n[103] = 84.849;",
"n[104] = 85.083;",
"n[105] = 85.314;",
"n[106] = 85.543;",
"n[107] = 85.769;",
"n[108] = 85.993;",
"n[109] = 86.214;",
"n[110] = 86.433;",
"n[111] = 86.65;",
"n[112] = 86.864;",
"n[113] = 87.076;",
"n[114] = 87.286;",
"n[115] = 87.493;",
"n[116] = 87.698;",
"n[117] = 87.9;",
"n[118] = 88.1;",
"n[119] = 88.298;",
"n[120] = 88.493;",
"n[121] = 88.686;",
"n[122] = 88.877;",
"n[123] = 89.065;",
"n[124] = 89.251;",
"n[125] = 89.435;",
"n[126] = 89.617;",
"n[127] = 89.796;",
"n[128] = 89.973;",
"n[129] = 90.147;",
"n[130] = 90.32;",
"n[131] = 90.49;",
"n[132] = 90.658;",
"n[133] = 90.824;",
"n[134] = 90.988;",
"n[135] = 91.149;",
"n[136] = 91.308;",
"n[137] = 91.466;",
"n[138] = 91.621;",
"n[139] = 91.774;",
"n[140] = 91.924;",
"n[141] = 92.073;",
"n[142] = 92.22;",
"n[143] = 92.364;",
"n[144] = 92.507;",
"n[145] = 92.647;",
"n[146] = 92.785;",
"n[147] = 92.922;",
"n[148] = 93.056;",
"n[149] = 93.189;",
"n[150] = 93.319;",
"n[151] = 93.448;",
"n[152] = 93.574;",
"n[153] = 93.699;",
"n[154] = 93.822;",
"n[155] = 93.943;",
"n[156] = 94.062;",
"n[157] = 94.179;",
"n[158] = 94.295;",
"n[159] = 94.408;",
"n[160] = 94.52;",
"n[161] = 94.63;",
"n[162] = 94.738;",
"n[163] = 94.845;",
"n[164] = 94.95;",
"n[165] = 95.053;",
"n[166] = 95.154;",
"n[167] = 95.254;",
"n[168] = 95.352;",
"n[169] = 95.449;",
"n[170] = 95.543;",
"n[171] = 95.637;",
"n[172] = 95.728;",
"n[173] = 95.818;",
"n[174] = 95.907;",
"n[175] = 95.994;",
"n[176] = 96.08;",
"n[177] = 96.164;",
"n[178] = 96.246;",
"n[179] = 96.327;",
"n[180] = 96.407;",
"n[181] = 96.485;",
"n[182] = 96.562;",
"n[183] = 96.638;",
"n[184] = 96.712;",
"n[185] = 96.784;",
"n[186] = 96.856;",
"n[187] = 96.926;",
"n[188] = 96.995;",
"n[189] = 97.062;",
"n[190] = 97.128;",
"n[191] = 97.193;",
"n[192] = 97.257;",
"n[193] = 97.32;",
"n[194] = 97.381;",
"n[195] = 97.441;",
"n[196] = 97.5;",
"n[197] = 97.558;",
"n[198] = 97.615;",
"n[199] = 97.67;",
"n[200] = 97.725;",
"n[201] = 97.778;",
"n[202] = 97.831;",
"n[203] = 97.882;",
"n[204] = 97.932;",
"n[205] = 97.982;",
"n[206] = 98.03;",
"n[207] = 98.077;",
"n[208] = 98.124;",
"n[209] = 98.169;",
"n[210] = 98.214;",
"n[211] = 98.257;",
"n[212] = 98.3;",
"n[213] = 98.341;",
"n[214] = 98.382;",
"n[215] = 98.422;",
"n[216] = 98.461;",
"n[217] = 98.5;",
"n[218] = 98.537;",
"n[219] = 98.574;",
"n[220] = 98.61;",
"n[221] = 98.645;",
"n[222] = 98.679;",
"n[223] = 98.713;",
"n[224] = 98.745;",
"n[225] = 98.778;",
"n[226] = 98.809;",
"n[227] = 98.84;",
"n[228] = 98.87;",
"n[229] = 98.899;",
"n[230] = 98.928;",
"n[231] = 98.956;",
"n[232] = 98.983;",
"n[233] = 99.01;",
"n[234] = 99.036;",
"n[235] = 99.061;",
"n[236] = 99.086;",
"n[237] = 99.111;",
"n[238] = 99.134;",
"n[239] = 99.158;",
"n[240] = 99.18;",
"n[241] = 99.202;",
"n[242] = 99.224;",
"n[243] = 99.245;",
"n[244] = 99.266;",
"n[245] = 99.286;",
"n[246] = 99.305;",
"n[247] = 99.324;",
"n[248] = 99.343;",
"n[249] = 99.361;",
"n[250] = 99.379;",
"n[251] = 99.396;",
"n[252] = 99.413;",
"n[253] = 99.43;",
"n[254] = 99.446;",
"n[255] = 99.461;",
"n[256] = 99.477;",
"n[257] = 99.492;",
"n[258] = 99.506;",
"n[259] = 99.52;",
"n[260] = 99.534;",
"n[261] = 99.547;",
"n[262] = 99.56;",
"n[263] = 99.573;",
"n[264] = 99.585;",
"n[265] = 99.598;",
"n[266] = 99.609;",
"n[267] = 99.621;",
"n[268] = 99.632;",
"n[269] = 99.643;",
"n[270] = 99.653;",
"n[271] = 99.664;",
"n[272] = 99.674;",
"n[273] = 99.683;",
"n[274] = 99.693;",
"n[275] = 99.702;",
"n[276] = 99.711;",
"n[277] = 99.72;",
"n[278] = 99.728;",
"n[279] = 99.736;",
"n[280] = 99.744;",
"n[281] = 99.752;",
"n[282] = 99.76;",
"n[283] = 99.767;",
"n[284] = 99.774;",
"n[285] = 99.781;",
"n[286] = 99.788;",
"n[287] = 99.795;",
"n[288] = 99.801;",
"n[289] = 99.807;",
"n[290] = 99.813;",
"n[291] = 99.819;",
"n[292] = 99.825;",
"n[293] = 99.831;",
"n[294] = 99.836;",
"n[295] = 99.841;",
"n[296] = 99.846;",
"n[297] = 99.851;",
"n[298] = 99.856;",
"n[299] = 99.861;",
"n[300] = 99.865;",
"n[301] = 99.869;",
"n[302] = 99.874;",
"n[303] = 99.878;",
"n[304] = 99.882;",
"n[305] = 99.886;",
"n[306] = 99.889;",
"n[307] = 99.893;",
"n[308] = 99.896;",
"n[309] = 99.9;",
"",
"function ZtoPercentile(z){",
"with (document.WHOGrowthBoys_form){",
"az = Math.abs(z);",
"if (z < -3.09) return 0.1;",
"if (z > 3.09) return 99.9;",
"thispercentile = n[Math.round(az * 100)];",
"if (z >= 0) { return thispercentile }",
"else { return 100 - thispercentile }",
"}}",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function WHOGrowthBoys_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.WHOGrowthBoys_form){",
"",
"",
"doCalc = true;",
"if (Age_param.value.indexOf(',') >= 0){ Age_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Age_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Age_unit.options[Age_unit.selectedIndex].value.split('|');",
"Age = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Height_param.value.indexOf(',') >= 0){ Height_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Height_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Height_unit.options[Height_unit.selectedIndex].value.split('|');",
"Height = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Weight_param.value.indexOf(',') >= 0){ Weight_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Weight_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Weight_unit.options[Weight_unit.selectedIndex].value.split('|');",
"Weight = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"if(Age >= 24 && Age < 25){L = 1; M = 87.1161; S = 0.03507;};",
"if(Age >= 25 && Age < 26){L = 1; M = 87.9720; S = 0.03542;};",
"if(Age >= 26 && Age < 27){L = 1; M = 88.8065; S = 0.03576;};",
"if(Age >= 27 && Age < 28){L = 1; M = 89.6197; S = 0.03610;};",
"if(Age >= 28 && Age < 29){L = 1; M = 90.4120; S = 0.03642;};",
"if(Age >= 29 && Age < 30){L = 1; M = 91.1828; S = 0.03674;};",
"if(Age >= 30 && Age < 31){L = 1; M = 91.9327; S = 0.03704;};",
"if(Age >= 31 && Age < 32){L = 1; M = 92.6631; S = 0.03733;};",
"if(Age >= 32 && Age < 33){L = 1; M = 93.3753; S = 0.03761;};",
"if(Age >= 33 && Age < 34){L = 1; M = 94.0711; S = 0.03787;};",
"if(Age >= 34 && Age < 35){L = 1; M = 94.7532; S = 0.03812;};",
"if(Age >= 35 && Age < 36){L = 1; M = 95.4236; S = 0.03836;};",
"if(Age >= 36 && Age < 37){L = 1; M = 96.0835; S = 0.03858;};",
"if(Age >= 37 && Age < 38){L = 1; M = 96.7337; S = 0.03879;};",
"if(Age >= 38 && Age < 39){L = 1; M = 97.3749; S = 0.03900;};",
"if(Age >= 39 && Age < 40){L = 1; M = 98.0073; S = 0.03919;};",
"if(Age >= 40 && Age < 41){L = 1; M = 98.6310; S = 0.03937;};",
"if(Age >= 41 && Age < 42){L = 1; M = 99.2459; S = 0.03954;};",
"if(Age >= 42 && Age < 43){L = 1; M = 99.8515; S = 0.03971;};",
"if(Age >= 43 && Age < 44){L = 1; M = 100.4485; S = 0.03986;};",
"if(Age >= 44 && Age < 45){L = 1; M = 101.0374; S = 0.04002;};",
"if(Age >= 45 && Age < 46){L = 1; M = 101.6186; S = 0.04016;};",
"if(Age >= 46 && Age < 47){L = 1; M = 102.1933; S = 0.04031;};",
"if(Age >= 47 && Age < 48){L = 1; M = 102.7625; S = 0.04045;};",
"if(Age >= 48 && Age < 49){L = 1; M = 103.3273; S = 0.04059;};",
"if(Age >= 49 && Age < 50){L = 1; M = 103.8886; S = 0.04073;};",
"if(Age >= 50 && Age < 51){L = 1; M = 104.4473; S = 0.04086;};",
"if(Age >= 51 && Age < 52){L = 1; M = 105.0041; S = 0.04100;};",
"if(Age >= 52 && Age < 53){L = 1; M = 105.5596; S = 0.04113;};",
"if(Age >= 53 && Age < 54){L = 1; M = 106.1138; S = 0.04126;};",
"if(Age >= 54 && Age < 55){L = 1; M = 106.6668; S = 0.04139;};",
"if(Age >= 55 && Age < 56){L = 1; M = 107.2188; S = 0.04152;};",
"if(Age >= 56 && Age < 57){L = 1; M = 107.7697; S = 0.04165;};",
"if(Age >= 57 && Age < 58){L = 1; M = 108.3198; S = 0.04177;};",
"if(Age >= 58 && Age < 59){L = 1; M = 108.8689; S = 0.0419;};",
"if(Age >= 59 && Age < 60){L = 1; M = 109.4170; S = 0.04202;};",
"if(Age >= 60 && Age < 61){L = 1; M = 109.9638; S = 0.04214;};",
"Z_Score_Height =  (power((Height / M), L) - 1) / (L * S);",
"",
"if (doCalc) Z_Score_Height_param.value = fixDP(Z_Score_Height, dp);",
"",
"",
"",
"if(Height >= 65 && Height < 65.5){L = -0.3521; M = 7.4327; S = 0.08217;};",
"if(Height >= 65.5 && Height < 66){L = -0.3521; M = 7.5504; S = 0.08214;};",
"if(Height >= 66 && Height < 66.5){L = -0.3521; M = 7.6673; S = 0.08212;};",
"if(Height >= 66.5 && Height < 67){L = -0.3521; M = 7.7834; S = 0.08212;};",
"if(Height >= 67 && Height < 67.5){L = -0.3521; M = 7.8986; S = 0.08213;};",
"if(Height >= 67.5 && Height < 68){L = -0.3521; M = 8.0132; S = 0.08214;};",
"if(Height >= 68 && Height < 68.5){L = -0.3521; M = 8.1272; S = 0.08217;};",
"if(Height >= 68.5 && Height < 69){L = -0.3521; M = 8.2410; S = 0.08221;};",
"if(Height >= 69 && Height < 69.5){L = -0.3521; M = 8.3547; S = 0.08226;};",
"if(Height >= 69.5 && Height < 70){L = -0.3521; M = 8.4680; S = 0.08231;};",
"if(Height >= 70 && Height < 70.5){L = -0.3521; M = 8.5808; S = 0.08237;};",
"if(Height >= 70.5 && Height < 71){L = -0.3521; M = 8.6927; S = 0.08243;};",
"if(Height >= 71 && Height < 71.5){L = -0.3521; M = 8.8036; S = 0.08250;};",
"if(Height >= 71.5 && Height < 72){L = -0.3521; M = 8.9135; S = 0.08257;};",
"if(Height >= 72 && Height < 72.5){L = -0.3521; M = 9.0221; S = 0.08264;};",
"if(Height >= 72.5 && Height < 73){L = -0.3521; M = 9.1292; S = 0.08272;};",
"if(Height >= 73 && Height < 73.5){L = -0.3521; M = 9.2347; S = 0.08278;};",
"if(Height >= 73.5 && Height < 74){L = -0.3521; M = 9.3390; S = 0.08285;};",
"if(Height >= 74 && Height < 74.5){L = -0.3521; M = 9.4420; S = 0.08292;};",
"if(Height >= 74.5 && Height < 75){L = -0.3521; M = 9.5438; S = 0.08298;};",
"if(Height >= 75 && Height < 75.5){L = -0.3521; M = 9.6440; S = 0.08303;};",
"if(Height >= 75.5 && Height < 76){L = -0.3521; M = 9.7425; S = 0.08308;};",
"if(Height >= 76 && Height < 76.5){L = -0.3521; M = 9.8392; S = 0.08312;};",
"if(Height >= 76.5 && Height < 77){L = -0.3521; M = 9.9341; S = 0.08315;};",
"if(Height >= 77 && Height < 77.5){L = -0.3521; M = 10.0274; S = 0.08317;};",
"if(Height >= 77.5 && Height < 78){L = -0.3521; M = 10.1194; S = 0.08318;};",
"if(Height >= 78 && Height < 78.5){L = -0.3521; M = 10.2105; S = 0.08317;};",
"if(Height >= 78.5 && Height < 79){L = -0.3521; M = 10.3012; S = 0.08315;};",
"if(Height >= 79 && Height < 79.5){L = -0.3521; M = 10.3923; S = 0.08311;};",
"if(Height >= 79.5 && Height < 80){L = -0.3521; M = 10.4845; S = 0.08305;};",
"if(Height >= 80 && Height < 80.5){L = -0.3521; M = 10.5781; S = 0.08298;};",
"if(Height >= 80.5 && Height < 81){L = -0.3521; M = 10.6737; S = 0.08290;};",
"if(Height >= 81 && Height < 81.5){L = -0.3521; M = 10.7718; S = 0.08279;};",
"if(Height >= 81.5 && Height < 82){L = -0.3521; M = 10.8728; S = 0.08268;};",
"if(Height >= 82 && Height < 82.5){L = -0.3521; M = 10.9772; S = 0.08255;};",
"if(Height >= 82.5 && Height < 83){L = -0.3521; M = 11.0851; S = 0.08241;};",
"if(Height >= 83 && Height < 83.5){L = -0.3521; M = 11.1966; S = 0.08225;};",
"if(Height >= 83.5 && Height < 84){L = -0.3521; M = 11.3114; S = 0.08209;};",
"if(Height >= 84 && Height < 84.5){L = -0.3521; M = 11.4290; S = 0.08191;};",
"if(Height >= 84.5 && Height < 85){L = -0.3521; M = 11.5490; S = 0.08174;};",
"if(Height >= 85 && Height < 85.5){L = -0.3521; M = 11.6707; S = 0.08156;};",
"if(Height >= 85.5 && Height < 86){L = -0.3521; M = 11.7937; S = 0.08138;};",
"if(Height >= 86 && Height < 86.5){L = -0.3521; M = 11.9173; S = 0.08121;};",
"if(Height >= 86.5 && Height < 87){L = -0.3521; M = 12.0411; S = 0.08105;};",
"if(Height >= 87 && Height < 87.5){L = -0.3521; M = 12.1645; S = 0.08090;};",
"if(Height >= 87.5 && Height < 88){L = -0.3521; M = 12.2871; S = 0.08076;};",
"if(Height >= 88 && Height < 88.5){L = -0.3521; M = 12.4089; S = 0.08064;};",
"if(Height >= 88.5 && Height < 89){L = -0.3521; M = 12.5298; S = 0.08054;};",
"if(Height >= 89 && Height < 89.5){L = -0.3521; M = 12.6495; S = 0.08045;};",
"if(Height >= 89.5 && Height < 90){L = -0.3521; M = 12.7683; S = 0.08038;};",
"if(Height >= 90 && Height < 90.5){L = -0.3521; M = 12.8864; S = 0.08032;};",
"if(Height >= 90.5 && Height < 91){L = -0.3521; M = 13.0038; S = 0.08028;};",
"if(Height >= 91 && Height < 91.5){L = -0.3521; M = 13.1209; S = 0.08025;};",
"if(Height >= 91.5 && Height < 92){L = -0.3521; M = 13.2376; S = 0.08024;};",
"if(Height >= 92 && Height < 92.5){L = -0.3521; M = 13.3541; S = 0.08025;};",
"if(Height >= 92.5 && Height < 93){L = -0.3521; M = 13.4705; S = 0.08027;};",
"if(Height >= 93 && Height < 93.5){L = -0.3521; M = 13.5870; S = 0.08031;};",
"if(Height >= 93.5 && Height < 94){L = -0.3521; M = 13.7041; S = 0.08036;};",
"if(Height >= 94 && Height < 94.5){L = -0.3521; M = 13.8217; S = 0.08043;};",
"if(Height >= 94.5 && Height < 95){L = -0.3521; M = 13.9403; S = 0.08051;};",
"if(Height >= 95 && Height < 95.5){L = -0.3521; M = 14.0600; S = 0.08060;};",
"if(Height >= 95.5 && Height < 96){L = -0.3521; M = 14.1811; S = 0.08071;};",
"if(Height >= 96 && Height < 96.5){L = -0.3521; M = 14.3037; S = 0.08083;};",
"if(Height >= 96.5 && Height < 97){L = -0.3521; M = 14.4282; S = 0.08097;};",
"if(Height >= 97 && Height < 97.5){L = -0.3521; M = 14.5547; S = 0.08112;};",
"if(Height >= 97.5 && Height < 98){L = -0.3521; M = 14.6832; S = 0.08129;};",
"if(Height >= 98 && Height < 98.5){L = -0.3521; M = 14.8140; S = 0.08146;};",
"if(Height >= 98.5 && Height < 99){L = -0.3521; M = 14.9468; S = 0.08165;};",
"if(Height >= 99 && Height < 99.5){L = -0.3521; M = 15.0818; S = 0.08185;};",
"if(Height >= 99.5 && Height < 100){L = -0.3521; M = 15.2187; S = 0.08206;};",
"if(Height >= 100 && Height < 100.5){L = -0.3521; M = 15.3576; S = 0.08229;};",
"if(Height >= 100.5 && Height < 101){L = -0.3521; M = 15.4985; S = 0.08252;};",
"if(Height >= 101 && Height < 101.5){L = -0.3521; M = 15.6412; S = 0.08277;};",
"if(Height >= 101.5 && Height < 102){L = -0.3521; M = 15.7857; S = 0.08302;};",
"if(Height >= 102 && Height < 102.5){L = -0.3521; M = 15.9320; S = 0.08328;};",
"if(Height >= 102.5 && Height < 103){L = -0.3521; M = 16.0801; S = 0.08354;};",
"if(Height >= 103 && Height < 103.5){L = -0.3521; M = 16.2298; S = 0.08381;};",
"if(Height >= 103.5 && Height < 104){L = -0.3521; M = 16.3812; S = 0.08408;};",
"if(Height >= 104 && Height < 104.5){L = -0.3521; M = 16.5342; S = 0.08436;};",
"if(Height >= 104.5 && Height < 105){L = -0.3521; M = 16.6889; S = 0.08464;};",
"if(Height >= 105 && Height < 105.5){L = -0.3521; M = 16.8454; S = 0.08493;};",
"if(Height >= 105.5 && Height < 106){L = -0.3521; M = 17.0036; S = 0.08521;};",
"if(Height >= 106 && Height < 106.5){L = -0.3521; M = 17.1637; S = 0.08551;};",
"if(Height >= 106.5 && Height < 107){L = -0.3521; M = 17.3256; S = 0.08580;};",
"if(Height >= 107 && Height < 107.5){L = -0.3521; M = 17.4894; S = 0.08611;};",
"if(Height >= 107.5 && Height < 108){L = -0.3521; M = 17.6550; S = 0.08641;};",
"if(Height >= 108 && Height < 108.5){L = -0.3521; M = 17.8226; S = 0.08673;};",
"if(Height >= 108.5 && Height < 109){L = -0.3521; M = 17.9924; S = 0.08704;};",
"if(Height >= 109 && Height < 109.5){L = -0.3521; M = 18.1645; S = 0.08736;};",
"if(Height >= 109.5 && Height < 110){L = -0.3521; M = 18.3390; S = 0.08768;};",
"if(Height >= 110 && Height < 110.5){L = -0.3521; M = 18.5158; S = 0.08800;};",
"if(Height >= 110.5 && Height < 111){L = -0.3521; M = 18.6948; S = 0.08832;};",
"if(Height >= 111 && Height < 111.5){L = -0.3521; M = 18.8759; S = 0.08864;};",
"if(Height >= 111.5 && Height < 112){L = -0.3521; M = 19.0590; S = 0.08896;};",
"if(Height >= 112 && Height < 112.5){L = -0.3521; M = 19.2439; S = 0.08928;};",
"if(Height >= 112.5 && Height < 113){L = -0.3521; M = 19.4304; S = 0.08960;};",
"if(Height >= 113 && Height < 113.5){L = -0.3521; M = 19.6185; S = 0.08991;};",
"if(Height >= 113.5 && Height < 114){L = -0.3521; M = 19.8081; S = 0.09022;};",
"if(Height >= 114 && Height < 114.5){L = -0.3521; M = 19.9990; S = 0.09054;};",
"if(Height >= 114.5 && Height < 115){L = -0.3521; M = 20.1912; S = 0.09085;};",
"if(Height >= 115 && Height < 115.5){L = -0.3521; M = 20.3846; S = 0.09116;};",
"if(Height >= 115.5 && Height < 116){L = -0.3521; M = 20.5789; S = 0.09147;};",
"if(Height >= 116 && Height < 116.5){L = -0.3521; M = 20.7741; S = 0.09177;};",
"if(Height >= 116.5 && Height < 117){L = -0.3521; M = 20.9700; S = 0.09208;};",
"if(Height >= 117 && Height < 117.5){L = -0.3521; M = 21.1666; S = 0.09239;};",
"if(Height >= 117.5 && Height < 118){L = -0.3521; M = 21.3636; S = 0.09270;};",
"if(Height >= 118 && Height < 118.5){L = -0.3521; M = 21.5611; S = 0.09300;};",
"if(Height >= 118.5 && Height < 119){L = -0.3521; M = 21.7588; S = 0.09331;};",
"if(Height >= 119 && Height < 119.5){L = -0.3521; M = 21.9568; S = 0.09362;};",
"if(Height >= 119.5 && Height < 120){L = -0.3521; M = 22.1549; S = 0.09393;};",
"if(Height >= 120 && Height < 120.5){L = -0.3521; M = 22.3530; S = 0.09424;};",
"Z_Score_Weight_for_Height =  (power((Weight / M), L) - 1) / (L * S);",
"",
"if (doCalc) Z_Score_Weight_for_Height_param.value = fixDP(Z_Score_Weight_for_Height, dp);",
"",
"",
"",
"Height_Percentile =  ZtoPercentile(Z_Score_Height);",
"",
"if (doCalc) Height_Percentile_param.value = fixDP(Height_Percentile, dp);",
"",
"",
"",
"Weight_for_Height_Percentile =  ZtoPercentile(Z_Score_Weight_for_Height);",
"",
"if (doCalc) Weight_for_Height_Percentile_param.value = fixDP(Weight_for_Height_Percentile, dp);",
"",
"",
"",
"",
"if (doCalc){",
"",
"rrclr();",
"if (Z_Score_Height > -2){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((Z_Score_Height > -3) && (Z_Score_Height <= -2)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if (Z_Score_Height <= -3){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"if (doCalc){",
"",
"rrclr();",
"if (Z_Score_Height > -2){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((Z_Score_Height > -3) && (Z_Score_Height <= -2)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if (Z_Score_Height <= -3){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"if (Z_Score_Weight_for_Height > -2){ document.getElementById('rr2_1').bgColor = \"#cccccc\";",
"}",
"if ((Z_Score_Weight_for_Height > -3) && (Z_Score_Weight_for_Height <= -2)){ document.getElementById('rr2_2').bgColor = \"#cccccc\";",
"}",
"if (Z_Score_Weight_for_Height <= -3){ document.getElementById('rr2_3').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.WHOGrowthBoys_form){",
"",
"if (Age_param.value && Age < 24) {",
"Age = 0;",
"Age_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Age is 24 mo.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Age_param.value && Age > 60) {",
"Age_param.value = \"\";",
"clrResults();",
"Age = 0;",
"doCalc = false;",
"alert(\"The maximum value for Age is 60 mo.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height < 65) {",
"Height = 0;",
"Height_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Height is 65 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height > 120) {",
"Height_param.value = \"\";",
"clrResults();",
"Height = 0;",
"doCalc = false;",
"alert(\"The maximum value for Height is 120 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Weight_param.value && Weight < 7) {",
"Weight = 0;",
"Weight_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Weight is 7 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Weight_param.value && Weight > 25) {",
"Weight_param.value = \"\";",
"clrResults();",
"Weight = 0;",
"doCalc = false;",
"alert(\"The maximum value for Weight is 25 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.WHOGrowthBoys_form){",
"",
"Z_Score_Height_param.value = '';",
"Z_Score_Weight_for_Height_param.value = '';",
"Height_Percentile_param.value = '';",
"Weight_for_Height_Percentile_param.value = '';",
"",
"rrclr();",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"document.getElementById('rr2_1').bgColor = \"\";",
"document.getElementById('rr2_2').bgColor = \"\";",
"document.getElementById('rr2_3').bgColor = \"\";",
"}",
"",
"",
"/* ]]> */"].join("\n");
var outline_f29_32_30213=null;
var title_f29_32_30214="Liver biopsy - bleeding from esophageal varices and splenomegaly";
var content_f29_32_30214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Liver biopsy from a 59-year-old man who had recurrent bleeding from large esophageal varices and splenomegaly (high power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the enlarged blue-gray stained Kupffer cells filling a sinusoid (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30214=[""].join("\n");
var outline_f29_32_30214=null;
var title_f29_32_30215="Tendon sheath anatomy";
var content_f29_32_30215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    Flexor tendons, common flexor sheath, fibrous digital sheaths, and synovial sheaths of the digits",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 526px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dissection of the palm of the hand illustrating the tendons and fibrous digital tendon sheaths. The fibrous sheaths of the digits are strong coverings of the flexor tendons, which extend from the heads of the metacarpals to the base of the distal phalanges. They prevent the tendons from pulling away from the bones of the digits. They attach along the borders of the proximal and middle phalanges, to capsules of the interphalangeal joints, and to the surface of the distal phalanx.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moore KL, PhD, FRSM, FIAC &amp; Dalley AF II, PhD. Clinical Oriented Anatomy (4th ed.). Baltimore, Lippincott Williams &amp; Wilkins 1999. Copyright &copy;1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30215=[""].join("\n");
var outline_f29_32_30215=null;
var title_f29_32_30216="Soft tissue lesions of the oral cavity in children";
var content_f29_32_30216=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Soft tissue lesions of the oral cavity in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30216/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30216/contributors\">",
"     Martha Ann Keels, DDS, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30216/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30216/contributors\">",
"     Ann Griffen, DDS, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30216/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30216/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/32/30216/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft tissue lesions of the oral cavity are common in children. When evaluating soft tissue lesions, it is important to distinguish between findings that are normal and those that are indicative of gingivitis, periodontal disease, local or systemic infection, and potentially life-threatening systemic conditions.",
"   </p>",
"   <p>",
"    The clinical findings, diagnostic criteria, and treatment recommendations for common soft tissue lesions will be reviewed here. Gingivitis, periodontal disease, and the oral manifestations of systemic conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=see_link\">",
"     \"Overview of gingivitis and periodontitis in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/60/8137?source=see_link\">",
"     \"Systemic conditions associated with periodontal disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMIC PROBLEMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Gingiva",
"    </span>",
"    &nbsp;&mdash;&nbsp;The teeth erupt through an existing band of keratinized gingiva, known as the attached gingiva. In dark-skinned individuals, pigmentation of the attached gingiva, due to melanin, is a normal finding.",
"   </p>",
"   <p>",
"    The width of the keratinized band and its relationship to the teeth remain relatively constant during the child's growth and development. Deflections in the path of eruption (eg, due to crowding or overretention of primary teeth) may result in a narrowed band of attached gingiva [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/1\">",
"     1",
"    </a>",
"    ]. This finding is particularly common when mandibular incisors erupt labial to the alveolar ridge (",
"    <a class=\"graphic graphic_picture graphicRef75024 \" href=\"UTD.htm?8/58/9120\">",
"     picture 1",
"    </a>",
"    ). If the band of attached gingiva is very narrow (eg, less than 3 mm), subsequent loss of attachment can result in the absence of attached gingiva or a \"mucogingival defect.\" Mucogingival defects, defined by a pocket depth that exceeds the width of keratinized gingiva, predispose to rapid gingival recession (",
"    <a class=\"graphic graphic_picture graphicRef75024 \" href=\"UTD.htm?8/58/9120\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Labially erupted teeth are particularly vulnerable to attachment loss and periodontal disease because they are difficult to clean, especially after recession has occurred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of gingivitis and periodontitis in children and adolescents\", section on 'Gingivitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Orthodontic repositioning may place labially malpositioned teeth in a more stable position and produce a small increase in attached gingiva. This is the preferred treatment for labially erupted teeth unless gingival recession is severe. Significant recession is treated by gingival grafting with palatal tissue. Gingival grafting repairs and stabilizes the attached gingiva.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Frenum",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infancy, the maxillary frenum typically extends over the alveolar ridge to form a raphe that reaches the palatal papilla. The persistence of this raphe during dental eruption may lead to widely spaced central incisors (diastema).",
"   </p>",
"   <p>",
"    Orthodontic treatment for diastema is typically delayed until the permanent incisors and cuspids have erupted to allow natural space closure. Immediate treatment is necessary if the frenum attachment exerts tension on the attached gingiva of a permanent tooth (a rare occurrence). Surgical treatment (frenectomy) is indicated if the appearance is unacceptable after natural and orthodontic closure of the diastema. Surgical treatment is also indicated if the maxillary frenum interferes with crown placement on either the primary or permanent central incisors.",
"   </p>",
"   <p>",
"    Ankyloglossia (restrictive lingual frenum or \"tongue-tie\") is the term used to describe restriction of tongue movement caused by a prominent or short lingual frenum (",
"    <a class=\"graphic graphic_picture graphicRef74275 \" href=\"UTD.htm?2/3/2098\">",
"     picture 2",
"    </a>",
"    ). It is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44615?source=see_link\">",
"     \"Ankyloglossia (tongue-tie) in infants and children\"",
"    </a>",
"    .) The traction caused by extension of the mandibular frenum to the mandibular incisors also can cause gingival recession and bone loss that can be prevented by frenectomy.",
"   </p>",
"   <p>",
"    Absence of the inferior labial and lingual frenum is associated with the Ehlers-Danlos syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/2\">",
"     2",
"    </a>",
"    ] and infantile hypertrophic pyloric stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=see_link\">",
"     \"Infantile hypertrophic pyloric stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DEVELOPMENTAL LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental lesions of the oral cavity include geographic tongue, fissured tongue, retrocuspid papillae, and gingival overgrowth. Congenital anomalies of the oral cavity and pharynx are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=see_link\">",
"     \"Congenital anomalies of the jaw, mouth, oral cavity, and pharynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Geographic tongue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Geographic tongue (benign migratory glossitis) is a chronic, recurring disorder characterized by pink to red, slightly depressed lesions with irregular, elevated, white or yellow borders (",
"    <a class=\"graphic graphic_picture graphicRef74654 \" href=\"UTD.htm?4/1/4113\">",
"     picture 3",
"    </a>",
"    ). The lesions are areas of dekeratinization and desquamation of filiform papilla. The pattern of dekeratinization and desquamation continuously changes, creating a migratory appearance. The lesions occur predominantly on the dorsum and lateral borders of the anterior two-thirds of the tongue. They are typically asymptomatic but may be painful when inflamed [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/4\">",
"     4",
"    </a>",
"    ]. Geographic tongue is more common in girls than boys. The etiology is not known, but it has been associated with childhood allergies [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/5\">",
"     5",
"    </a>",
"    ]. Reassurance is usually the only necessary treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fissured tongue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fissured tongue (lingua plicata) is a developmental anomaly characterized by one marked central, anterior-posterior fissure from which smaller fissures radiate laterally (",
"    <a class=\"graphic graphic_picture graphicRef77550 \" href=\"UTD.htm?22/1/22545\">",
"     picture 4",
"    </a>",
"    ). The depth of the fissures varies from shallow to deep; deep fissures may trap food debris, which can cause inflammation (",
"    <a class=\"graphic graphic_picture graphicRef64810 \" href=\"UTD.htm?9/39/9841\">",
"     picture 5",
"    </a>",
"    ) or secondary fungal infections. Patients with tongue fissures should be advised to brush the surface of the tongue to remove trapped food particles [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tongue fissuring with normal-appearing filiform papillae occurs in approximately 5 percent of the general population and is considered to be a normal variant [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/7\">",
"     7",
"    </a>",
"    ]. Fissured tongue occurs more frequently in adults than children but is a common finding in children with Down syndrome. It is seen in the Melkersson-Rosenthal syndrome, a rare disorder consisting of recurrent facial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lip edema and relapsing facial nerve paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link&amp;anchor=H3#H3\">",
"     \"Facial nerve palsy in children\", section on 'Epidemiology and causes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Retrocuspid papillae",
"    </span>",
"    &nbsp;&mdash;&nbsp;The retrocuspid papilla is a firm, round, pink to red, fibroepithelial papule, 2 to 3 mm in diameter, that is present on the attached gingiva lingual to the mandibular canines in most children (",
"    <a class=\"graphic graphic_picture graphicRef76421 \" href=\"UTD.htm?34/9/34975\">",
"     picture 6",
"    </a>",
"    ). Retrocuspid papillae are frequently present bilaterally. No treatment is necessary since they usually are asymptomatic and decrease in size with age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Gingival overgrowth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gingival overgrowth or enlargement in children can be hereditary, inflammatory, infiltrative, or an adverse effect of certain medications.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hereditary &mdash; Hereditary gingival fibromatosis (also called idiopathic hyperplasia) is a rare condition with onset in early childhood [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. It is characterized by progressive fibrous enlargement of the buccal and lingual gingival surfaces of both jaws. Hereditary gingival fibromatosis is frequently complicated by failure or delay of eruption of primary and permanent teeth. The treatment of choice is gingivectomy. Meticulous oral hygiene is recommended to reduce the risk of recurrence.",
"     </li>",
"     <li>",
"      Inflammatory &mdash; Chronic inflammatory gingival enlargement can result from longstanding gingivitis in young patients, particularly when plaque accumulates around orthodontic appliances (",
"      <a class=\"graphic graphic_picture graphicRef81784 \" href=\"UTD.htm?4/27/4532\">",
"       picture 7",
"      </a>",
"      ) or in areas that are chronically dry due to mouth breathing. Gingival enlargement in these cases can be localized or generalized, with involvement of the interdental papillae and the marginal gingiva. These tissues become enlarged and erythematous, with a shiny, smooth, friable surface that bleeds easily. Gingivectomy is sometimes required, but inflammatory gingival enlargement often resolves when adequate plaque control is instituted.",
"     </li>",
"     <li>",
"      Infiltrative &mdash; Leukemia, particularly the monocytic type, can cause gingival enlargement due to infiltration of the gingival tissues [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/11\">",
"       11",
"      </a>",
"      ]. In contrast to the dense, fibrous gingival overgrowth described above, the gingival enlargement due to leukemia is typically edematous and hemorrhagic. Patients with leukemic gingival hypertrophy may have difficulty maintaining good oral hygiene because of gingival bleeding. The inflammation that results may act as a stimulus for further connective tissue hyperplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=see_link\">",
"       \"Overview of the presentation and classification of acute lymphoblastic leukemia in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Drug-induced &mdash; Drug-induced gingival overgrowth occurs as a side effect of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/19/33082?source=see_link\">",
"       phenytoin",
"      </a>",
"      , cyclosporin-A, and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/2/9256?source=see_link\">",
"       nifedipine",
"      </a>",
"      &nbsp;(",
"      <a class=\"graphic graphic_picture graphicRef54440 \" href=\"UTD.htm?27/45/28368\">",
"       picture 8",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/13\">",
"       13",
"      </a>",
"      ]. The fibrous overgrowth that occurs is painless and firm, with little tendency to bleed. Initial enlargement occurs in the interdental region and may appear lobular; it gradually proceeds to involve the gingival margin and may progress to cover the crowns of the teeth, where it can interfere with occlusion. Drug-induced gingival overgrowth can cause delay or failure of tooth eruption if it occurs before tooth eruption is complete.",
"      <br/>",
"      <br/>",
"      Susceptibility to drug-induced gingival overgrowth appears to have a genetic component [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/14\">",
"       14",
"      </a>",
"      ]. The severity of gingival overgrowth is related to the gingival concentration of the medication and the adequacy of oral hygiene [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/15\">",
"       15",
"      </a>",
"      ]. The inflammatory response to dental plaque can exacerbate overgrowth, particularly on the labial aspects of the anterior teeth. Thus, close attention to dental hygiene is recommended for children who must take drugs that can cause gingival overgrowth. The use of electric toothbrushes may help to prevent further overgrowth by improving gum care.",
"      <br/>",
"      <br/>",
"      Drug-induced gingival overgrowth is not dose related but can progress rapidly if two or more overgrowth-inducing drugs are used in combination [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/14,16\">",
"       14,16",
"      </a>",
"      ]. Such situations may require alteration in the medication regimen. The gingival overgrowth may be partially reversible if the offending drug is discontinued. Gingivectomy may be necessary in severe cases, although recurrence is probable unless the precipitating medication is discontinued. Additional indications for gingivectomy include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Gingival appearance is unacceptable to the patient",
"     </li>",
"     <li>",
"      Interference with normal function",
"     </li>",
"     <li>",
"      Production of a periodontal pocket that cannot be maintained in a healthy state",
"      <br/>",
"      <br/>",
"      The risk of considerable postgingivectomy discomfort should be carefully weighed against the potential benefits of the procedure. This is particularly important to consider in patients with intellectual disability (in whom the most severe cases of gingival hypertrophy are seen), who may not be able to give fully informed consent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     BENIGN TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign tumors of the oral cavity include hemangiomas, lymphangiomas, mucoceles, and fibromas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hemangioma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemangiomas, enlarged vascular hamartomas, are tumors of mesenchymal origin, characterized by the formation of vascular tubes of endothelial cells. They can occur in any soft tissue location and are common on the lip (",
"    <a class=\"graphic graphic_picture graphicRef60003 \" href=\"UTD.htm?0/32/512\">",
"     picture 9",
"    </a>",
"    ), dorsum of the tongue, gingiva, and buccal mucosa (",
"    <a class=\"graphic graphic_picture graphicRef54866 \" href=\"UTD.htm?27/29/28127\">",
"     picture 10",
"    </a>",
"    ). They are red or bluish-red, slightly raised lesions that are moderately firm to palpation. Hemangiomas appear early in life and typically enlarge rapidly during infancy and regress slowly during childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/17\">",
"     17",
"    </a>",
"    ]. They are usually painless but can ulcerate or bleed if traumatized.",
"   </p>",
"   <p>",
"    Treatment is indicated if the hemangioma interferes with breathing, eating, or speech, or is grossly deforming. The treatment of infantile hemangiomas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44665?source=see_link\">",
"     \"Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25546?source=see_link\">",
"     \"Management of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Lymphatic malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphangiomas, benign tumors of the lymphatic vessels, can be present at birth or develop early in life. Superficial lymphangiomas are pink to reddish-blue, soft, and compressible (",
"    <a class=\"graphic graphic_picture graphicRef65778 \" href=\"UTD.htm?17/37/18003\">",
"     picture 11",
"    </a>",
"    ); deeper lymphangiomas may not be apparent at the surface. The tongue, lips, and buccal mucosa are the most common sites of occurrence. Large lymphangiomas that involve the floor of the mouth and the neck are called cystic hygromas. Surgical resection is the most common treatment, despite a high frequency of recurrences and complications. Newer techniques using image-guided percutaneous chemoablation have shown 100 percent efficacy and minimal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Mucocele",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucoceles are pseudocysts of minor salivary origin. They are formed when salivary gland secretions dissect into the soft tissues surrounding the gland, usually as a result of trauma to a minor salivary gland that causes pooling of mucous in an obstructed and dilated excretory duct [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mucoceles typically present as painless swellings on the lower lip, buccal mucosa, midway between the midline and the commissure (",
"    <a class=\"graphic graphic_picture graphicRef75671 \" href=\"UTD.htm?12/31/12790\">",
"     picture 12",
"    </a>",
"    ). They are usually less than 1 cm in diameter, smooth walled, and bluish or translucent. They may spontaneously resolve, but if they persist, the surface may become keratinized.",
"   </p>",
"   <p>",
"    Mucoceles can be unroofed or marsupialized if they interfere with feeding, swallowing, or speech. Removal of the associated minor salivary glands is necessary to prevent recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Fibroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibromas are one of the most common lesions of the oral cavity and are formed when chronic irritation results in reactive connective tissue hyperplasia. They may occur on any oral mucosal surface, particularly the palate, tongue, cheek, and lip (",
"    <a class=\"graphic graphic_picture graphicRef67437 \" href=\"UTD.htm?29/41/30352\">",
"     picture 13",
"    </a>",
"    ). Fibromas are typically pale pink, smooth, firm, less than 1 cm in diameter, and have a sessile or pedunculated base. They can be surgically removed; recurrence is rare if the source of irritation is removed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CYSTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystic soft tissue lesions of the oral cavity include parulis and eruption cysts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pulpal necrosis and parulis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A parulis, or \"gum boil,\" occurs at the exit point of the draining fistulous tract of a primary tooth with necrotic pulp. It appears as a soft, solitary, reddish papule and is located apical and facial to the abscessed tooth (",
"    <a class=\"graphic graphic_picture graphicRef73999 \" href=\"UTD.htm?1/48/1792\">",
"     picture 14",
"    </a>",
"    ). Pus and drainage may be observed. Obstruction of the sinus tract can cause acute pain and swelling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16873?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections\", section on 'Pulpitis and periapical abscess'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment consists of extracting or performing complete pulpectomy of the abscessed tooth, depending upon the prognosis and the strategic importance of the tooth. The parulis typically regresses shortly after either of these procedures. If the tooth is left untreated, the parulis may persist for years or mature into a fibroma (",
"    <a class=\"graphic graphic_picture graphicRef67437 \" href=\"UTD.htm?29/41/30352\">",
"     picture 13",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Eruption cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eruption cysts are the dome-shaped soft tissue lesions associated with erupting primary and permanent teeth. They are caused by fluid accumulation within the follicular space of the erupting tooth. Eruption cysts are called eruption hematomas when the cyst fluid is mixed with blood (",
"    <a class=\"graphic graphic_picture graphicRef51727 \" href=\"UTD.htm?32/28/33231\">",
"     picture 15",
"    </a>",
"    ). No treatment is needed; eruption cysts resolve spontaneously as the tooth erupts through the lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ULCERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ulcerative lesions of the oral cavity include traumatic and aphthous ulcers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Traumatic ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic ulcers are the most common oral ulcers in children. They are caused by mechanical, chemical, or thermal injury to the oral tissues and can occur on the peripheral borders of the tongue, buccal mucosa, lips, or palate. The appearance of the lesions varies depending upon the source and intensity of the trauma.",
"   </p>",
"   <p>",
"    Thermal burns of the anterior palate can be caused by eating foods or drinking liquids that are too hot (eg, pizza); mechanical trauma to the soft palate can be caused by digit or pacifier sucking. Traumatic ulcers also may occur when an anesthetized lip is inadvertently chewed after dental treatment. Less common causes include factitious injury (eg, fingernail scratching of the gingiva) (",
"    <a class=\"graphic graphic_picture graphicRef61973 \" href=\"UTD.htm?28/59/29631\">",
"     picture 16",
"    </a>",
"    ) or lip-biting due to a self-injurious behavior disorder (eg, Lesch-Nyhan syndrome) (",
"    <a class=\"graphic graphic_picture graphicRef73786 \" href=\"UTD.htm?26/5/26718\">",
"     picture 17",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Traumatic ulcers typically heal within two weeks of removal of the source of trauma. Children who have self-abusive behaviors may need a comprehensive treatment plan, including sedation, bite guards, lip bumpers, or extraction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Aphthous ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aphthae, also called canker sores, are painful oral lesions that appear as localized, shallow, round to oval ulcers with a grayish base (",
"    <a class=\"graphic graphic_picture graphicRef56488 graphicRef63475 \" href=\"UTD.htm?12/44/12997\">",
"     picture 18A-B",
"    </a>",
"    ). Susceptibility appears to be familial. The clinical features and management of aphthous ulcers are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25786?source=see_link&amp;anchor=H16#H16\">",
"     \"Oral lesions\", section on 'Aphthous ulcerations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious causes of oral lesions in children include herpes simplex virus, coxsackievirus, Candida albicans, and HIV infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Herpes simplex virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The manifestations of herpes simplex virus (HSV) infection of the oral cavity depend upon whether the infection is primary or recurrent. Primary herpes simplex virus (HSV) infection occurs in young children approximately one week after contact with an infected child or adult. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38021?source=see_link\">",
"     \"Epidemiology of herpes simplex virus type 1 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Primary HSV infection may be subclinical or associated with flu-like symptoms, such as fever, malaise, irritability, or sleeplessness. Signs of oral infection include red, edematous marginal gingivae that bleed easily, and clusters of small vesicles that become yellow after rupture and are surrounded by a red halo (",
"    <a class=\"graphic graphic_picture graphicRef58542 \" href=\"UTD.htm?27/3/27702\">",
"     picture 19",
"    </a>",
"    ). The vesicles coalesce to form large, painful ulcers of the oral and perioral tissues. The oral lesions may be accompanied by fever, arthralgia, headache, and cervical lymphadenopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/27/31160?source=see_link&amp;anchor=H7#H7\">",
"     \"Herpetic gingivostomatitis in young children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the primary infection, HSV migrates to the trigeminal ganglion, where it remains in a latent state unless it is reactivated. Reactivation can be induced by exposure to sunlight, cold, trauma, stress, or immunosuppression and may occur on the lips (herpes labialis) or in the oral cavity (herpetic stomatitis). Herpes labialis occurs as a vesicular eruption on the skin adjacent to the vermilion border of the lip (",
"    <a class=\"graphic graphic_picture graphicRef80183 \" href=\"UTD.htm?0/55/881\">",
"     picture 20",
"    </a>",
"    ). These lesions are commonly known as fever blisters or cold sores and are typically preceded by prodromal symptoms, including tingling, burning, or pain. The vesicles rupture to form ulcers and crusts and heal without scarring in one to two weeks. Intraoral reactivation of HSV occurs primarily on the hard palate or attached gingiva. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=see_link\">",
"     \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36488?source=see_link\">",
"     \"Treatment of herpes simplex virus type 1 infection in immunocompetent patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Coxsackievirus",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Herpangina",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herpangina, usually caused by group A coxsackieviruses, is a vesicular enanthem of the tonsillar fauces and soft palate that principally affects children 3 to 10 years of age during the summer and early fall [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/20\">",
"     20",
"    </a>",
"    ]. Herpangina is highly contagious and has an incubation period of four days.",
"   </p>",
"   <p>",
"    Herpangina may be accompanied by fever, sore throat, and pain with swallowing as the gray, pinhead-sized vesicles rupture to form large, fibrin-covered ulcers. In addition to fever and the oral lesions, headache, vomiting, and abdominal pain may occur. Treatment is palliative since the symptoms are usually mild, and lesions heal spontaneously after three to five days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Hand, foot, mouth",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hand, foot, and mouth (HFM) syndrome, caused by a number of coxsackie A and B viruses, principally affects children younger than five years of age in the spring and early summer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/26/41383?source=see_link\">",
"     \"Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hand, foot, and mouth disease is characterized by fever, oral vesicles on the palate, tongue, and buccal mucosa, and peripherally distributed small, tender, cutaneous lesions on the hands, feet, buttocks and (less commonly) genitalia (",
"    <a class=\"graphic graphic_picture graphicRef52800 \" href=\"UTD.htm?4/12/4293\">",
"     picture 21",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/21\">",
"     21",
"    </a>",
"    ]. The oral lesions begin as vesicles that rupture to form ulcers and are painful; the cutaneous vesicles ulcerate and crust. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Concomitant central nervous system (CNS) disease may occur when HFM syndrome is caused by enterovirus 71 [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=see_link&amp;anchor=H6#H6\">",
"     \"Viral meningitis: Clinical features and diagnosis in children\", section on 'Enteroviruses'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=see_link&amp;anchor=H7#H7\">",
"     \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Viral etiologies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hand, foot, and mouth disease usually resolves in two to three days without complication. Treatment is palliative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Candida albicans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pseudomembranous candidiasis, or thrush, is a common local infection caused by the overgrowth of the fungus Candida albicans. It often occurs in infants after exposure to the microorganisms of the vaginal tract; children treated with antibiotics, chemotherapy, radiation therapy, and inhaled glucocorticoids; and patients with cellular immunodeficiency.",
"   </p>",
"   <p>",
"    The pseudomembranous form of candidiasis is the most common and is characterized by white plaques on the buccal mucosa, palate, tongue, or oropharynx (",
"    <a class=\"graphic graphic_picture graphicRef69465 \" href=\"UTD.htm?9/63/10228\">",
"     picture 22",
"    </a>",
"    ). The plaques can be wiped off to leave a red, raw, painful surface. Candida species also cause angular cheilitis or perleche, a painful fissuring at the corners of the mouth (",
"    <a class=\"graphic graphic_picture graphicRef71723 \" href=\"UTD.htm?32/40/33410\">",
"     picture 23",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The clinical manifestations and treatment of oropharyngeal candidiasis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/47/31481?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of Candida infections in children\", section on 'Oropharyngeal candidiasis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral manifestations of HIV infection in children include oral candidiasis, which may progress to esophageal candidiasis; herpes simplex virus infections; parotid gland swelling; and generalized or localized HIV gingivitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/3/3130?source=see_link&amp;anchor=H18840505#H18840505\">",
"     \"Natural history and classification of pediatric HIV infection\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV gingivitis, also called linear gingival erythema, presents as a brightly inflamed band of marginal gingiva (",
"    <a class=\"graphic graphic_picture graphicRef62628 \" href=\"UTD.htm?23/1/23571\">",
"     picture 24",
"    </a>",
"    ). The gingiva can be painful and bleeds easily; there may be rapid tissue destruction. The microbiology of HIV gingivitis is unique: the cultivable organisms are primarily gram-negative anaerobes, enteric strains, and yeast (Candida albicans), organisms that are not found in routine cases of gingivitis.",
"   </p>",
"   <p>",
"    In contrast to gingivitis that is not related to HIV, HIV gingivitis is unresponsive to improved oral hygiene [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30216/abstract/24\">",
"     24",
"    </a>",
"    ]. Treatment consists of debridement plus antibiotic administration. Antibacterial rinses (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/9/44180?source=see_link\">",
"     chlorhexidine",
"    </a>",
"    , fluoride) and antifungal",
"    <span class=\"nowrap\">",
"     rinses/troches",
"    </span>",
"    (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/23/34160?source=see_link\">",
"     nystatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    , etc.) may be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gingival lesions include narrowing of the attached gingiva and mucogingival defects (",
"      <a class=\"graphic graphic_picture graphicRef75024 \" href=\"UTD.htm?8/58/9120\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Gingiva'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Frenum lesions include persistence of the maxillary frenum during dental eruption, which may lead to widely spaced central incisors (diastema), periodontal defects, and bone loss; and ankyloglossia (restrictive lingual frenum) (",
"      <a class=\"graphic graphic_picture graphicRef74275 \" href=\"UTD.htm?2/3/2098\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Frenum'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44615?source=see_link\">",
"       \"Ankyloglossia (tongue-tie) in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Developmental lesions of the oral cavity include geographic tongue (",
"      <a class=\"graphic graphic_picture graphicRef74654 \" href=\"UTD.htm?4/1/4113\">",
"       picture 3",
"      </a>",
"      ), fissured tongue (",
"      <a class=\"graphic graphic_picture graphicRef77550 \" href=\"UTD.htm?22/1/22545\">",
"       picture 4",
"      </a>",
"      ), retrocuspid papillae (",
"      <a class=\"graphic graphic_picture graphicRef76421 \" href=\"UTD.htm?34/9/34975\">",
"       picture 6",
"      </a>",
"      ), and gingival overgrowth (",
"      <a class=\"graphic graphic_picture graphicRef81784 \" href=\"UTD.htm?4/27/4532\">",
"       picture 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef54440 \" href=\"UTD.htm?27/45/28368\">",
"       picture 8",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Developmental lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Benign tumors of the oral cavity include hemangiomas (",
"      <a class=\"graphic graphic_picture graphicRef60003 \" href=\"UTD.htm?0/32/512\">",
"       picture 9",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef54866 \" href=\"UTD.htm?27/29/28127\">",
"       picture 10",
"      </a>",
"      ), lymphangiomas, mucoceles (",
"      <a class=\"graphic graphic_picture graphicRef75671 \" href=\"UTD.htm?12/31/12790\">",
"       picture 12",
"      </a>",
"      ), and fibromas (",
"      <a class=\"graphic graphic_picture graphicRef67437 \" href=\"UTD.htm?29/41/30352\">",
"       picture 13",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Benign tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cysts of the oral cavity include parulis (\"gum boil\") at the exit point of the draining fistulous tract of a necrotic primary tooth (",
"      <a class=\"graphic graphic_picture graphicRef73999 \" href=\"UTD.htm?1/48/1792\">",
"       picture 14",
"      </a>",
"      ) and eruption cysts or hematomas associated with erupting teeth (",
"      <a class=\"graphic graphic_picture graphicRef51727 \" href=\"UTD.htm?32/28/33231\">",
"       picture 15",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Traumatic ulcers are caused by mechanical, chemical, or thermal injury to the oral tissues and can occur on the peripheral borders of the tongue, buccal mucosa, lips, or palate (",
"      <a class=\"graphic graphic_picture graphicRef61973 \" href=\"UTD.htm?28/59/29631\">",
"       picture 16",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef73786 \" href=\"UTD.htm?26/5/26718\">",
"       picture 17",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Traumatic ulcers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aphthous ulcers, also called canker sores, are painful oral lesions that appear as localized, shallow, round to oval ulcers with a grayish base (",
"      <a class=\"graphic graphic_picture graphicRef56488 graphicRef63475 \" href=\"UTD.htm?12/44/12997\">",
"       picture 18A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25786?source=see_link&amp;anchor=H16#H16\">",
"       \"Oral lesions\", section on 'Aphthous ulcerations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infectious causes of soft tissue lesions include herpes simplex virus (",
"      <a class=\"graphic graphic_picture graphicRef58542 \" href=\"UTD.htm?27/3/27702\">",
"       picture 19",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef80183 \" href=\"UTD.htm?0/55/881\">",
"       picture 20",
"      </a>",
"      ), coxsackievirus (",
"      <a class=\"graphic graphic_picture graphicRef52800 \" href=\"UTD.htm?4/12/4293\">",
"       picture 21",
"      </a>",
"      ), Candida albicans (",
"      <a class=\"graphic graphic_picture graphicRef69465 \" href=\"UTD.htm?9/63/10228\">",
"       picture 22",
"      </a>",
"      ), and HIV infection (",
"      <a class=\"graphic graphic_picture graphicRef62628 \" href=\"UTD.htm?23/1/23571\">",
"       picture 24",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Infections'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/1\">",
"      Andlin-Sobocki A, Bodin L. Dimensional alterations of the gingiva related to changes of facial/lingual tooth position in permanent anterior teeth of children. A 2-year longitudinal study. J Clin Periodontol 1993; 20:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/2\">",
"      De Felice C, Toti P, Di Maggio G, et al. Absence of the inferior labial and lingual frenula in Ehlers-Danlos syndrome. Lancet 2001; 357:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/3\">",
"      De Felice C, Di Maggio G, Zagordo L, et al. Hypoplastic or absent mandibular frenulum: a new predictive sign of infantile hypertrophic pyloric stenosis. J Pediatr 2000; 136:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/4\">",
"      Sigal MJ, Mock D. Symptomatic benign migratory glossitis: report of two cases and literature review. Pediatr Dent 1992; 14:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/5\">",
"      Barton DH, Spier SK, Crovello TJ. Benign migratory glossitis and allergy. Pediatr Dent 1982; 4:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/6\">",
"      Mueller DT, Callanan VP. Congenital malformations of the oral cavity. Otolaryngol Clin North Am 2007; 40:141.",
"     </a>",
"    </li>",
"    <li>",
"     Geographic tongue and fissured tongue. In: Online Mendelian Inheritance in Man. file://omim.org/entry/137400 (Accessed on November 07, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/8\">",
"      Orlando MR, Atkins JS Jr. Melkersson-Rosenthal syndrome. Arch Otolaryngol Head Neck Surg 1990; 116:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/9\">",
"      Singer SL, Goldblatt J, Hallam LA, Winters JC. Hereditary gingival fibromatosis with a recessive mode of inheritance. Case reports. Aust Dent J 1993; 38:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/10\">",
"      Raeste AM, Collan Y, Kilpinen E. Hereditary fibrous hyperplasia of the gingiva with varying penetrance and expressivity. Scand J Dent Res 1978; 86:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/11\">",
"      Delaney JE, Keels MA. Pediatric oral pathology. Soft tissue and periodontal conditions. Pediatr Clin North Am 2000; 47:1125.",
"     </a>",
"    </li>",
"    <li>",
"     Oral Pathology: Clinical-Pathologic Correlations, 2nd, Regezi JA, Sciubba J (Eds), WB Saunders, Philadelphia 1993. p.196.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/13\">",
"      Dongari A, McDonnell HT, Langlais RP. Drug-induced gingival overgrowth. Oral Surg Oral Med Oral Pathol 1993; 76:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/14\">",
"      Thomason JM, Seymour RA, Ellis JS, et al. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the r&ocirc;le of HLA phenotype. J Clin Periodontol 1996; 23:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/15\">",
"      Majola MP, McFadyen ML, Connolly C, et al. Factors influencing phenytoin-induced gingival enlargement. J Clin Periodontol 2000; 27:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/16\">",
"      B&ouml;kenkamp A, Bohnhorst B, Beier C, et al. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994; 8:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/17\">",
"      Fishman SJ, Mulliken JB. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am 1993; 40:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/18\">",
"      Shiels WE 2nd, Kang DR, Murakami JW, et al. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg 2009; 141:219.",
"     </a>",
"    </li>",
"    <li>",
"     Langlais RP, Miller CS. Color Atlas of Common Oral Diseases, Lea &amp; Febiger, Philadelphia 1992. p.32.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/20\">",
"      Cherry JD, Jahn CL. Herpangina: the etiologic spectrum. Pediatrics 1965; 36:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/21\">",
"      Adler JL, Mostow SR, Mellin H, et al. Epidemiologic investigation of hand, foot, and mouth disease. Infection caused by coxsackievirus A 16 in Baltimore, June through September 1968. Am J Dis Child 1970; 120:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/22\">",
"      Chonmaitree T, Menegus MA, Schervish-Swierkosz EM, Schwalenstocker E. Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics 1981; 67:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/23\">",
"      Lum LC, Wong KT, Lam SK, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998; 133:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30216/abstract/24\">",
"      Leggott PJ. Oral manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol 1992; 73:187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6282 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-1AFF26D322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30216=[""].join("\n");
var outline_f29_32_30216=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMIC PROBLEMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Gingiva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Frenum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DEVELOPMENTAL LESIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Geographic tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fissured tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Retrocuspid papillae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Gingival overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      BENIGN TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Lymphatic malformations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Mucocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Fibroma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CYSTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pulpal necrosis and parulis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Eruption cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ULCERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Traumatic ulcers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Aphthous ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Herpes simplex virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Coxsackievirus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Herpangina",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Hand, foot, mouth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Candida albicans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6282\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6282|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/58/9120\" title=\"picture 1\">",
"      Labial eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/3/2098\" title=\"picture 2\">",
"      Abnormally short frenulum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/1/4113\" title=\"picture 3\">",
"      Geographic tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/1/22545\" title=\"picture 4\">",
"      Fissured tongue 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/39/9841\" title=\"picture 5\">",
"      Fissured tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/9/34975\" title=\"picture 6\">",
"      Retrocuspid papilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/27/4532\" title=\"picture 7\">",
"      Inflammatory gingival overgrowth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/45/28368\" title=\"picture 8\">",
"      Gingival overgrowth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/32/512\" title=\"picture 9\">",
"      Lip hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/29/28127\" title=\"picture 10\">",
"      Buccal hemangioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/37/18003\" title=\"picture 11\">",
"      Lymphangioma tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/31/12790\" title=\"picture 12\">",
"      Mucoceles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/41/30352\" title=\"picture 13\">",
"      Fibroma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/48/1792\" title=\"picture 14\">",
"      Parulis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/28/33231\" title=\"picture 15\">",
"      Eruption hematoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/59/29631\" title=\"picture 16\">",
"      Traumatic ulcer 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/5/26718\" title=\"picture 17\">",
"      Traumatic ulcer 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/61/30687\" title=\"picture 18A\">",
"      Aphthous ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/25/13713\" title=\"picture 18B\">",
"      Aphthous ulcers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/3/27702\" title=\"picture 19\">",
"      Herpetic stomatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/55/881\" title=\"picture 20\">",
"      Cold sore PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/12/4293\" title=\"picture 21\">",
"      Hand-foot-and-mouth disease - lip and hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/63/10228\" title=\"picture 22\">",
"      Thrush infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/40/33410\" title=\"picture 23\">",
"      Perleche",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/1/23571\" title=\"picture 24\">",
"      Linear gingival erythema",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44615?source=related_link\">",
"      Ankyloglossia (tongue-tie) in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=related_link\">",
"      Congenital anomalies of the jaw, mouth, oral cavity, and pharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38021?source=related_link\">",
"      Epidemiology of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16873?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/26/41383?source=related_link\">",
"      Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44665?source=related_link\">",
"      Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=related_link\">",
"      Facial nerve palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/27/31160?source=related_link\">",
"      Herpetic gingivostomatitis in young children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=related_link\">",
"      Infantile hypertrophic pyloric stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25546?source=related_link\">",
"      Management of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/3/3130?source=related_link\">",
"      Natural history and classification of pediatric HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25786?source=related_link\">",
"      Oral lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/47/31481?source=related_link\">",
"      Overview of Candida infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=related_link\">",
"      Overview of gingivitis and periodontitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=related_link\">",
"      Overview of the presentation and classification of acute lymphoblastic leukemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/60/8137?source=related_link\">",
"      Systemic conditions associated with periodontal disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36488?source=related_link\">",
"      Treatment of herpes simplex virus type 1 infection in immunocompetent patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10586?source=related_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_32_30217="Clinical presentation, pathologic features, and diagnosis of primary central nervous system lymphoma";
var content_f29_32_30217=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical presentation, pathologic features, and diagnosis of primary central nervous system lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Fred H Hochberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Tracy Batchelor, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30217/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30217/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/32/30217/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary central nervous system lymphoma (PCL) is an uncommon variant of extranodal non-Hodgkin lymphoma (NHL) that involves the brain, leptomeninges, eyes, or spinal cord without evidence of systemic disease.",
"   </p>",
"   <p>",
"    The epidemiology and clinical presentation vary depending upon the immunocompetence of the patient. This discussion will be devoted to PCL arising in immunocompetent individuals. AIDS-related PCL is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7321?source=see_link\">",
"     \"AIDS-related lymphomas: Primary central nervous system lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will discuss the clinical presentation, pathologic features, and diagnosis of PCL in immunocompetent patients. Staging, treatment and prognosis of PCL are discussed separately, as is the lymphomatous involvement of the central nervous system in patients harboring widespread nodal or extra-nodal systemic lymphoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37914?source=see_link\">",
"     \"Treatment and prognosis of primary central nervous system lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=see_link\">",
"     \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;PCL represents approximately 4 percent of newly diagnosed primary central nervous system (CNS) tumors, with an age-adjusted incidence rate of four cases per million persons per year [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. There was an increase in incidence, especially in older adults, from the 1960s to the 1990s, which peaked in the mid-1990s and has since declined [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/1,3-13\">",
"     1,3-13",
"    </a>",
"    ]. This is likely related to changes in",
"    <span class=\"nowrap\">",
"     HIV/AIDS",
"    </span>",
"    incidence and management during that time period.",
"   </p>",
"   <p>",
"    Most cases of non-AIDS related PCL are diagnosed in patients between 45 and 70 years of age, with a median age at diagnosis in the fifth decade [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/3,14-16\">",
"     3,14-16",
"    </a>",
"    ]. Rare cases have been described in children with a median age of 14 years [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/17\">",
"     17",
"    </a>",
"    ]. The incidence appears to increase with advancing age; few cases have been reported in children [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/4\">",
"     4",
"    </a>",
"    ]. Men and women are equally affected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREDISPOSING FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most notable risk factor for the development of PCL is immunodeficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/7,18\">",
"     7,18",
"    </a>",
"    ]. This includes HIV infection, iatrogenic immune suppression, and congenital immune deficiency including ataxia-telangiectasia, Wiskott-Aldrich syndrome and severe common and combined variable immunodeficiencies.",
"   </p>",
"   <p>",
"    Sporadic PCL, in apparently immunocompetent individuals, has been reported in association with other diseases. Antecedent flu-like or gastrointestinal illnesses have been seen in up to 15 percent of patients and many patients with PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/4\">",
"     4",
"    </a>",
"    ]. In addition, patients with autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren syndrome, myasthenia gravis, sarcoidosis, and vasculitis may be predisposed to develop PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/18\">",
"     18",
"    </a>",
"    ]. Rarely, patients have experienced a demyelinating disease, either sporadic or Lyme disease-related, that anteceded PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cellular and molecular events leading to neoplastic lymphocytic infiltration of the central nervous system (CNS) seen in PCL remain to be clarified [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/20\">",
"     20",
"    </a>",
"    ]. The CNS normally lacks lymphoid aggregates and it remains speculative whether malignant transformation develops locally within normally trafficking CNS lymphocytes, or systemically in a sub-population of lymphocytes with specific tropism for the CNS [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Such tropism may be facilitated through the expression of specific cell-surface adhesion molecules, such as CD44 and CD18, and various chemokine receptors. Spreading of malignant lymphoid cells within the CNS is believed to involve a complex interaction of selectin and adherin molecules, such as adhesion molecule CD44 and transmembrane protein receptor Fas(CD95) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The observation that systemic dissemination of PCL is rare suggests that the cells of origin in PCL may be derived from neoplastic lymphocytes that are eradicated from the periphery by an intact immune system, but which are able to survive in an immunologically aberrant CNS [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/14\">",
"     14",
"    </a>",
"    ]. The high incidence of PCL in immunodeficient states strongly implicates the immune system in the pathogenesis of PCL.",
"   </p>",
"   <p>",
"    In addition, Epstein-Barr virus (EBV) may have a causal link to the development of PCL. Genomic material from EBV has been detected within PCL cells in both immunocompromised and non-immunocompromised individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/3,26\">",
"     3,26",
"    </a>",
"    ]. However, the majority of non-immunosuppressed patients do not appear to have EBV genomic DNA within their tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/27\">",
"     27",
"    </a>",
"    ]. PCL may be a consequence of EBV-mediated clonal expansion and malignant transformation of B-lymphocytes, a process that may be regulated by immune mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/14,27\">",
"     14,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7321?source=see_link&amp;anchor=H2#H2\">",
"     \"AIDS-related lymphomas: Primary central nervous system lymphoma\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunoglobulin variable heavy gene (IgHV) analysis has offered some insight into cell origin in PCL. Almost all PCL cells demonstrate IgHV genes that have high levels of somatic mutations and show intraclonal heterogeneity pointing towards their derivation from mutated germinal center B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/28\">",
"     28",
"    </a>",
"    ]. However, immunohistochemical evaluation suggests that PCL are derived from post-germinal center B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;PCL can manifest in the brain, its coverings, the eye, or spinal cord. Five distinct clinicopathological entities have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/4,14,15,31-33\">",
"     4,14,15,31-33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intracranial lesion (solitary or multiple)",
"     </li>",
"     <li>",
"      Diffuse leptomeningeal or periventricular lesions",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Vitreous/uveal",
"      </span>",
"      deposits",
"     </li>",
"     <li>",
"      Intradural spinal cord lesion",
"     </li>",
"     <li>",
"      Nerve seeking lymphoma (Neurolymphomatosis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Presenting symptoms and signs vary, depending on the site of involvement. Although much less common, the clinical presentation of T-cell PCL appears to be similar to that of B-cell PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Primary cerebral lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of PCL present as symptoms related to periventricular lesions in the brain. As an example, a retrospective series of 248 immunocompetent patients with primary intracerebral lymphoma reported the following symptoms at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Focal neurological deficits &mdash; 70 percent",
"     </li>",
"     <li>",
"      Neuropsychiatric symptoms &mdash; 43 percent",
"     </li>",
"     <li>",
"      Signs of raised intracranial pressure &mdash; 33 percent",
"     </li>",
"     <li>",
"      Seizures &mdash; 14 percent",
"     </li>",
"     <li>",
"      Ocular symptoms &mdash; 4 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Presenting symptoms may include headaches, blurred vision, motor difficulties, and personality changes. The latter may manifest as depression, apathy, psychosis, confusion, memory impairment, slowness of thought, or visual hallucinations. Personality changes are most often associated with lesions of the frontal lobes, periventricular white matter, or corpus callosum. Although a frequent symptom, personality changes tend to develop slowly and remain unnoticed for long periods.",
"   </p>",
"   <p>",
"    Visual hallucinations may result from infiltration of visual pathways or the brainstem, or may result from ocular or leptomeningeal involvement. This may result in delayed diagnosis, as it is the later development of motor difficulties, such as hemiparesis or speech disturbances, that usually prompts neurologic evaluation.",
"   </p>",
"   <p>",
"    Cranial neuropathies, in particular facial nerve palsies, can occur either as a result of meningeal involvement or infiltration of the brainstem. Headache, especially late in the course of the disease, may be indicative of increased intracranial pressure or involvement of the leptomeninges.",
"   </p>",
"   <p>",
"    While most cases of PCL are comprised of aggressive lymphoma subtypes such as diffuse large B-cell lymphoma, a small number of patients with indolent lymphoma have been reported in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. These may mimic meningioma, sometimes involving the dura rather than the CNS proper.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Primary leptomeningeal lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ten to 25 percent of patients with PCL will develop meningeal involvement. On the other hand, it is extremely rare for patients without brain involvement to present with primary meningeal involvement. Therefore, symptomatic leptomeningeal involvement at presentation should prompt serious consideration of an underlying systemic lymphoma.",
"   </p>",
"   <p>",
"    Leptomeningeal disease can manifest with worsening headaches, cranial nerve palsies, meningismus,",
"    <span class=\"nowrap\">",
"     cervical/lumbar",
"    </span>",
"    radiculopathies, and hydrocephalus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Primary intraocular lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary intraocular lymphoma (PIOL) refers to a PCNSL, which initially presents in the eye with or without concurrent central nervous system (CNS) involvement. It is estimated that 15 to 25 percent of patients with PCNSL will have involvement of the eye. Diagnosis can be made by biopsy of the involved vitreous, choroid, or retina [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/39\">",
"     39",
"    </a>",
"    ]. Primary ocular lymphoma should be differentiated from retro-orbital lymphoma, which is frequently associated with systemic extranodal disease.",
"   </p>",
"   <p>",
"    Ocular involvement, either unilateral or bilateral, can be the initial presentation of PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/40\">",
"     40",
"    </a>",
"    ]. In almost half of patients, it precedes the development of clinically evident deposits within the brain parenchyma or cerebrospinal fluid (CSF) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/33\">",
"     33",
"    </a>",
"    ]. Alternatively, the vitreous and uvea may be a site of relapse in patients with established cerebral lymphoma. In this case, ocular involvement and symptoms occur months after the diagnosis of PCL.",
"   </p>",
"   <p>",
"    Primary ocular lymphoma tends to involve the posterior segment of the eye, including the vitreous, choroid, or retina, with subsequent development of uveitis (usually chronic and bilateral and occasionally atypical), exudative retinal detachment, and",
"    <span class=\"nowrap\">",
"     retinal/vitreous",
"    </span>",
"    hemorrhages (",
"    <a class=\"graphic graphic_picture graphicRef85793 \" href=\"UTD.htm?28/56/29568\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Occasionally, visual symptoms may follow occlusion of the retinal artery as a result of lymphomatous infiltration.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     Fluorescein",
"    </a>",
"    angiography may help to confirm retinal involvement. If ocular involvement is noted, color photography of the posterior pole of the eye should be obtained (",
"    <a class=\"graphic graphic_picture graphicRef85794 \" href=\"UTD.htm?8/40/8833\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The ocular symptoms and findings are frequently subtle and non-specific and not easily distinguished from those due to sarcoidosis, viral infections, or collagen-vascular diseases. They manifest as",
"    <span class=\"nowrap\">",
"     obscured/blurred",
"    </span>",
"    vision, altered visual acuity, floaters, or visual hallucinations [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/32,40,42\">",
"     32,40,42",
"    </a>",
"    ]. Typically symptoms are unilateral initially, but then usually progress to involve both eyes [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective analysis of 221 patients with PCNSL with ocular involvement at diagnosis reported the following symptoms at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/39\">",
"     39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ocular symptoms &mdash; 62 percent (isolated in 3 percent)",
"     </li>",
"     <li>",
"      Behavioral or cognitive change &mdash; 27 percent",
"     </li>",
"     <li>",
"      Hemiparesis &mdash; 14 percent",
"     </li>",
"     <li>",
"      Headache &mdash; 14 percent",
"     </li>",
"     <li>",
"      Aphasia &mdash; 11 percent",
"     </li>",
"     <li>",
"      Seizure &mdash; 5 percent",
"     </li>",
"     <li>",
"      Ataxia &mdash; 4 percent",
"     </li>",
"     <li>",
"      Visual field defect &mdash; 2 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Note that up to 38 percent of patients with ocular involvement will not have ocular symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/39\">",
"     39",
"    </a>",
"    ]. Diagnosis, therefore, requires a high degree of suspicion [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/44\">",
"     44",
"    </a>",
"    ]. Patients diagnosed with ocular involvement should undergo cranial imaging with magnetic resonance imaging (MRI) and lumbar puncture with cytologic examination of the CSF. In one study, positive CSF cytology was found in 35 of 151 patients (23 percent) with ocular involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Primary spinal lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary spinal involvement occurs in less than 1 percent of patients with PCL. The lesions are almost always discrete intramedullary nodules. This is in contrast to spinal involvement in systemic lymphoma, where there is usually diffuse leptomeningeal involvement or extradural nodules.",
"   </p>",
"   <p>",
"    In either case, spinal cord involvement manifests as a myelopathy. The pattern of weakness and sensory level (if present) will depend on the localization and extent of the lesion. The majority of reported cases of primary spinal lymphoma have involved the lower cervical or upper thoracic regions.",
"   </p>",
"   <p>",
"    A single institution retrospective analysis of 14 patients with primary intramedullary spinal cord lymphoma reported that all patients initially presented with a progressive myelopathy, which was subacute (&lt;8 weeks) in nine patients and insidious (&gt;8 weeks) in five patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/45\">",
"     45",
"    </a>",
"    ]. The diagnosis was often delayed with a median time to diagnosis of eight months (range 1 to 22 months). Presenting signs and symptoms included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progressive myelopathy &mdash; 100 percent",
"     </li>",
"     <li>",
"      Systemic B symptoms",
"      <span class=\"nowrap\">",
"       (fever/chills,",
"      </span>",
"      night sweats, weight loss, malaise) &mdash; 64 percent",
"     </li>",
"     <li>",
"      Back pain &mdash; 64 percent",
"     </li>",
"     <li>",
"      Evidence of lower motor neuron involvement on examination (areflexia or flaccid paralysis) &mdash; 43 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of importance, this study demonstrated that the clinical presentation and findings on MRI were nonspecific and the cerebrospinal fluid was nondiagnostic. Most patients had a concomitant lesion in the brain, a biopsy of which confirmed the diagnosis. Three patients had associated comorbidities: one with HIV, one with post-transplant lymphoproliferative disorder, and one with intravascular lymphoma. The lower motor neuron findings are not easily explained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neurolymphomatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurolymphomatosis (NL) refers to the lymphomatous invasion of nerve roots of the cranial or spinal nerves. Symptoms include loss of facial sensation or motor function, such as asymmetric weakness of the extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. The hallmark of NL is poorly localized severe pain in the absence of parenchymal lesions of the brain or spinal cord. The process frequently spares the meninges; thus CSF cytologic studies may not be revealing.",
"   </p>",
"   <p>",
"    The largest detailed series was a retrospective study performed by the International Primary CNS Lymphoma Collaborative Group that analyzed the presentation and outcomes of 50 patients with NL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/49\">",
"     49",
"    </a>",
"    ]. The majority of cases were due to B-cell non-Hodgkin lymphoma. NL was the initial presenting feature in 26 percent of cases. Over half of cases involved multiple neural structures with the following distribution:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Peripheral nerves (60 percent)",
"     </li>",
"     <li>",
"      Spinal nerve roots (48 percent)",
"     </li>",
"     <li>",
"      Cranial nerves (46 percent)",
"     </li>",
"     <li>",
"      Plexus (40 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most patients had both sensory and motor dysfunction on examination [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/49\">",
"     49",
"    </a>",
"    ]. Approximately 50 to 75 percent complained of painful neuropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION OF SUSPECTED DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to a detailed history and physical examination, the evaluation of persons suspected of having PCL should include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging of the central nervous system (CNS), ideally with contrast-enhanced magnetic resonance imaging (MRI).",
"     </li>",
"     <li>",
"      Cerebrospinal fluid (CSF) analysis, unless contraindicated due to elevated intracranial pressure.",
"     </li>",
"     <li>",
"      Slit lamp examination of both eyes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pathologic evaluation of material from the eyes or CSF may provide sufficient diagnostic material in some patients thereby avoiding brain biopsy. For patients who do not have evidence of CSF or ocular involvement, a stereotactic needle biopsy is the diagnostic procedure of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/50\">",
"     50",
"    </a>",
"    ]. Nerve biopsy is necessary if isolated neurolymphomatosis is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Radiographic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with symptoms suggesting the diagnosis of PCL should have a radiographic evaluation of the central nervous system. Contrast-enhanced magnetic resonance imaging (MRI) of the brain is the preferred imaging modality. Contrast-enhanced computed tomography (CT) may be used for patients with contraindications to MRI. Approximately 10 percent of PCL are missed on CT scans. MRI may detect lesions missed by CT, although both CT and MRI commonly fail to detect leptomeningeal or vitreal disease. Spinal disease can be detected by MRI.",
"   </p>",
"   <p>",
"    Several distinctive radiographic features suggest the diagnosis of PCL in immunocompetent individuals. Approximately 50 to 70 percent of immunocompetent patients with PCL develop solitary lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/27\">",
"     27",
"    </a>",
"    ], with the remainder (approximately 25 percent) developing multifocal disease. Periventricular lesions (eg, thalamus, basal ganglia, and corpus callosum) are most common (60 percent) followed by lesions in the frontal, parietal, temporal, and occipital lobes in 20, 18, 15, and 4 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The radiographic lesion tends to be a solitary non-hemorrhagic mass, situated in the deep white matter adjacent to the ventricular surface [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/51\">",
"     51",
"    </a>",
"    ]. The borders are sharply circumscribed in the majority of lesions (87 percent), but may be ill-defined (15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/35\">",
"     35",
"    </a>",
"    ]. Although mild surrounding edema is present in the majority of cases, it is usually less profound than that which accompanies metastatic foci of carcinoma. Mass effect may be seen in over half of the cases.",
"   </p>",
"   <p>",
"    Lesions appear isodense to hyperdense on CT images, isointense to hypointense on T2-weighted MRI images, and enhance homogeneously after contrast administration (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83271 \" href=\"UTD.htm?7/24/7559\">",
"     image 1",
"    </a>",
"    ). Diffusion weighted MRI images, sensitive to the intracellular water of masses of lymphoma cells, are frequently abnormal but similar changes may be seen in stroke and other brain tumors. Enhancement of the perivascular component surrounding small blood vessels as they course from the subarachnoid space and penetrate the brain parenchyma (eg, Virchow-Robin space) may be seen.",
"   </p>",
"   <p>",
"    Calcification, necrosis, cystic appearance, and ring enhancement are uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/51\">",
"     51",
"    </a>",
"    ]. However, cystic appearance may characterize PCL in immunosuppressed patients. The role of positron emission tomography (PET) scans in diagnosis is unclear. FDG-PET scans may be used to distinguish glucose-absorbing neoplastic lesions from areas of radiation necrosis, infection or inflammation, which may also enhance on conventional",
"    <span class=\"nowrap\">",
"     CT/MRI",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cerebrospinal fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the cerebrospinal fluid (CSF) may reveal the presence of malignant lymphoid cells in up to 30 percent of patients with PCL. If no mass effect exists, lumbar puncture should be performed on patients with suspected PCL. This examination should be performed either before or at least one week after surgical biopsy to avoid false-positive results.",
"   </p>",
"   <p>",
"    The CSF analysis should include cell counts, protein and glucose measurements, cytology, flow cytometry, and immunoglobulin heavy-chain gene (IgH) rearrangement studies by polymerase chain reaction (PCR). The latter study is particularly suited to the evaluation of pauci-cellular samples. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CSF often reveals an elevated protein concentration and a lymphocytic predominant pleocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/4,32,45\">",
"     4,32,45",
"    </a>",
"    ]. Glucose concentration is usually normal, but may be lowered in the presence of leptomeningeal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/4,32\">",
"     4,32",
"    </a>",
"    ]. There may be difficulty distinguishing between reactive and malignant cells or distinguishing reactive cells in the CSF from small cells of medulloblastoma as distinct from malignant B-cells. In such cases, immunophenotypic analysis using antibodies against lymphocytic antigens is particularly helpful in establishing the lymphoid origin and clonality of the malignant cells, when present, and to differentiate between B- and T-cell subtypes.",
"   </p>",
"   <p>",
"    The sensitivity and specificity of cytomorphologic analysis and PCR analysis of the CSF have not been fully evaluated. Each may have false negative or false positive results. This was best demonstrated in a prospective randomized trial that included 282 immunocompetent patients with PCL. Meningeal dissemination was evaluated using CSF cytomorphology, PCR of the rearranged IgH genes, and MRI in conjunction with cell count and protein concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/53\">",
"     53",
"    </a>",
"    ]. It is not clear if immunophenotypic analysis was performed. PCR and morphologic analysis produced discordant results. Lymphoma cells were confirmed by PCR in only 32 percent of cytomorphologically positive samples while only 35 percent of samples with a monoclonal result on PCR demonstrated lymphoma cells on cytology. These results suggest that both PCR for rearranged IgH genes and cytologic examination of the CSF may provide complimentary information regarding meningeal dissemination. It also suggests that serial CSF samples may increase the sensitivity of this analysis. Studies are ongoing to evaluate other methods of CSF analysis, such as the measurement of specific microRNA levels, to differentiate PCL from other neurologic disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The demonstration of neoplastic lymphocytes in the CSF is sufficient to confirm the diagnosis of PCL and obviates the need for a brain biopsy. However, while a positive CSF analysis can provide valuable diagnostic information, negative results do not exclude PCL or the infiltration of the leptomeninges by PCL.",
"   </p>",
"   <p>",
"    The diagnosis of leptomeningeal involvement can be made by:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Demonstration of immunoglobulin gene rearrangement of B cells in the cerebrospinal fluid (CSF)",
"     </li>",
"     <li>",
"      Immunocytologic identification of clonal B-cells in the CSF",
"     </li>",
"     <li>",
"      Identification of lymphoma nodules on lumbar nerve roots via scanning procedures such as CT or MRI in patients with pathologically diagnosed PCL.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Slit lamp examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Slit lamp examination is the diagnostic procedure of choice for evaluation of possible ocular disease in patients with suspected or confirmed PCL. Initial signs of primary ocular lymphoma include yellowish-white infiltrates at the sub-retinal pigment epithelium",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vitreous opacity (",
"    <a class=\"graphic graphic_picture graphicRef69592 \" href=\"UTD.htm?4/17/4369\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/55\">",
"     55",
"    </a>",
"    ]. Ophthalmic ultrasonography may be a useful adjunctive technique for detecting ocular or retro-bulbar involvement in PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ocular involvement can be evaluated with biopsy of the vitreous, choroid, or retina. Multiple biopsy attempts may be necessary to confirm the diagnosis. Vitrectomy, when combined with cytopathology, flow cytometry, and analysis of immunoglobulin heavy chain gene arrangement, can facilitate diagnosis of vitreous involvement with specificities of 1.0 and sensitivities approaching 0.64 [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not validated, some ocular immunologists have come to assume intraocular involvement in the setting of vitreal fluids with elevated ratios of interleukin 10 to interleukin 6; the former is elevated in B-cell lymphoma while the latter is increased in inflammatory states. At this time, these ratios are considered suggestive, but not diagnostic of intraocular lymphoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stereotactic needle biopsy of involved tissue is the diagnostic procedure of choice for PCL if there is no evidence of ocular or CNS involvement. The reason for this is two-fold; patients do not benefit clinically from the surgical resection of PCL and their frequent periventricular location increases the risk of surgical complications.",
"   </p>",
"   <p>",
"    The pathologic evaluation and classification of PCL tumors is similar to that of tumors of systemic non-Hodgkin lymphoma (NHL). Tumors are evaluated based upon their morphology and immunophenotype. The vast majority of PCL tumors (80 to 85 percent) are of the aggressive or highly aggressive, diffuse large cell subtypes, and almost all are of B-cell phenotypic origin [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/3,4,11,14,58,59\">",
"     3,4,11,14,58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We have encountered only two patients (out of over 200) with PCL of T-cell origin [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/60\">",
"     60",
"    </a>",
"    ]. However, the relative frequency of different lymphoma subtypes may differ by geography. As an example, an analysis from Korea reported seven of 42 patients were found to have primary CNS lymphoma of T-cell origin [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/61\">",
"     61",
"    </a>",
"    ]. Primary CNS Hodgkin lymphoma and low-grade primary CNS lymphoma are extremely rare [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/62\">",
"     62",
"    </a>",
"    ]. The latter has a better long-term outcome than aggressive histology primary CNS lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common histopathologic subtype of PCL is diffuse large B-cell lymphoma (DLBCL). As examples, a series of 33 patients with PCL reported that all of these tumors were DLBCL, with the vast majority being of the centroblastic subtype [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/16\">",
"     16",
"    </a>",
"    ]. The majority was positive for BCL-6, MUM1, and BCL-2; all were negative for CD138. Similar results were seen in a series of 51 patients with HIV-unrelated PCL and a histologic diagnosis of DLBCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/64\">",
"     64",
"    </a>",
"    ]. Positivity for MUM-1, BCL-6, BCL-2, CD10, or CD 138 was seen in 84, 61, 49, 18, and zero percent, respectively. The diagnosis of DLBCL is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/45/24282?source=see_link\">",
"     \"Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tumors tend to infiltrate along the perivascular spaces and surrounding parenchyma, occasionally invading the blood vessel wall. The vast majority of these tumors are composed of large immunoblastic and centroblastic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/3,10,11\">",
"     3,10,11",
"    </a>",
"    ]. Endothelial proliferation and cyst formation are uncommon.",
"   </p>",
"   <p>",
"    The edges of the infiltrating growth often contain mixtures of tumor cells, reactive astrocytes and T lymphocytes. T cells appear within the spinal fluid. In one study, reactive perivascular T-cell infiltrates (RPVIs) were found in 36 percent of 73 assessable cases [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/65\">",
"     65",
"    </a>",
"    ]. RPVIs were associated with significantly better overall survival than RPVI-negative cases, particularly among those treated with high-dose methotrexate-based chemotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical manifestations of PCL are insidious and may evade diagnosis over extended periods of time. As a result, the duration of symptoms before diagnosis in immunocompetent patients varies between three to seven months. Early diagnosis, therefore, requires a high degree of suspicion.",
"   </p>",
"   <p>",
"    Tissue diagnosis should not be delayed in patients with suspected PCL. Definitive diagnosis requires histopathological evaluation of tissue obtained from lesions suspected to be PCL. Some patients may be diagnosed based upon the pathologic evaluation of vitreal biopsies or CSF analysis. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Cerebrospinal fluid analysis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Slit lamp examination'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients without ocular or CSF involvement, stereotactic biopsy is usually the method of choice, providing a high rate of positive tissue diagnosis, with a low rate (&lt;2 percent) of morbidity and mortality. Extensive resection of the lesion(s) is impractical in the majority of cases, given the deep location of the lesions. Moreover, resection results in high rates of complication and does not improve prognosis.",
"   </p>",
"   <p>",
"    In general, we avoid the use of corticosteroids prior to biopsy, as these agents are lymphocytotoxic; a single injection is known to alter proper histopathologic evaluation, and a short course of treatment may cause the tumor to disappear temporarily. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37914?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment and prognosis of primary central nervous system lymphoma\", section on 'Initial Treatment'",
"    </a>",
"    .) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/66-69\">",
"     66-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pathologic evaluation of the tissue specimen should include both light microscopy and immunohistochemistry. Occasionally, the initial specimen fails to confirm the pathological diagnosis of PCL. The pathology may be suggestive of \"inflammation,\" \"demyelination,\" or \"viral encephalitis.\" These may represent sentinel lesions eventually progressing into lymphoma, since some patients with these findings have returned with new lesions that are pathologically proven to be PCL [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/3,4,32\">",
"     3,4,32",
"    </a>",
"    ]. Similarly uncertain diagnoses may accompany partially treated PCL or biopsies performed on the edge of the tumor.",
"   </p>",
"   <p>",
"    Occasional cases can be diagnosed using polymerase chain reaction techniques on tissue biopsies or cells from the cerebrospinal fluid by showing clonal rearrangements of the T-cell receptor or IgH genes [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/61\">",
"     61",
"    </a>",
"    ]. As the PCR primers employed do not include the entire range of possible rearranged sites, and as some PCL may be initially polyclonal in nature, the IgH analyses have a sensitivity rate of 70 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other primary or secondary CNS tumors are frequently considered in the radiological differential diagnosis of PCL. The peritumoral edema surrounding most glial tumors and metastatic lesions is uncommonly encountered in PCL. Calcification, hemorrhage, necrosis, cystic appearance, and ring enhancement pattern are uncommon in PCL in immunocompetent individuals. Their presence should raise the possibility of a diagnosis other than PCL. Occasionally, dural-based lymphomas may mimic a meningioma. These tumors may also be mistaken for inflammatory pseudotumors of the dura, plasma cell granulomas, Castleman's disease, Rosai-Dorfman disease, and non-Hodgkin lymphoma of the skull extending into the dura [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/4,32\">",
"     4,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pathologically, diseases of small \"blue cells\" similar to lymphoma include primitive neuroectodermal tumors (PNET), undifferentiated carcinoma, anaplastic oligodendroglioma, metastatic amelanotic melanoma, and toxoplasmosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Immunohistochemical studies are invaluable in this regard. In particular, leukocyte common antigen (CD45) can help to confirm the diagnosis of lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/18\">",
"     18",
"    </a>",
"    ]. Patients with initial tissue pathology suggestive of demyelination or non-specific inflammation should be followed carefully, as these findings may be precursors of frank lymphomatous pathology later in the course of the disease.",
"   </p>",
"   <p>",
"    Several variants of systemic non-Hodgkin lymphoma with predilection for CNS involvement have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30217/abstract/32\">",
"     32",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intravascular lymphoma (angioendotheliomatosis) is a rare form of systemic lymphoma in which neoplastic lymphocytes can be seen within the lumen of cerebral blood vessels without extravasation into the brain parenchyma. These patients often develop acute neurologic deficits or rapidly progressive encephalopathy as a result of multifocal ischemic cerebrovascular accidents, secondary to occlusion of small arteries with lymphoma cells. Unlike PCL, skin and adrenals are often involved. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13511?source=see_link\">",
"       \"Intravascular large cell lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Systemic T-cell lymphomas not uncommonly disseminate to the leptomeninges, presenting with a mass lesion or meningeal signs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Occasionally, solitary masses of benign lymphocytes are seen in the CNS. They are thought to represent low-grade lymphoma. Similarly, lymphocytic infiltrates that do not have a malignant phenotype are said to be pseudolymphomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary central nervous system lymphoma (PCL) is an uncommon variant of extranodal non-Hodgkin lymphoma (NHL) that involves the brain, leptomeninges, eyes, or spinal cord without evidence of systemic disease. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most notable risk factor for the development of PCL is immunodeficiency and this may play a role in the pathogenesis of disease. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Predisposing factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PCL can manifest in the brain, its coverings, the eye, or spinal cord. Presenting symptoms and signs vary, depending on the site of involvement. Symptoms may include focal neurological deficits, neuropsychiatric symptoms, signs of raised intracranial pressure, seizures, and ocular symptoms. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to a detailed history and physical examination, the evaluation of persons suspected of having PCL should include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Imaging of the central nervous system (CNS), ideally with contrast-enhanced magnetic resonance imaging (MRI). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Radiographic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cerebrospinal fluid (CSF) analysis, unless contraindicated due to elevated intracranial pressure. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Cerebrospinal fluid analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Slit lamp examination of both eyes. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Slit lamp examination'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pathologic evaluation of material from the eyes or CSF may provide sufficient diagnostic material in some patients, thereby avoiding brain biopsy. For patients who do not have evidence of CSF or ocular involvement, a stereotactic needle biopsy is the diagnostic procedure of choice. Nerve biopsy is necessary if isolated neurolymphomatosis is suspected. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/1\">",
"      Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 2006; 8:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/2\">",
"      Villano JL, Koshy M, Shaikh H, et al. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer 2011; 105:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/3\">",
"      Miller DC, Hochberg FH, Harris NL, et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 1994; 74:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/4\">",
"      Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/5\">",
"      Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997; 79:2409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/6\">",
"      Ahsan H, Neugut AI, Bruce JN. Trends in incidence of primary malignant brain tumors in USA, 1981-1990. Int J Epidemiol 1995; 24:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/7\">",
"      Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999; 43:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/8\">",
"      Haldorsen IS, Krossnes BK, Aarseth JH, et al. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey. Cancer 2007; 110:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/9\">",
"      Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002; 95:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/10\">",
"      Krogh-Jensen M, d'Amore F, Jensen MK, et al. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol 1994; 5:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/11\">",
"      Krogh-Jensen M, D'Amore F, Jensen MK, et al. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma 1995; 19:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/12\">",
"      Aalen OO, Farewell VT, De Angelis D, et al. New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expected. AIDS 1999; 13:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/13\">",
"      Kadan-Lottick NS, Skluzacek MC, Gurney JG. Decreasing incidence rates of primary central nervous system lymphoma. Cancer 2002; 95:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/14\">",
"      Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/15\">",
"      Herrlinger U, Schabet M, Clemens M, et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 1998; 97:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/16\">",
"      Braaten KM, Betensky RA, de Leval L, et al. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 2003; 9:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/17\">",
"      Abla O, Weitzman S, Blay JY, et al. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Clin Cancer Res 2011; 17:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/18\">",
"      Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med 2008; 132:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/19\">",
"      Brecher K, Hochberg FH, Louis DN, et al. Case report of unusual leukoencephalopathy preceding primary CNS lymphoma. J Neurol Neurosurg Psychiatry 1998; 65:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/20\">",
"      Montesinos-Rongen M, Siebert R, Deckert M. Primary lymphoma of the central nervous system: just DLBCL or not? Blood 2009; 113:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/21\">",
"      Smith JR, Braziel RM, Paoletti S, et al. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003; 101:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/22\">",
"      Kadoch C, Treseler P, Rubenstein JL. Molecular pathogenesis of primary central nervous system lymphoma. Neurosurg Focus 2006; 21:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/23\">",
"      Aho R, Kalimo H, Salmi M, et al. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. J Neuropathol Exp Neurol 1997; 56:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/24\">",
"      Baiocchi RA, Khatri VP, Lindemann MJ, et al. Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome. Blood 1997; 90:1737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/25\">",
"      Tun HW, Personett D, Baskerville KA, et al. Pathway analysis of primary central nervous system lymphoma. Blood 2008; 111:3200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/26\">",
"      Mittra RA, Pulido JS, Hanson GA, et al. Primary ocular Epstein-Barr virus-associated non-Hodgkin's lymphoma in a patient with AIDS: a clinicopathologic report. Retina 1999; 19:45.",
"     </a>",
"    </li>",
"    <li>",
"     Rock, JP, Cher, L, Hochberg, FH, et al. Primary CNS lymphoma. In: Neurological surgery, 4th ed., Yomans, JR (Ed), WB Saunders, Philadelphia 1996. p.2688.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/28\">",
"      Montesinos-Rongen M, K&uuml;ppers R, Schl&uuml;ter D, et al. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 1999; 155:2077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/29\">",
"      Malumbres R, Davis J, Ruiz P, Lossos IS. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas. Br J Haematol 2007; 138:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/30\">",
"      Camilleri-Bro&euml;t S, Crini&egrave;re E, Bro&euml;t P, et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 2006; 107:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/31\">",
"      Blay JY. [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects]. Bull Cancer 1997; 84:976.",
"     </a>",
"    </li>",
"    <li>",
"     Rock JP, Cher L, Hochberg FH, et al. Central nervous system lymphomas in AIDS and non-AIDS patients. In: Neurological Surgery, 4th ed, Yomans JR (Ed), WB Saunders, Philadelphia 1995. p.593.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/33\">",
"      Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist 2011; 16:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/34\">",
"      Shenkier TN, Blay JY, O'Neill BP, et al. Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 2005; 23:2233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/35\">",
"      Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/36\">",
"      Tu PH, Giannini C, Judkins AR, et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol 2005; 23:5718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/37\">",
"      Giordano A, Perrone T, Guarini A, et al. Primary intracranial dural B cell small lymphocytic lymphoma. Leuk Lymphoma 2007; 48:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/38\">",
"      Jahnke K, Thiel E, Schilling A, et al. Low-grade primary central nervous system lymphoma in immunocompetent patients. Br J Haematol 2005; 128:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/39\">",
"      Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 2008; 71:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/40\">",
"      Hormigo A, Abrey L, Heinemann MH, DeAngelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 2004; 126:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/41\">",
"      Park S, Abad S, Tulliez M, et al. Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients. Medicine (Baltimore) 2004; 83:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/42\">",
"      Rivero ME, Kuppermann BD, Wiley CA, et al. Acquired immunodeficiency syndrome-related intraocular B-cell lymphoma. Arch Ophthalmol 1999; 117:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/43\">",
"      Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: A review. Semin Ophthalmol 2006; 21:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/44\">",
"      Merle-B&eacute;ral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol 2004; 124:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/45\">",
"      Flanagan EP, O'Neill BP, Porter AB, et al. Primary intramedullary spinal cord lymphoma. Neurology 2011; 77:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/46\">",
"      Khong P, Pitham T, Owler B. Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine (Phila Pa 1976) 2008; 33:E807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/47\">",
"      Levin N, Soffer D, Grissaru S, et al. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol 2008; 90:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/48\">",
"      Da Silva AN, Lopes MB, Schiff D. Rare pathological variants and presentations of primary central nervous system lymphomas. Neurosurg Focus 2006; 21:E7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/49\">",
"      Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 2010; 115:5005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/50\">",
"      Abrey LE, Batchelor TT, Ferreri AJ, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005; 23:5034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/51\">",
"      B&uuml;hring U, Herrlinger U, Krings T, et al. MRI features of primary central nervous system lymphomas at presentation. Neurology 2001; 57:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/52\">",
"      Karantanis D, O'Neill BP, Subramaniam RM, et al. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Clin Nucl Med 2007; 32:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/53\">",
"      Fischer L, Martus P, Weller M, et al. Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology 2008; 71:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/54\">",
"      Baraniskin A, Kuhnhenn J, Schlegel U, et al. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 2011; 117:3140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/55\">",
"      Matsuo T, Yamaoka A, Shiraga F, Matsuo N. Two types of initial ocular manifestations in intraocular-central nervous system lymphoma. Retina 1998; 18:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/56\">",
"      Ursea R, Heinemann MH, Silverman RH, et al. Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement. Retina 1997; 17:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/57\">",
"      Baehring JM, Androudi S, Longtine JJ, et al. Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 2005; 104:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/58\">",
"      Rubenstein JL, Fridlyand J, Shen A, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood 2006; 107:3716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/59\">",
"      Montesinos-Rongen M, Brunn A, Bentink S, et al. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia 2008; 22:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/60\">",
"      Gijtenbeek JM, Rosenblum MK, DeAngelis LM. Primary central nervous system T-cell lymphoma. Neurology 2001; 57:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/61\">",
"      Choi JS, Nam DH, Ko YH, et al. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 2003; 27:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/62\">",
"      de Castro AF, J&uacute;nior AS, de Lins e Horta H, et al. Primary intracerebral Hodgkin lymphoma. Br J Haematol 2007; 138:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/63\">",
"      Jahnke K, Korfel A, O'Neill BP, et al. International study on low-grade primary central nervous system lymphoma. Ann Neurol 2006; 59:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/64\">",
"      Lin CH, Kuo KT, Chuang SS, et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin. Clin Cancer Res 2006; 12:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/65\">",
"      Ponzoni M, Berger F, Chassagne-Clement C, et al. Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol 2007; 138:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/66\">",
"      Heckmann JG, Bockhorn J, Stolte M, et al. An instructive false diagnosis: steroid-induced complete remission of a CNS tumor--probably lymphoma. Neurosurg Rev 1998; 21:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/67\">",
"      Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003; 361:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/68\">",
"      Alderson L, Fetell MR, Sisti M, et al. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 1996; 60:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30217/abstract/69\">",
"      Porter AB, Giannini C, Kaufmann T, et al. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol 2008; 63:662.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4693 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-259ED97FEC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30217=[""].join("\n");
var outline_f29_32_30217=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREDISPOSING FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Primary cerebral lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Primary leptomeningeal lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Primary intraocular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Primary spinal lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neurolymphomatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION OF SUSPECTED DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Radiographic features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cerebrospinal fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Slit lamp examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/4693\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4693|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/24/7559\" title=\"diagnostic image 1\">",
"      MRI of primary CNS lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4693|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/56/29568\" title=\"picture 1\">",
"      CNS lymphoma subretinal pigment epithelium infiltrates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/40/8833\" title=\"picture 2\">",
"      Vitreous cells in intraocular-CNS lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/17/4369\" title=\"picture 3\">",
"      Primary vitreoretinal lymphoma fundoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7321?source=related_link\">",
"      AIDS-related lymphomas: Primary central nervous system lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/45/24282?source=related_link\">",
"      Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13511?source=related_link\">",
"      Intravascular large cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=related_link\">",
"      Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=related_link\">",
"      Secondary involvement of the central nervous system by non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37914?source=related_link\">",
"      Treatment and prognosis of primary central nervous system lymphoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_32_30218="Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient";
var content_f29_32_30218=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30218/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30218/contributors\">",
"     Barbara H McGovern, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30218/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30218/contributors\">",
"     David Thomas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?29/32/30218/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?29/32/30218/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?29/32/30218/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intersection of the HIV and hepatitis C virus (HCV) epidemics has significant clinical implications and raises many challenging issues for patients and their health care providers [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/1\">",
"     1",
"    </a>",
"    ]. A thorough understanding of the natural history of liver disease in this complex patient population is critical for optimal management.",
"   </p>",
"   <p>",
"    The epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient will be discussed here. Evaluation and treatment and data from major clinical trials are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38536?source=see_link\">",
"     \"Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VIROLOGY OF HCV",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Viral kinetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV (a retrovirus) and HCV (a flavivirus) are RNA viruses. The viral kinetics of HIV and HCV have been determined by perturbation of the steady-state between virus production and clearance with potent antiviral agents [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. HIV viral production rates approximate 10(10) virions a day with a half-life of less than six hours [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/2\">",
"     2",
"    </a>",
"    ]. Virion production rates are even greater with HCV, approaching 10(12) virions a day with a virion half-life of 2.7 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Viral load",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the chronic stage of either HIV or HCV infection, a relatively stable viral load or \"set point\" is maintained [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. However, in the setting of combined infection, HCV RNA levels increase after HIV seroconversion and continue to increase over time compared with patients with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The level of HCV viremia is inversely correlated with lower CD4 counts in most, but not all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/7,8\">",
"     7,8",
"    </a>",
"    ] and may transiently increase with initiation of antiretroviral therapy (ART) or heavy alcohol use [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/9\">",
"     9",
"    </a>",
"    ]. Overall increases in the HCV viral load do not have implications for the severity of liver-related disease, but do have an impact on treatment response. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study evaluated whether higher levels of HCV viremia in HIV-infected patients may be related to immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/10\">",
"     10",
"    </a>",
"    ]. The researchers reasoned that if high levels of replication were due to decreased immune selective pressure, then a reduced rate of nucleotide changes would be expected within the virus itself. However, in an investigation of HCV envelope sequences in 79 patients, with or without HIV coinfection, no significant divergence was demonstrated over time between the two groups. Another way HIV infection may increase HCV replication is through the virus itself; one in vitro study demonstrated that the envelope protein of HIV (gp120) increased HCV replication through engagement of cellular coreceptors of HIV (ie, CXCR4 or CCR5) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Viral reservoirs",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV replicates in many cell types in addition to CD4+ T-cells [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/12\">",
"     12",
"    </a>",
"    ]. More controversial is whether HCV also replicates in extrahepatic sites such as peripheral blood mononuclear cells (PBMCs) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/13\">",
"     13",
"    </a>",
"    ]. While some studies have documented HCV RNA-negative strands (the viral replicative intermediate) in PBMCs, others have not confirmed this finding [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Some have suggested that HCV RNA replication in PBMCs may occur in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients, but not in those with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The implications for HIV-infected patients are unclear, but in other chronic infections (eg, tuberculosis and cytomegalovirus), continuous activation of the immune system can lead to an increase in activated CD4+ T-cells, which are preferential targets of HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. HCV replication in PBMCs or dendritic cells could also be a mechanism for the relapse of HCV viremia that is seen in HIV-infected patients after treatment is discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38536?source=see_link\">",
"     \"Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HCV has also been isolated from cervicovaginal lavage fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/19\">",
"     19",
"    </a>",
"    ] in HIV-seropositive women, but not in women with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/20\">",
"     20",
"    </a>",
"    ]. This may explain the higher rates of perinatal HCV transmission observed in the setting of coinfection. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Epidemiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetic heterogeneity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single-stranded RNA viruses, like HIV and HCV, lack proofreading mechanisms, resulting in high mutational rates [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/21\">",
"     21",
"    </a>",
"    ]. This leads to the formation of genetically distinct viral variants that collectively comprise a \"quasispecies.\" Whether a particular nucleotide substitution results in a replication-competent mutant depends upon the involved site.",
"   </p>",
"   <p>",
"    With HIV, it is estimated that all possible single-point mutations occur between 10(4) and 10(5) times per day in an infected individual [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/22\">",
"     22",
"    </a>",
"    ]. This leads to a large pool of genetic variants able to adapt rapidly to changing selective drug pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During replication of HCV, RNA-dependent RNA polymerase frequently introduces random nucleotide errors, resulting in a high rate of spontaneous nucleotide substitutions [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/24\">",
"     24",
"    </a>",
"    ]. Like HIV, sequence heterogeneity is concentrated in certain regions, such as the first hypervariable region (HVR1) of the E2 gene, which encodes the envelope protein of HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/25\">",
"     25",
"    </a>",
"    ]. This is analogous to the hypervariable region in the V3 loop of gp120, the envelope protein of HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/26\">",
"     26",
"    </a>",
"    ]. Increased sequence variability of the E2 HVR of the HCV genome has been noted in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    individuals when compared with HCV-infected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These similarities between HIV and HCV viral diversity have treatment implications. The extent of the quasispecies evolution in an individual and the level of viremia have been implicated as predictors of response to interferon [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/25,27\">",
"     25,27",
"    </a>",
"    ]. In one study of",
"    <span class=\"nowrap\">",
"     HIV/HCV",
"    </span>",
"    coinfected patients, lower quasispecies complexity of HCV was associated with earlier viral clearance in response to interferon-based regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/28\">",
"     28",
"    </a>",
"    ]. Furthermore, there is evidence of different evolution of the quasispecies of HCV in various compartments as has been noted for HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential for HCV drug resistance parallels that of HIV, as demonstrated with the introduction of specifically targeted antiviral agents against HCV (eg, STAT-C) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/30\">",
"     30",
"    </a>",
"    ]. As described in the past with HIV, resistance mutations to specific HCV protease and polymerase inhibitors have been identified even in treatment-naive HCV and",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. These issues will become more important with the introduction of STAT-C agents into clinical practice in the future [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38378?source=see_link\">",
"     \"Investigational therapies for hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coinfection with HIV and HCV is common since both infections share similar routes of transmission. In the United States, approximately 30 percent of patients who are HIV-infected are also coinfected with HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/33\">",
"     33",
"    </a>",
"    ]. Similar rates have been reported in Europe. However, since the relative efficiency of transmission differs according to route, the prevalence of coinfection varies markedly among various risk groups. In one clinical trial, for example, HCV seroprevalence in HIV-infected patients ranged from 73 percent in intravenous drug users to only 4 percent in patients considered to be at low risk [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sequence of infections also tends to aggregate by transmission route. For example, injection drug users usually acquire HCV before HIV infection while men who have sex with men (MSM) typically are infected with HIV before they acquire HCV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Percutaneous exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCV is transmitted efficiently via percutaneous routes, so seroprevalence rates are highest in intravenous drug users and hemophiliacs who received contaminated blood products prior to the introduction of HCV screening in 1990. Injection drug use is currently the leading route of HCV transmission in the United States, since the risk of posttransfusion HCV infection is now very low. Approximately 50 to 90 percent of drug users are infected with HCV after sharing contaminated needles or drug paraphernalia [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=see_link&amp;anchor=H11#H11\">",
"     \"Laboratory testing of donated blood\", section on 'Hepatitis C virus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Heterosexual partners",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among heterosexual partners, HIV is much more easily transmissible than HCV via intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. The risk of HCV transmission is exceedingly low in monogamous couples [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/40\">",
"     40",
"    </a>",
"    ], but appears to increase in patients who report multiple sexual partners [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/37,41\">",
"     37,41",
"    </a>",
"    ]. Whether underlying HIV infection increases the risk of heterosexual HCV transmission to an uninfected partner is unclear due to contradictory study results [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology and transmission of hepatitis C virus infection\", section on 'Sexual or household contact'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Men who have sex with men",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of hepatitis C in HIV-infected men who have sex with men (MSM) varies by geographic region. The seroprevalence of HCV in MSM in the United States ranges from about 4 to 8 percent, which is similar to that found in HIV-uninfected homosexual men [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/45\">",
"     45",
"    </a>",
"    ] but higher than that reported for the entire population (1.8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/46\">",
"     46",
"    </a>",
"    ]. In a study of 689 MSM from the Netherlands, HCV prevalence was 0.4 percent among HIV-negative MSM and 18 percent among HIV-positive MSM [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/47\">",
"     47",
"    </a>",
"    ]. Over the study period, HCV prevalence among HIV-infected MSM increased significantly (15 to 21 percent).",
"   </p>",
"   <p>",
"    Accumulating data from the United States and Europe suggest that an increased risk of HCV transmission exists among MSM who have no other identifiable risk factor except unsafe sex [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/48-53\">",
"     48-53",
"    </a>",
"    ]. Molecular methodology has been useful in identifying transmission clusters of HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/52,54,55\">",
"     52,54,55",
"    </a>",
"    ]. For example, phylogenetic analysis of genotype 4 HCV virus in 12 HIV-infected MSM found that 10 had an identical source of infection, which appeared to be sexually transmitted [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/54\">",
"     54",
"    </a>",
"    ]. In recent years, new HCV infections appear to be especially common among HIV-infected MSM; HCV transmission may be enhanced by mucosal injury",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    concomitant sexually transmitted diseases. [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/41\">",
"     41",
"    </a>",
"    ]. Among MSM, unprotected anal sex, fisting, group sex, and recreational drugs (eg, gamma hydroxy butyrate) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/47\">",
"     47",
"    </a>",
"    ] are associated with HCV acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/52,55,56\">",
"     52,55,56",
"    </a>",
"    ]. The importance of mucosal damage as a risk factor for HCV acquisition was highlighted in a report in which 18 of 20 MSM reported either genital ulcerative disease (lymphogranuloma venereum, syphilis, or HSV-2) or fisting within the period of acute HCV seroconversion [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Perinatal transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertical transmission of HCV appears to be facilitated by HIV-coinfection. A meta-analysis of 10 studies demonstrated that maternal coinfection increases the odds of vertical HCV transmission by approximately 90 percent (odds ratio, 1.9; 95% CI 1.4-2.7), compared with maternal HCV infection alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26936?source=see_link\">",
"     \"Vertical transmission of hepatitis C virus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Health care workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are rare case reports of health care workers who have simultaneously acquired HIV and HCV via percutaneous exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <span class=\"nowrap\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23416?source=see_link\">",
"      \"Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus\"",
"     </a>",
"     .)",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF LIVER DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV/HCV-coinfected",
"    patients have accelerated rates of fibrosis progression compared with patients with HCV alone. Insight into the mechanisms that underlie the immunopathogenesis of these persistent viral infections could lead to new therapeutic strategies [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Cellular immune responses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver fibrosis progression may be related to weak cellular immune responses to HCV antigens in HIV-infected patients. HIV infection is characterized by marked decreases in the number of circulating CD4 cells, functional impairment of both CD4 and CD8 cells, and down-regulation of CD28 expression, a costimulatory molecule required for effective lymphocyte activation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/59\">",
"     59",
"    </a>",
"    ]. Patients with low absolute CD4+ T-cell counts have a diminished frequency of HCV-specific CD8+ T-cell responses [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/60\">",
"     60",
"    </a>",
"    ]. This observation provides a possible link between advanced immunosuppression and liver disease progression since CD8+ T-cell responses are thought to be of primary importance in the immune response to viral infection. Furthermore, successful antiretroviral therapy (ART) may restore cellular immune responses to HCV antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     HIV-associated immune activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another hypothesis suggests that chronic immune activation, secondary to HIV infection, influences liver disease progression through increased circulation of pro-inflammatory cytokines.",
"   </p>",
"   <p>",
"    Chronic immune activation may be mediated by translocation of microbial products due to impaired gut mucosal integrity [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/62\">",
"     62",
"    </a>",
"    ]. Disruption of mucosal barriers occurs in conjunction with severe CD4 depletion in gut-associated lymphoid tissue during early HIV infection. Translocation of microbial products is inferred by high circulating levels of serum lipopolysaccharide; in contrast, treatment with ART reduces LPS levels.",
"   </p>",
"   <p>",
"    One study of",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients found that CD4 lymphocyte depletion was strongly associated with markers of microbial translocation (eg, LPS, soluble CD14, and others); these markers were also associated with the development of cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/63\">",
"     63",
"    </a>",
"    ]. The development of fibrosis may be related to Kupffer cell depletion, which is directly associated with CD4 T cell decline [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Activation of hepatic stellate cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activated hepatic stellate cells (HSCs) mediate collagen formation in hepatitis C virus (HCV)-related liver fibrosis. One study found that HSC activation levels were directly associated with CD4 and CD8 T cell immune activation and enhanced interleukin-15 (IL-15) gene expression, suggesting a pathogenic role for IL-15 in mediating liver fibrosis progression in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     HIV and apoptosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates apoptosis in normal hepatocytes and is upregulated during HCV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/66\">",
"     66",
"    </a>",
"    ]. One in vitro study has suggested that glycoproteins of HIV (ie, gp120) may sensitize hepatocytes to cell death through upregulation of TRAIL-mediated apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     HCV-associated proinflammatory cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCV infection itself induces immunoregulatory and proinflammatory pathways that may contribute to progression of liver fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/65\">",
"     65",
"    </a>",
"    ]. These same proinflammatory cytokines may have a deleterious effect on HIV disease as well. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Effect of HCV on the natural history of HIV'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     EFFECT OF HIV ON THE NATURAL HISTORY OF HCV",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with chronic HCV infection, concomitant HIV infection is associated with higher rates of morbidity and mortality related to end-stage liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/68,69\">",
"     68,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Viral clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients have lower rates of spontaneous virologic clearance during acute infection, which may be due to impaired lymphoproliferative responses to HCV antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Fibrosis progression rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hepatitis C and underlying HIV progress faster to cirrhosis than patients with hepatitis C alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/72-75\">",
"     72-75",
"    </a>",
"    ]. In one cohort, individuals with HCV and HIV were noted to have liver fibrosis stages similar to those without HIV who were nearly a decade older [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/74\">",
"     74",
"    </a>",
"    ]. Risk factors associated with higher rates of fibrosis progression include alcohol use, age, and CD4+ T-cell counts &lt;200",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/72,74,76\">",
"     72,74,76",
"    </a>",
"    ]. Especially high rates of progression to cirrhosis have been reported among HIV-infected men who have sex with men who are subsequently infected with hepatitis C [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some cross-sectional studies have utilized one biopsy and have calculated liver disease progression rates based on estimated duration of HCV infection. Studies using paired biopsies over time can offer greater insight into rates of fibrosis progression and risk factors for the development of advanced disease [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study of paired liver biopsy samples in 174 noncirrhotic HIV-infected patients over a median interval of 2.9 years demonstrated that significant fibrosis progression (defined as an increase of two or more Ishak fibrosis units) occurred in 24 percent of the study participants [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/77\">",
"       77",
"      </a>",
"      ]. In this study an elevated serum aspartate aminotransferase level between biopsies was associated with a threefold increased risk of fibrosis progression.",
"     </li>",
"     <li>",
"      Another study involving 135 patients with paired biopsies found that 44 percent had progression of one or more stages over a median of 3.3 years [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/78\">",
"       78",
"      </a>",
"      ]. Protective factors that were independently associated with slower rates of fibrosis progression included minimal necroinflammatory changes at baseline, attainment of viral clearance with HCV therapy, and receipt of ART.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10494767\">",
"    <span class=\"h3\">",
"     Role of hepatic steatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In studies of patients with HCV alone, steatosis (fatty liver) has also been associated with an increased risk of fibrosis progression compared with patients without concomitant steatosis. Subsequent studies suggest that steatosis may have an important role in fibrosis progression in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients as well, as illustrated by the following [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/79-81\">",
"     79-81",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 183 patients with available liver biopsies, the presence of steatosis was correlated with more advanced fibrosis (OR 1.37, 95% CI 1.03-1.81) [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/79\">",
"       79",
"      </a>",
"      ]. In a multivariate analysis, factors associated with steatosis included use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"       stavudine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"       didanosine",
"      </a>",
"      and the presence of genotype 3 infection.",
"     </li>",
"     <li>",
"      In a subsequent prospective study, a total of 708 HCV-infected patients were enrolled, including 154 with HIV coinfection [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/80\">",
"       80",
"      </a>",
"      ]. Compared with patients with HCV alone,",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients were significantly more likely to have steatosis, and the fibrosis progression rate increased in a linear fashion with the grade of steatosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Steatosis in HIV-infected patients may be related to a variety of factors, including genotype 3 infection, antiretroviral therapy, or metabolic factors, such as visceral obesity and insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/79,82\">",
"     79,82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Liver histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies comparing the liver biopsies of",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients to those with HCV alone have reported conflicting results as to whether or not coinfected patients are more likely to have more severe necroinflammatory activity and fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/72,83,84\">",
"     72,83,84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A possible explanation for these discrepant findings may be related to varying degrees of immunosuppression in the patient populations [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/85\">",
"     85",
"    </a>",
"    ]. One study found that HIV status was not associated with increased necroinflammatory activity or fibrosis compared with patients with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/85\">",
"     85",
"    </a>",
"    ], while another confirmed a marked increase in histologic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/72\">",
"     72",
"    </a>",
"    ]. However, the median CD4 counts among the participants in these two studies were markedly different (503",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    versus 305",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10494880\">",
"    <span class=\"h3\">",
"     Relationship of liver disease stage and clinical outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a prospective cohort of 638 coinfected patients (80 percent African-American), the risk of incident end-stage liver disease, hepatocellular carcinoma, or death was associated with the initial stage of fibrosis on liver biopsy evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/86\">",
"     86",
"    </a>",
"    ]. Biopsies were scored for fibrosis stage according to the METAVIR system: F0, no fibrosis; F1, portal fibrosis without septa; F2, portal fibrosis with few septa; F3, numerous septa without cirrhosis; and F4, cirrhosis. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared with F0, the incidence rate ratio (IRR) was 2.31 for F2 (95% CI, 1.2-4.3); 3.2 for F3 (95% CI, 1.5-6.9); and 3.6 for F4 (95% CI, 2.1-6.2).",
"     </li>",
"     <li>",
"      For the 226 patients who underwent HCV treatment, the incidence of clinical events did not differ between treatment nonresponders and untreated patients.",
"     </li>",
"     <li>",
"      In contrast, no clinical events were observed in the 51 patients with a sustained virologic response or relapse, including 19 with significant disease at baseline. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data support the current paradigm to stage patients before treatment since those patients with minimal fibrosis may be able to wait for future therapies, while HCV therapy should be offered to patients with F2 or higher stages of fibrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link&amp;anchor=H21#H21\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\", section on 'Staging of liver disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Morbidity and mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coinfected patients have higher rates of fibrosis progression, decompensated liver disease and morbidity and mortality secondary to end-stage liver disease compared with patients with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/68,69,87-89\">",
"     68,69,87-89",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective observational international study of 23,441 HIV-infected patients who were followed for five years (Data Collection on Adverse Events of Anti-HIV drugs, the D:A:D Study), there were 1246 deaths; 14.5 percent were related to chronic viral hepatitis [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/69\">",
"       69",
"      </a>",
"      ]. A strong association was found between mortality from liver disease and advanced immunosuppression.",
"     </li>",
"     <li>",
"      In a study of 3990 HIV-infected patients from Denmark from 1995 to 2005, persons with HIV and HCV coinfection had considerably higher mortality rates than those who were HCV-seronegative (mortality rate, 59 per 1000 person-years versus 39 per 1000 person-years) [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/87\">",
"       87",
"      </a>",
"      ]. Furthermore, the widening gap in mortality rates was even more significant in the late ART period from 2000 to 2005 (mortality rate, 57 per 1000 person-years versus 19 per 1000 person-years).",
"     </li>",
"     <li>",
"      In another prospective five-year study of more than 1000",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients in Spain, a lower CD4 cell count gain after initiating ART was associated with an increased risk of decompensated liver disease [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/90\">",
"       90",
"      </a>",
"      ]. In a subsequent study of 154",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients with compensated cirrhosis from the same group, lack of prior therapy against HCV and higher Child-Pugh Turcotte scores were related to liver decompensation [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Median survival time after diagnosis of decompensated liver disease ranges from only 13 to 16 months [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/92\">",
"       92",
"      </a>",
"      ]. The most frequent complication seen with decompensated cirrhosis is ascites [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/93\">",
"       93",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These cumulative observations led the United States Public Health Service to recommend that all patients with HIV undergo testing for HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/94\">",
"     94",
"    </a>",
"    ]. Treatment, with a sustained virologic response, may alter disease outcomes. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Screening for HCV infection'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Hepatocellular carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from the United States and Europe suggest that hepatocellular carcinoma (HCC) occurs at a younger age and is associated with shorter survival in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients compared with those with HCV infection alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/95\">",
"     95",
"    </a>",
"    ]. In a prospective, observational cohort in the United States, the incidence of liver cancer was eightfold higher in HIV-infected patients compared with the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/96\">",
"     96",
"    </a>",
"    ]. In addition, a multicenter study in the United States and Canada also confirmed that progression from initial HCV infection to HCC was significantly faster in coinfected patients (26 years) than in HCV-monoinfected patients (34 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HCC is an emerging complication in the HIV-infected population. Proportions of liver-related deaths among HIV-infected patients that were attributable to HCC increased from 15 to 25 percent in France from 2000 to 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/98\">",
"     98",
"    </a>",
"    ]. Similarly, in a study from Spain, the incidence of HCC among HIV-infected patients increased from 0.1 to 1.1 cases per 1000 person years between 1999 and 2009 [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/99\">",
"     99",
"    </a>",
"    ]. Almost all of the cases were associated with HCV coinfection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Effect of ART on HCV progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some, but not all studies, have suggested that the introduction of potent ART has been associated with a decline in liver-related mortality and slower rates of fibrosis progression [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/100,101\">",
"     100,101",
"    </a>",
"    ]. ART may slow down disease progression due to immune reconstitution [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/102\">",
"     102",
"    </a>",
"    ]. In an observational study of 638",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients, 69 percent of whom were taking ART, viral suppression was associated with a lower risk of end-stage liver disease, hepatocellular carcinoma, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/86\">",
"     86",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10494880\">",
"     'Relationship of liver disease stage and clinical outcome'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Another study demonstrated that fibrosis progression rates were slower in patients who had achieved HIV viral load suppression on ART compared with those who still had detectable viremia on therapy, suggesting that HIV viral suppression is important as well [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/103\">",
"     103",
"    </a>",
"    ]. A subsequent cross-sectional study also demonstrated that viral suppression on ART was associated with lower necroinflammatory activity on liver biopsy specimens while another retrospective study demonstrated that ART interruption was associated with an increased risk of fibrosis progression [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/104,105\">",
"     104,105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The early initiation of ART in HIV-infected patients with HCV coinfection has been suggested by several HIV treatment guideline committees [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/106\">",
"     106",
"    </a>",
"    ]. This approach may be particularly important in patients who are unable or unwilling to take pegylated",
"    <span class=\"nowrap\">",
"     interferon/",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"      ribavirin",
"     </a>",
"    </span>",
"    therapy or in those who have not responded to HCV antiviral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/107\">",
"     107",
"    </a>",
"    ]. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9786?source=see_link\">",
"     \"When to initiate antiretroviral therapy in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are conflicting data as to whether any particular drug or class of drugs affect liver fibrosis progression rates [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/108,109\">",
"     108,109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     EFFECT OF HCV ON THE NATURAL HISTORY OF HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are conflicting results as to whether HCV infection does [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/7,110-113\">",
"     7,110-113",
"    </a>",
"    ] or does not [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/114,115\">",
"     114,115",
"    </a>",
"    ] have a deleterious effect on the course of HIV infection.",
"   </p>",
"   <p>",
"    The following examples illustrate the range of findings in the largest reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective cohort study of 1955 patients, no difference was detected in the risk of acquiring an AIDS-defining illness (ADI) or the risk of death when comparing HCV-infected or HCV-uninfected patients [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/114\">",
"       114",
"      </a>",
"      ]. The findings were not affected by whether or not the patient was treated with ART.",
"     </li>",
"     <li>",
"      By contrast, in a study of 3111 antiretroviral-na&iuml;ve patients who initiated HAART, HCV seropositivity was an independent risk factor for progression to a new AIDS-defining clinical event or to death [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/103\">",
"       103",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased mortality was also seen in a retrospective study of 5914 HIV-infected patients, 37 percent of whom were HCV-positive [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/113\">",
"       113",
"      </a>",
"      ]. Compared with the general population, the standardized mortality rate (SMR) was 11.5 for HCV-positive patients, and 2.4 for HCV-negative patients. Among the patients with HCV co-infection and AIDS, the SMR was 20.8, compared with 4.8 for those with AIDS who were HCV-negative.",
"     </li>",
"     <li>",
"      In another retrospective study of 5397 HIV-infected patients (half of whom were HCV-seropositive), the incidence of new ADIs was significantly higher in the HCV-seropositive group compared with the HCV-seronegative group (adjusted relative risk [ARR], 2.61; 95% CI 1.88-3.61). The rate of mycotic infection, bacterial infection, toxoplasmosis, and HIV-related ADIs among patients with cirrhosis were significantly higher than HCV-infected patients without cirrhosis and patients with HIV alone [",
"      <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/116\">",
"       116",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The factors responsible for these disparate findings are not well understood, although one factor may be HCV viral load [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/7,112,117,118\">",
"     7,112,117,118",
"    </a>",
"    ]. Two studies have demonstrated a relationship between higher HCV RNA levels and increased risk of clinical progression to AIDS and AIDS-related mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/7,119\">",
"     7,119",
"    </a>",
"    ]. HCV replication may result in generalized immune activation, which is associated with shorter survival in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/119,120\">",
"     119,120",
"    </a>",
"    ]. One study also demonstrated that the rate of CD4 cell gains was lower among patients who had chronic HCV infection compared with those who had spontaneously cleared their viremia [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/121\">",
"     121",
"    </a>",
"    ]. Immune activation, with subsequent T-cell apoptosis, could also explain the observation that CD4+ gains after antiretroviral therapy (ART) initiation are generally lower in coinfected patients compared with those with HIV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/103\">",
"     103",
"    </a>",
"    ]. In addition, two observational studies have suggested that discordance between absolute CD4 cell counts and CD4 T-cell percentages may be seen in patients with advanced liver disease, which may be related to splenic sequestration [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/122,123\">",
"     122,123",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'HIV-associated immune activation'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21320?source=see_link\">",
"     \"Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SCREENING FOR HCV INFECTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Chronic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;All HIV-infected persons should be screened for HCV infection using enzyme immunoassays; those with antibody to HCV should have quantitative HCV RNA testing, which confirms the presence of viremia and serves as a baseline prior to therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/124\">",
"     124",
"    </a>",
"    ]. These recommendations also apply to patients with persistently normal aminotransferases, since patients can have advanced fibrosis despite these laboratory findings [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sensitivity and specificity of third generation ELISA assays approach 99 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/124\">",
"     124",
"    </a>",
"    ]. However, patients with severe immunosuppression (eg, CD4 cell counts &lt;100",
"    <span class=\"nowrap\">",
"     cells/mm3)",
"    </span>",
"    may have a false negative serology due to impaired antibody formation; however, this occurs in than less than 5 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/126,127\">",
"     126,127",
"    </a>",
"    ]. Thus, any HCV-seronegative HIV-infected patient who has significant risk factors for HCV acquisition (eg, injection drug use), or has unexplained abnormal aminotransferases should be screened further with hepatitis C RNA testing [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/128\">",
"     128",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with HIV infection are more likely to have HCV viremia compared with those without HIV infection. In two studies, for example, 91 percent of coinfected patients had HCV viremia compared with approximately 75 percent of those with HCV alone. A possible explanation is that clearance of HCV is less likely to occur in patients with underlying HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/7,129\">",
"     7,129",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two rapid screening assays are under development for HCV screening (ie, Chembio and MedMira); another (ie, OraQuick) is approved for use in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/130\">",
"     130",
"    </a>",
"    ]. All assays give results within 40 minutes using serum, blood, or plasma; the OraQuick and Chembio can also be used on saliva. The test performance of these rapid assays has not been thoroughly evaluated in HIV-infected individuals; however, preliminary data suggest that false test results (both negative and positive) can occur when using the Chembio or MedMira assays for screening of specimens from HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Acute HCV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with suspected acute HCV infection, an HCV antibody and HCV RNA level should both be obtained since viremia precedes seroconversion. HCV antibody is detected approximately 8 to 12 weeks after infection although delayed antibody responses have been described in one small study of 43 HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/132,133\">",
"     132,133",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Screening for other hepatitis viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;All HIV-infected patients should also be screened for past exposure to other hepatitis viruses (eg, hepatitis A IgG antibody and hepatitis B surface antigen and surface antibody). Immunizations for hepatitis A and hepatitis B are recommended if the patient is not immune [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/134-136\">",
"     134-136",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     HCV AND RISK OF HEPATOTOXICITY WITH ART",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic viral hepatitis increases the risk of hepatotoxicity from antiretroviral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/137-146\">",
"     137-146",
"    </a>",
"    ]. Some have suggested that hepatitis C is associated with an increased risk of hepatotoxicity for all ART regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/147,148\">",
"     147,148",
"    </a>",
"    ], while others found an increased risk only with certain antiretroviral agents, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/12/18633?source=see_link\">",
"     nevirapine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/137,138\">",
"     137,138",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although hepatotoxicity is more common in patients with chronic viral hepatitis, the clear benefit of antiretroviral therapy outweighs the risk of liver injury. Studies also support the positive impact of antiretroviral treatment on the progression of hepatic fibrosis in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/100\">",
"     100",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Effect of ART on HCV progression'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    When patients with concomitant HCV are initiated on ART, close laboratory follow-up is prudent and patients should be educated about symptoms that may suggest liver injury such as jaundice or darkening of urine, right upper quadrant pain, nausea, anorexia, pruritus and fatigue.",
"   </p>",
"   <p>",
"    The pathogenesis of ART-associated hepatotoxicity may be related to immune reconstitution, which leads to hepatocyte necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/145\">",
"     145",
"    </a>",
"    ]. Supporting this hypothesis is the observation that hepatotoxicity correlated with a rise in CD4 count in some reports [",
"    <a class=\"abstract\" href=\"UTD.htm?29/32/30218/abstract/144,145\">",
"     144,145",
"    </a>",
"    ]. However, an increase in the CD4 count may simply be a marker of a patient who is adherent with their medications and therefore at higher risk of drug injury compared with the patient who is not taking their medications at all.",
"   </p>",
"   <p>",
"    The evaluation and treatment of hepatitis C in the HIV-infected patient is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During the chronic stage of both HIV and HCV, a relatively stable viral load or \"set point\" is maintained over long periods of time. However, in the setting of HIV, HCV RNA levels increase after HIV seroconversion and continue to increase over time. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Virology of HCV'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Coinfection with HIV and HCV is common since both infections share similar routes of transmission. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients have accelerated rates of fibrosis progression compared with patients with HCV alone, which may be related to HIV-associated immune activation, CD4 T cell depletion or immunodysregulation with production of proinflammatory cytokines. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pathogenesis of liver disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with chronic HCV infection, concomitant HIV infection is associated with higher rates of morbidity and mortality related to end-stage liver disease. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Effect of HIV on the natural history of HCV'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are conflicting studies as to whether HCV affects the clinical progression of HIV disease. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Effect of HCV on the natural history of HIV'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All HIV-infected persons should be evaluated for chronic HCV infection using a third generation enzyme immunoassay. Patients who are found to be HCV seropositive should undergo quantitative HCV RNA testing in order to confirm the presence of viremia. Patients who are found to be HCV seronegative should undergo HCV RNA testing if they have advanced immunosuppression (eg, CD4 counts &lt;100",
"      <span class=\"nowrap\">",
"       cells/mm3),",
"      </span>",
"      risk factors for HCV infection, or elevated aminotransferases. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Screening for HCV infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic viral hepatitis increases the risk of hepatotoxicity from antiretroviral therapy. Patients should be counseled regarding the symptoms and signs of drug-induced liver injury prior to starting antiretroviral therapy. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'HCV and risk of hepatotoxicity with ART'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/1\">",
"      McGovern BH. Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr 2007; 45 Suppl 2:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/2\">",
"      Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/3\">",
"      Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/4\">",
"      Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/5\">",
"      Nguyen TT, Sedghi-Vaziri A, Wilkes LB, et al. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hepat 1996; 3:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/6\">",
"      Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/7\">",
"      Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001; 26:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/8\">",
"      Ghany MG, Leissinger C, Lagier R, et al. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996; 41:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/9\">",
"      Cooper CL, Cameron DW. Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis 2005; 41 Suppl 1:S105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/10\">",
"      Netski DM, Mao Q, Ray SC, Klein RS. Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression. J Acquir Immune Defic Syndr 2008; 49:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/11\">",
"      Lin W, Weinberg EM, Tai AW, et al. HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology 2008; 134:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/12\">",
"      Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003; 187:1951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/13\">",
"      Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/14\">",
"      Lanford RE, Chavez D, Chisari FV, Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 1995; 69:8079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/15\">",
"      Blackard JT, Smeaton L, Hiasa Y, et al. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. J Infect Dis 2005; 192:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/16\">",
"      Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/17\">",
"      Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996; 157:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/18\">",
"      Graham CS, Koziel MJ. Why should hepatitis C affect immune reconstitution in HIV-1-infected patients? Lancet 2000; 356:1865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/19\">",
"      Minosse C, Calcaterra S, Abbate I, et al. Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women. J Infect Dis 2006; 194:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/20\">",
"      Nowicki MJ, Laskus T, Nikolopoulou G, et al. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women. J Infect Dis 2005; 192:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/21\">",
"      Holland JJ, De La Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992; 176:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/22\">",
"      Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/23\">",
"      Havlir DV, Richman DD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med 1996; 124:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/24\">",
"      Davis GL. Hepatitis C virus genotypes and quasispecies. Am J Med 1999; 107:21S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/25\">",
"      Sherman KE, Andreatta C, O'Brien J, et al. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 1996; 23:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/26\">",
"      Speck RF, Wehrly K, Platt EJ, et al. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol 1997; 71:7136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/27\">",
"      Toyoda H, Kumada T, Nakano S, et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 1997; 26:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/28\">",
"      Sherman KE, Rouster SD, Stanford S, et al. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis 2010; 201:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/29\">",
"      Blackard JT, Hiasa Y, Smeaton L, et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis 2007; 195:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/30\">",
"      McGovern BH, Abu Dayyeh BK, Chung RT. Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 2008; 48:1700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/31\">",
"      Kuntzen T, Timm J, Berical A, et al. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-na&iuml;ve patients. Hepatology 2008; 48:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/32\">",
"      Gaudieri S, Rauch A, Pfafferott K, et al. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology 2009; 49:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/33\">",
"      Staples CT Jr, Rimland D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 1999; 29:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/34\">",
"      Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/35\">",
"      Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/36\">",
"      Kim AY, Chung RT. Coinfection with HIV-1 and HCV--a one-two punch. Gastroenterology 2009; 137:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/37\">",
"      Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/38\">",
"      Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships. J Infect Dis 1995; 171:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/39\">",
"      Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/40\">",
"      Osmond DH, Padian NS, Sheppard HW, et al. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993; 269:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/41\">",
"      Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology 2010; 52:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/42\">",
"      Eyster ME, Alter HJ, Aledort LM, et al. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 1991; 115:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/43\">",
"      Soto B, Rodrigo L, Garcia-Bengoechea M, et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings. J Intern Med 1994; 236:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/44\">",
"      Wyld R, Robertson JR, Brettle RP, et al. Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals. J Infect 1997; 35:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/45\">",
"      Osmond DH, Charlebois E, Sheppard HW, et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/46\">",
"      Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/47\">",
"      Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009; 23:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/48\">",
"      Luetkemeyer A, Hare CB, Stansell J, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr 2006; 41:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/49\">",
"      van de Laar TJ, van der Bij AK, Prins M, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007; 196:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/50\">",
"      Rauch A, Rickenbach M, Weber R, et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis 2005; 41:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/51\">",
"      Fierer DS, Uriel AJ, Carriero DC, et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis 2008; 198:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/52\">",
"      Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011; 60:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/53\">",
"      Wandeler G, Gsponer T, Bregenzer A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis 2012; 55:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/54\">",
"      Serpaggi J, Chaix ML, Batisse D, et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 2006; 20:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/55\">",
"      Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007; 21:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/56\">",
"      G&ouml;tz HM, van Doornum G, Niesters HG, et al. A cluster of acute hepatitis C virus infection among men who have sex with men--results from contact tracing and public health implications. AIDS 2005; 19:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/57\">",
"      Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis 2007; 44:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/58\">",
"      Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997; 336:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/59\">",
"      Yonkers NL, Rodriguez B, Post AB, et al. HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells. J Infect Dis 2006; 194:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/60\">",
"      Kim AY, Lauer GM, Ouchi K, et al. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood 2005; 105:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/61\">",
"      Rohrbach J, Robinson N, Harcourt G, et al. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010; 59:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/62\">",
"      Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/63\">",
"      Balagopal A, Philp FH, Astemborski J, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008; 135:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/64\">",
"      Balagopal A, Ray SC, De Oca RM, et al. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. AIDS 2009; 23:2397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/65\">",
"      Allison RD, Katsounas A, Koziol DE, et al. Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV. J Infect Dis 2009; 200:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/66\">",
"      Volkmann X, Fischer U, Bahr MJ, et al. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology 2007; 46:1498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/67\">",
"      Babu CK, Suwansrinon K, Bren GD, et al. HIV induces TRAIL sensitivity in hepatocytes. PLoS One 2009; 4:e4623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/68\">",
"      Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/69\">",
"      Weber R, Sabin CA, Friis-M&oslash;ller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/70\">",
"      Danta M, Semmo N, Fabris P, et al. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis 2008; 197:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/71\">",
"      Kim AY, Schulze zur Wiesch J, Kuntzen T, et al. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 2006; 3:e492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/72\">",
"      Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/73\">",
"      Monga HK, Rodriguez-Barradas MC, Breaux K, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 33:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/74\">",
"      Kirk GD, Mehta SH, Astemborski J, et al. HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease: A Cohort Study. Ann Intern Med 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/75\">",
"      Fierer DS, Dieterich DT, Fiel MI, et al. Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-Infected Men After Primary Hepatitis C Virus Infection. Clin Infect Dis 2013; 56:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/76\">",
"      Martinez-Sierra C, Arizcorreta A, D&iacute;az F, et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003; 36:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/77\">",
"      Sulkowski MS, Mehta SH, Torbenson MS, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS 2007; 21:2209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/78\">",
"      Mac&iacute;as J, Berenguer J, Jap&oacute;n MA, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 2009; 50:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/79\">",
"      McGovern BH, Ditelberg JS, Taylor LE, et al. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis 2006; 43:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/80\">",
"      Gaslightwala I, Bini EJ. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. J Hepatol 2006; 44:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/81\">",
"      Sterling RK, Contos MJ, Smith PG, et al. Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2008; 47:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/82\">",
"      Mac&iacute;as J, Berenguer J, Jap&oacute;n MA, et al. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology 2012; 56:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/83\">",
"      Puoti M, Bonacini M, Spinetti A, et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 2001; 183:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/84\">",
"      Sterling RK, Wegelin JA, Smith PG, et al. Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples. Clin Gastroenterol Hepatol 2010; 8:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/85\">",
"      Sterling RK, Contos MJ, Sanyal AJ, et al. The clinical spectrum of hepatitis C virus in HIV coinfection. J Acquir Immune Defic Syndr 2003; 32:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/86\">",
"      Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012; 308:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/87\">",
"      Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/88\">",
"      Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/89\">",
"      Chen TY, Ding EL, Seage Iii GR, Kim AY. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009; 49:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/90\">",
"      Pineda JA, Garc&iacute;a-Garc&iacute;a JA, Aguilar-Guisado M, et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 2007; 46:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/91\">",
"      Pineda JA, Aguilar-Guisado M, Rivero A, et al. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients. Clin Infect Dis 2009; 49:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/92\">",
"      Merchante N, Gir&oacute;n-Gonz&aacute;lez JA, Gonz&aacute;lez-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006; 20:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/93\">",
"      Garc&iacute;a-Samaniego J, Rodr&iacute;guez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96:179.",
"     </a>",
"    </li>",
"    <li>",
"     file://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&amp;Search=Off&amp;GuidelineID=211&amp;ClassID=4 (Accessed on February 12, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/95\">",
"      Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18:2285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/96\">",
"      Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/97\">",
"      Br&auml;u N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/98\">",
"      Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalit&eacute; 2005 study. J Hepatol 2009; 50:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/99\">",
"      Merchante N, Merino E, L&oacute;pez-Aldeguer J, et al. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis 2013; 56:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/100\">",
"      Br&auml;u N, Salvatore M, R&iacute;os-Bedoya CF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006; 44:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/101\">",
"      Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008; 22:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/102\">",
"      Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004; 39:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/103\">",
"      Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/104\">",
"      Pascual-Pareja JF, Caminoa A, Larrauri C, et al. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy. AIDS 2009; 23:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/105\">",
"      Thorpe J, Saeed S, Moodie EE, et al. Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection. AIDS 2011; 25:967.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: file://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&amp;Search=Off&amp;GuidelineID=7&amp;ClassID=1 (Accessed on April 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/107\">",
"      Shafran SD. Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2007; 44:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/108\">",
"      Berenguer J, Bell&oacute;n JM, Miralles P, et al. Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2008; 46:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/109\">",
"      Mac&iacute;as J, Castellano V, Merchante N, et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS 2004; 18:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/110\">",
"      Yoo TW, Donfield S, Lail A, et al. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005; 191:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/111\">",
"      Daar ES, Lynn H, Donfield S, et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 2001; 183:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/112\">",
"      Tedaldi EM, Baker RK, Moorman AC, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003; 36:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/113\">",
"      Hernando V, Perez-Cachafeiro S, Lewden C, et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J Hepatol 2012; 57:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/114\">",
"      Sulkowski MS, Moore RD, Mehta SH, et al. Hepatitis C and progression of HIV disease. JAMA 2002; 288:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/115\">",
"      Rockstroh JK, Mocroft A, Soriano V, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/116\">",
"      Piroth L. Coinfection with hepatitis C virus and HIV: more than double trouble. Clin Infect Dis 2009; 49:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/117\">",
"      Sherman KE, O'Brien J, Gutierrez AG, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993; 31:2679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/118\">",
"      Dorrucci M, Pezzotti P, Phillips AN, et al. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis 1995; 172:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/119\">",
"      Kovacs A, Karim R, Mack WJ, et al. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis 2010; 201:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/120\">",
"      Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/121\">",
"      Potter M, Odueyungbo A, Yang H, et al. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. AIDS 2010; 24:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/122\">",
"      Hull MW, Rollet K, Odueyungbo A, et al. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2012; 54:1798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/123\">",
"      Claassen CW, Diener-West M, Mehta SH, et al. Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis. Clin Infect Dis 2012; 54:1806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/124\">",
"      Strader DB, Wright T, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/125\">",
"      Bani-Sadr F, Barange K, Daoud F, et al. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis. HIV Med 2009; 10:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/126\">",
"      Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr 2001; 26:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/127\">",
"      Thio CL, Nolt KR, Astemborski J, et al. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 2000; 38:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/128\">",
"      Chamie G, Bonacini M, Bangsberg DR, et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007; 44:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/129\">",
"      Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C. Lancet 2002; 359:1478.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/ucm217553.htm (Accessed on October 17, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/131\">",
"      Smith BD, Drobeniuc J, Jewett A, et al. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis 2011; 204:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/132\">",
"      Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/133\">",
"      Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009; 23:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/134\">",
"      Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med 2005; 118 Suppl 10A:75S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/135\">",
"      Nelson M, Matthews G, Brook MG, et al. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005). HIV Med 2005; 6 Suppl 2:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/136\">",
"      Alberti A, Clumeck N, Collins S, et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005; 42:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/137\">",
"      Bonfanti P, Valsecchi L, Parazzini F, et al. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. J Acquir Immune Defic Syndr 2000; 23:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/138\">",
"      Cooper CL, Parbhakar MA, Angel JB. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2002; 34:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/139\">",
"      den Brinker M, Wit FW, Wertheim-van Dillen PM, et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 2000; 14:2895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/140\">",
"      N&uacute;&ntilde;ez M, Lana R, Mendoza JL, et al. Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 27:426.",
"     </a>",
"    </li>",
"    <li>",
"     Reisler R, Burman W, et al. Incidence of grade IV events, AIDS, and mortality in a large multicenter cohort receiving HAART, Abstract #36. In: 9th Conference on Retroviruses and Opportunistic Infections, Foundation for Retrovirology and Human Health, Seattle, WA 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/142\">",
"      Vento S, Garofano T, Renzini C, et al. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS 1998; 12:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/143\">",
"      Puoti M, Torti C, Ripamonti D, et al. Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome. J Acquir Immune Defic Syndr 2003; 32:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/144\">",
"      French AL, Benning L, Anastos K, et al. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection. Clin Infect Dis 2004; 39:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/145\">",
"      Sav&egrave;s M, Vandentorren S, Daucourt V, et al. Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpid&eacute;miologie Clinique de Sida en Aquitaine (GECSA). AIDS 1999; 13:F115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/146\">",
"      Servoss JC, Kitch DW, Andersen JW, et al. Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999). J Acquir Immune Defic Syndr 2006; 43:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/147\">",
"      Marin&eacute;-Barjoan E, Saint-Paul MC, Pradier C, et al. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients. AIDS 2004; 18:2163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?29/32/30218/abstract/148\">",
"      John M, Flexman J, French MA. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS 1998; 12:2289.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3712 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-B869A8C837-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30218=[""].join("\n");
var outline_f29_32_30218=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VIROLOGY OF HCV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Viral kinetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Viral load",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Viral reservoirs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetic heterogeneity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Percutaneous exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Heterosexual partners",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Men who have sex with men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Perinatal transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Health care workers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PATHOGENESIS OF LIVER DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Cellular immune responses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      HIV-associated immune activation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Activation of hepatic stellate cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      HIV and apoptosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      HCV-associated proinflammatory cytokines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      EFFECT OF HIV ON THE NATURAL HISTORY OF HCV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Viral clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Fibrosis progression rates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10494767\">",
"      - Role of hepatic steatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Liver histology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10494880\">",
"      - Relationship of liver disease stage and clinical outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Morbidity and mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Effect of ART on HCV progression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      EFFECT OF HCV ON THE NATURAL HISTORY OF HIV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SCREENING FOR HCV INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Chronic infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Acute HCV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Screening for other hepatitis viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      HCV AND RISK OF HEPATOTOXICITY WITH ART",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38536?source=related_link\">",
"      Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=related_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=related_link\">",
"      Evaluation of the HIV-infected patient with chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=related_link\">",
"      Immunizations in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38378?source=related_link\">",
"      Investigational therapies for hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=related_link\">",
"      Laboratory testing of donated blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23416?source=related_link\">",
"      Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21320?source=related_link\">",
"      Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=related_link\">",
"      Treatment of hepatitis C virus infection in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26936?source=related_link\">",
"      Vertical transmission of hepatitis C virus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9786?source=related_link\">",
"      When to initiate antiretroviral therapy in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_32_30219="CRC chemo elderly guide";
var content_f29_32_30219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F71132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F71132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Guidelines for evaluating the suitability of chemotherapy in elderly patients with CRC",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Fitness category",
"      </td>",
"      <td class=\"subtitle1\">",
"       Criteria",
"      </td>",
"      <td class=\"subtitle1\">",
"       Suitability of chemotherapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Group I: fit",
"      </td>",
"      <td>",
"       Totally independent",
"      </td>",
"      <td rowspan=\"2\">",
"       Full-dose treatment, assuming life expectancy is longer than the life expectancy from cancer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       No serious comorbidity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Group II: intermediate",
"      </td>",
"      <td>",
"       Dependent in one or more IADLs or with some comorbidity",
"      </td>",
"      <td>",
"       Consideration of chemotherapy dose reduction for first administration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Group III: frail",
"      </td>",
"      <td>",
"       Dependence in one or more ADLs",
"      </td>",
"      <td rowspan=\"3\">",
"       Not suitable for chemotherapy; supportive care recommended",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Three or more comorbid conditions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       One or more geriatric syndromes",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ADLs: activities of daily living (eg, transferring, grooming, continence, using the toilet, dressing, feeding); IADLs: instrumental activities of daily living (eg, transportation, money management, shopping, taking medications, preparing meals).",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kohne CH, Folprecht G, Goldberg RM, et al. Chemotherapy in Elderly Patients with Colorectal Cancer. The Oncologist 2008; 13:390. Copyright &copy; 2008 AlphaMed Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30219=[""].join("\n");
var outline_f29_32_30219=null;
var title_f29_32_30220="EUS FNA periintestinal nodes";
var content_f29_32_30220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic characteristics of endoscopic ultrasound-guided fine-needle aspiration (EUS FNA) for periintestinal lymph nodes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        n",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specificity (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Accuracy (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bhutani, 1997",
"       </td>",
"       <td class=\"centered\">",
"        22",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chang, 1997",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        83",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        88",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erickson, 1997",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gress, 1997",
"       </td>",
"       <td class=\"centered\">",
"        56",
"       </td>",
"       <td class=\"centered\">",
"        --",
"       </td>",
"       <td class=\"centered\">",
"        --",
"       </td>",
"       <td class=\"centered\">",
"        93",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wiersema, 1997",
"       </td>",
"       <td class=\"centered\">",
"        192",
"       </td>",
"       <td class=\"centered\">",
"        92",
"       </td>",
"       <td class=\"centered\">",
"        93",
"       </td>",
"       <td class=\"centered\">",
"        92",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Binmoeller, 1998",
"       </td>",
"       <td class=\"centered\">",
"        43",
"       </td>",
"       <td class=\"centered\">",
"        91",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reed, 1999",
"       </td>",
"       <td class=\"centered\">",
"        57",
"       </td>",
"       <td class=\"centered\">",
"        72",
"       </td>",
"       <td class=\"centered\">",
"        97",
"       </td>",
"       <td class=\"centered\">",
"        86",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Williams, 1999",
"       </td>",
"       <td class=\"centered\">",
"        160",
"       </td>",
"       <td class=\"centered\">",
"        85",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        89",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Norton ID, Wiersema MJ. Endoscopic ultrasound-guided fine needle aspiration biopsy. In: Endoscopic Ultrasonography. Gress F, Bhattacharya I (Eds). Blackwell Science, Malden, MA 2001. p.136. Reprinted with permission of Blackwell Science, Inc.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30220=[""].join("\n");
var outline_f29_32_30220=null;
var title_f29_32_30221="Effect of T4 on sleep apnea";
var content_f29_32_30221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F50647&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F50647&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frequency of episodes of obstructive sleep apnea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 353px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Episodes of sleep apnea in six obese hypothyroid patients (shown in red bars) and three non-obese hypothyroid patients (blue bars) before and after 3 to 12 months of thyroxine therapy. The frequency of episodes decreased significantly without a change in weight.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Rajagopal KR, Abbrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism.&nbsp;Ann Intern Med 1984; 101:491.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30221=[""].join("\n");
var outline_f29_32_30221=null;
var title_f29_32_30222="Megak mass platelet production";
var content_f29_32_30222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Megakaryocyte mass and effective platelet production in megakaryocyte disorders",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 277px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow analysis was performed in normal subjects and patients with a variety of hematological conditions: hypoplastic bone marrow states (Hypo), B12 deficiency (B12 def), congestive splenomegaly (Congest), immune thrombocytopenia (ITP), chronic inflammation (Inflam), and essential thrombocythemia (ET). Left panel: The megakaryocyte mass was markedly reduced in hypoplastic bone marrow states but variably increased in all other conditions. Right panel: Effective platelet production, as determined by platelet kinetic study, was significantly reduced only in hypoplastic bone marrow states and B12 deficiency and variably increased in all other conditions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Harker LA, Finch CA. J Clin Invest 1969; 48:963.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30222=[""].join("\n");
var outline_f29_32_30222=null;
var title_f29_32_30223="Posterior fossa epidural hematoma";
var content_f29_32_30223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Posterior fossa epidural hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 289px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Rapid deterioration in previously awake patients with this type of injury is a major concern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_32_30223=[""].join("\n");
var outline_f29_32_30223=null;
